A controllable fluid dynamics system for processing pharmaceutical powders in a single vessel by Kay, Graham Richard
        
University of Bath
PHD









Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
A C o n t r o l l a b l e  F l u id  
D y n a m ic s  Sy st e m  F o r  
Pr o c e ssin g  P h a r m a c e u t ic a l  
P o w d e r s  In  A Sin g l e  V e sse l
Submitted by Graham Richard Kay 
for the degree of Ph.D. 
of the University of Bath 
2001
COPYRIGHT
Attention is drawn to the fact that copyright of this thesis rests with its author. This copy 
of the thesis has been supplied on condition that anyone who consults it is understood to 
recognise that its copyright rests with its author and that no quotation from the thesis and 
no information derived from it may be published without the prior written consent of the
author.
This thesis may be made available for consultation within the University Library and may 
be photocopied or lent to other libraries for the purposes of consultation.
Author: D ate:?./.:.® T '.2oo I
UMI Number: U157145
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U157145
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
UNIVERSITY OF BATH
4 0  2  5  MAR 2002
ACKNOWLEDGEMENTS
It is impossible to name and thank all of the people who have helped and inspired me on 
the long road to the completion of this work. Nevertheless my grateful thanks are 
extended to them all, but particularly to the following:
To my supervisor, Professor John Staniforth, for being the ideas man and for his attempts 
to broaden me.
To the Tobyns; to Sal for providing first class billeting on many occasions and to Mikee 
for being my ‘surrogate supervisor’ and for his (successful) attempts to broaden himself.
To Drs. Linda Newnes and Stuart MacGregor for taking care of the engineering side of 
things, to Dr. Ming ‘The Merciless’ Li for driving the CFD package, to Gerald Atherton 
for drawing and building the processors and to the other members of the SVP Project 
Team for their valued contributions.
To Dr. Martin Clarke for sharing with me his expert knowledge of DPI formulation and 
for his unique demonstration of the principle of ‘time of flight’. Also to the staff and 
students, past and present, of the Department of Pharmacy and Pharmacology at Bath, 
many of whom will be friends for life.
To my brother, Andy, for encouraging me to ‘do yerself a favour and do sum wurk’.
To my parents for their incredible support, especially my dad, without whose guidance 
and resolute project management I would have failed in this undertaking.
I reserve special gratitude for Sonia, firstly for her crucial contribution during the frantic 




Processing of dry powder inhaler formulations often requires equipment that is able to 
impart a high shearing force into the mixing bed in order to adequately disperse the active 
ingredient and/or other performance modifying ingredients. In addition, particle size of 
drug and excipient powders must be closely controlled in DPI formulation systems.
The selection of processing equipment available to achieve these conditions is limited 
and it often difficult to closely control the amount of shear generated within the 
processing environment.
A series of single vessel processors, so called due to their versatility in performing 
multiple powder processing operations, was developed, two of which were characterised 
for their performance in producing blends of an asthma drug, nedocromil sodium, in a 
formulation designed for dry powder inhalation.
The first vessel (FBSVP-A) was a fluidised bed system with a series of 12 tangential high 
pressure air nozzles supplying the energy for powder movement. This was found to 
provide some dry powder blending and particle size reduction performance but the 
existence of extensive areas of powder stagnation made the equipment inefficient and 
modification of the vessel was required.
These modifications resulted in fabrication of a second vessel, the FBSVP-B, in which a 
filter bag replaced the cyclone separator used in the previous design. This was found to 
offer some improvement in particle size reduction performance. The FBSVP-B was used 
to manufacture nedocromil sodium blends and was found to produce blends of poor 
overall homogeneity and variable in-vitro aerosol performance. Again, some areas of 
flow stagnation were found to exist, although these were much reduced from the previous 
design.
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Modelling of the FBSVP-B using computational fluid dynamics was able to successfully 
predict these areas of low flow activity, thus providing verification of the use of this 
software in simulating flow regimes in this application.
The CFD software was then used in the design of a final vessel, the SBSVP which 
utilised high volume air flows in place of the vertical fluidised bed and doubled the 
number of high pressure air nozzles from the previous vessel designs.
Nedocromil sodium blends processed in this vessel were found to exhibit excellent 
homogeneity and in-vitro aerosol characteristics that were at least equivalent to those 
found in blends produced in conventional high shear equipment. Rate and extent of 
particle size reduction were also shown to be enhanced considerably in this vessel design.
It was therefore concluded that further development of the SBSVP may result in a 
practical alternative to conventional equipment in the preparation of DPI and other 
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Delivery of aerosolised drugs to the respiratory tract by inhalation is a well- 
established route of administering pharmaceutical treatments and has now become the 
therapy of choice for delivery of medications whose site of action is in lung tissue 
(Asking and Olsson, 1997).
Inhalation therapy is also being used increasingly for delivery of large-molecule new 
chemical entities, such as proteins and peptides produced through biotechnology, 
since many of these materials have demonstrated good lung absorption compared to 
poor oral bioavailability (Johnson, 1997, Smith, 1997; Berressem, 1999). Other novel 
therapies have exhibited reduced dosage requirements when inhaled compared to 
intravenous administration (Nyce, 2000).
The most important uses of inhalation therapy are currently in the treatment of lung 
diseases such as asthma and chronic obstructive airways disease (Smith and Bernstein, 
1996). There is a number of advantages of inhalation over other drug delivery routes 
for treatment of these and other diseases since the drug is delivered directly to the site 
of action thus providing a rapid and predictable therapeutic response and avoiding 
hepatic first-pass and gastrointestinal degradation of the active (Timsina et al., 1994).
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1.2 Aerosol delivery systems
The three main systems used for generating medicinal aerosols are nebulisers, 
pressurised metered dose inhalers (pMDIs) and dry powder inhalers (DPIs), each of 
which has advantages and disadvantages.
It is generally considered that pMDIs are compact, portable and inexpensive to 
produce. However, many patients are found to experience difficulties in co-ordinating 
inhalation with device actuation, which can lead to increased deposition of the dose in 
the patient’s mouth and throat rather than in the deep lung (Crompton, 1982). More 
recently breath actuated pMDIs have become available that are able to counteract 
these problems (Hickey and Dunbar, 1997).
pMDIs are often found to discharge large droplets which leave the device at high 
initial velocities. This can lead to considerable loss of the dose to the oropharynx 
(Leach, 1999), although the use of spacer devices has been seen to mitigate these 
effects (Vidgren et al., 1987a).
Concerns regarding the adverse environmental effects of chlorofluorocarbon (CFC) 
propellants used in pMDIs have led to international regulations (Tansey, 1997) 
requiring these to be replaced with alternative methods of aerosolisation (Leach, 
1999). Although a number of formulations containing hydrofluorocarbon propellants 
have successfully replaced CFC products (Leach, 1999), presentations that do not 
require chemical propellants, such as DPIs, are clearly more desirable from an 
environmental perspective.
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DPIs allow generation of an aerosol without using a propellant and problems of co­
ordination of patient inspiration with device actuation are avoided since DPIs are 
breath-actuated. (Steckel and Muller, 1997).
Typical disadvantages of DPIs are a dependency on the patient’s inspiratory flow rate 
for efficient drug delivery, greater problems in dose uniformity than in pMDIs, less 
protection from environmental effects and increased expense compared to pMDIs 
(Ashurst et al., 2000).
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1.3 Factors influencing lung deposition of inhaled particles
1.3.1 Lung anatomy
The human respiratory tract is composed of a series of branching tubular airways, 
which become progressively smaller in diameter as they develop into the innermost 
regions of the lung. The lung can be divided into three sections of gradually 
decreasing airway diameter; these are the oropharynx, the tracheobronchial airways 
and the alveolar region, also known as the deep lung (Gerrity, 1990).
The airway diameter will cause particles to be deposited in different parts of the lung 
anatomy, dependent on a number of factors (Vidgren et al., 1988a).
Particles of >5 pm tend to deposit in the upper airways through inertial impaction 
(Hinds, 1982), since their momentum prevents particles greater than this size from 
following an airstream as it is drawn through tight turns in the airways. In order to 
become deposited in the deep lung, it is generally recognised that particles need to be 
in the size range 1-5pm (Gonda, 1992; Hinds, 1982). It has been found that particles 
below 0.5pm fail to deposit in the lung in large numbers and are mostly exhaled 
(Zanen et al., 1994).
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1.3.2 Aerosol properties
The physical properties of drug powders for inhalation determine the deposition 
characteristics of aerosol clouds generated from these powders. The most critical 
physical property is particle size (Hinds, 1982; Staniforth, 1996).
When characterising particles used in inhalation the most appropriate measure of 
particle size is represented by the aerodynamic equivalent diameter, Dae, which is 
defined as the diameter of a perfect sphere of density lgcm' that has a terminal 
velocity in still air equal to that of the particle examined; this parameter therefore 
considers the properties of size, shape and density of a particle (Gonda, 1988).
It is widely accepted that drug particles with a Dae 0 5  pm are most likely to be 
deposited within the deep lung when inhaled (Ganderton and Kassem, 1992).
Although the particle size of drug and excipient materials used in DPI systems can be 
carefully engineered, the interactions between particles can have a critical effect on 
aerosol properties (Stewart, 1986). These interactions will be influenced in turn by a 
number of factors such as the formulation, processing techniques, electrostatic 
charging and/or environmental conditions (Makin et al., 1997).
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1.4 Formulation factors influencing DPI performance
When undertaking formulation of powders for inhalation, three critical factors must be 
considered. The powder formulation must: (a) be homogeneous, (b) be capable of 
reliable, consistent filling into and delivery from a DPI device and (c) allow delivered 
drug particles to be available for deposition into the deep lung in a reliable, consistent 
manner.
The theory of random mixing, first proposed by Lacey in 1943, assumes that there is a 
small probability that an infinitely long mixing time will result in the production of an 
ideal mix through random events brought about by the mixing process (Staniforth, 
1982). However, this theory does not take into account attractive interactions that are 
likely to occur between the fine particles in a DPI formulation (Staniforth, 1987).
Such interactions are considered in more modem mixing theories, where fine particles 
have been shown to adhere to the surfaces of coarser (‘carrier’) particles (Travers and 
White, 1971); this phenomenon has been termed ordered mixing (Hersey, 1975). In 
an ordered mix, fine particles are bound to the carrier particles by interparticle forces 
that result from surface electrical attractions.
Staniforth (1982) proposed that both random and ordered mixing processes were 
likely to occur in combination as a dynamic equilibrium in any mixing system, since it 
is unlikely that formation of ideal random or partially ordered mixes occurs in 
pharmaceutical powders; this theory was termed total mixing (Staniforth, 1981).
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Drug particles of a size suitable for inhalation (i.e. in the range 1 to 5 pm) tend to exist 
as cohesive powder systems with poor flow, which can result in difficulties during 
processing of the powders into DPI delivery systems. The inherent cohesiveness of 
fine particles can also lead to the formation of self-aggregates from which respirable 
particles must be released upon patient inhalation to facilitate deep lung deposition 
(Hickey et al., 1994).
Two general approaches have been adopted to address these issues through 
formulation. The first approach entails formulations containing only the active drug 
powder. These are processed in such a way so as to encourage the formation of 
loosely bound drug agglomerates that are able to become dispersed into their primary 
fine particles upon inhalation (Trofast and Falk, 1996; Yang and Kenyon, 2000).
The second, and more common approach to formulation requires the micronised drug 
particles to be mixed with other excipient powders. These excipients are generally 
coarse particles of a size range 30 to 100pm and have a role as carrier particles in the 
formation of ordered powder mixes (Hersey, 1975). The fine drug particles are bound 
to active sites on the carrier surfaces (Staniforth, 1996). Such systems are dependant 
on a proportion of the fine drug becoming detached from the carrier surface upon 
inhalation of the formulation so that these particles can be carried to the deep lung. 
The carrier particles are generally designed to remain in the device or deposit in the 
mouth or upper airways once they have dissociated from the fines.
Such systems are often found to be inefficient since large numbers of the drug 
particles fail to separate from carrier surfaces and those particles that do become
dislodged may do so as aggregates or may re-form into aggregates, which are 
themselves too large to travel to the deep lung.
Many of the drug presentations used in inhalation therapy are highly potent and 
require only small doses for therapeutic efficacy. Such low doses generally require to 
be formulated with a large proportion of excipient powders, typically resulting in drug 
to carrier ratios of between 1:50 and 1:500. It is possible for mixing of such systems 
to result in the formation of ideal interactive mixtures in which a monolayer of drug 
particles is distributed over carrier surfaces (Wong et al., 1995a).
In contrast drugs requiring higher doses, where drug to carrier ratios may range from 
1:10 to 1:1, are unable to form pure monolayer interactive mixtures since the drug 
particles are too numerous. Drug particles in these formulations may exist in a variety 
of possible states: (a) individual drug particles, (b) drug-drug agglomerates, (c) drug 
particles bound to individual carrier particles in mono- or multi-layer configurations 
and (d) as combined drug and carrier agglomerates (French et al., 1996; Wong et al., 
1995b).
Low and high dose carrier based systems have been further improved by the addition 
of fine particle ternary excipients to the formulations (Lord and Staniforth, 1996; 
Lucas et al., 1998; Zeng et al., 1998; Peart, 1996; Louey et al., 2000). It has been 
proposed that these fine particle excipients act by occupying highly active binding 
sites on carrier particle surfaces, leaving more passive sites available for adhesion of 
drug particles at lower energy levels, thus facilitating separation of the drug during 
dose delivery (Staniforth, 1996).
Lucas et al. (1998) reported the formation of multiplets of drug particles with fine 
particle lactose which were thought to bring about improved deposition characteristics 
since drug particles were more easily liberated from the surfaces of fine particle 
lactose than from coarser particles.
The use of fine particle lactose as the excipient component in a binary mixture with 
nedocromil sodium has been shown by Clarke et al. (1998) to be effective in 
improving in-vitro deposition performance. It was proposed that this was brought 
about through intercalation of the fine particle lactose into the structure of drug 
agglomerates, which reduced their cohesive strength and resulted in an increase in the 
liberation of fine drug particles on application of a dispersive force (Lucas et al., 
1998; Clarke et al., 1998). The processing and binding characteristics of nedocromil 
sodium are considered in some detail below.
The forces of attraction that develop between particles in any DPI formulation system 
must be carefully controlled since cohesive drug-drug or adhesive drug-carrier 
interactions that are of too great a magnitude will prevent adequate dispersal of the 
drug particles (Zanen et al., 1992).
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1.5 Nedocromil sodium
1.5.1 Therapeutic use of nedocromil sodium
Current strategies for the pharmacological management of asthma are concentrated 
around symptomatic relief and preservation of lung function (Smith and Bernstein, 
1996). Acute symptoms are treated with selective /ife-adrenergic agonists, 
anticholinergic agents, theophylline and other xanthine-oxidase inhibitors. The most 
common treatments for long-term prophylaxis of asthma employ anti-inflammatory 
preparations containing corticosteroids and/or the anti-allergic drugs, cromolyn 
sodium or nedocromil sodium (Holgate, 1996; Smith and Bernstein, 1996).
Nedocromil sodium has a pharmacological action similar to that of sodium 
chromoglycate, thought to act by stabilising mast cell membranes and thus preventing 
release of pharmacological mediators of bronchospasm. The only formulation 
currently available for inhalation use containing nedocromil sodium is a pMDI 
presentation (Tilade ®, Patheon Healthcare Limited, London, U.K.). This is usually 
administered to adults at a dose of 4 mg twice to four times daily for the prophylactic 
treatment of asthma (Cairns et al., 1985; British National Formulary, 2001).
1.5.2 Physical properties of nedocromil sodium drug substance
Nedocromil sodium (disodium 9-ethyl-4, 6-dioxo-10-propyl-4H, 6H-pyrano[3,2- 
g]quinoline-2, 8-dicarboxylate) is a hydrophilic drug that has been found to exist in
10
four states of hydration dependent on humidity conditions; these are summarised in 
table 1.1 below.
% Relative Humidity Hydration
at 22C state
<6.4 Monohydrate
6.4 - 80 Tri hydrate
80 - 92.9 Heptahemihydrate
92.9 Saturated solution
>92.9 Unsaturated solution
Table 1.1. Hydration states of nedocromil sodium at different percent relative
humidities at 22°C.
1.5.3 DPI formulations containing nedocromil sodium
The aerosol performance of dry powder blends containing nedocromil sodium 
trihydrate was investigated by Clarke (1998); the findings from this work are 
summarised below.
This study investigated nedocromil sodium formulations in pure drug form, as mono­
component or bi-component coarse carrier systems, as fine particle lactose carrier 
systems and as aggregated powder systems. Processing of these formulations was 
carried out in a range of blending equipment; these were a pestle and mortar, a 
turbulent tumbling mixer and a rotary bladed high shear mixer.
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The effects of relative humidity were also investigated and this parameter was 
carefully controlled in conditioning and testing of the powders. All formulations were 
characterised for in-vitro aerosol performance during delivery of an 8mg dose to a 
modified twin stage impinger apparatus through a Cyclohaler® DPI device.
Carrier based formulations were prepared incorporating a high percentage of 
nedocromil sodium trihydrate (40%w/w) with a-lactose monohydrate powders.
These studies indicated an optimised formulation using fine particle lactose. Blending 
conditions that provided the highest amounts of shear were found to improve aerosol 
performance of the blends and deposition characteristics were also found to be 
enhanced with increased mixing times.
The mechanism for formation of the optimised blends was proposed as one of 
intercalation of fine particle lactose particles into the lattice of self-agglomerated 
nedocromil particles so causing the attractive forces between nedocromil particles to 
be weakened hence allowing greater deaggregation by a turbulent airstream during 
delivery from the DPI system.
It was clear that distribution of the fine particle lactose in relation to the nedocromil 
particles was critical to achieving optimal blend performance and that very high shear 
forces needed to be imparted into the formulation during blending to achieve ideal 
dispersal of ingredients.
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1.6 Powder blending equipment
1.6.1 Turbulent tumbling mixers
Tumbling mixers are frequently used in generating powder blends for inhalation. 
Various designs of tumbling mixers are available, all of which basically incorporate a 
mixer vessel, or shell, which is rotated so that the powder bed within it exceeds its 
angle of repose, thus causing it to flow over itself. The mechanism of mixing in this 
case is division and recombination of the powder bed by shearing in the bulk of the 
material and diffusion at the surfaces, brought about by turbulent conditions provided 
by the tumbling action of the mixer vessel (Scott, 1957).
The mixer vessel may be one of a number of geometrical shapes, such as a cylindrical 
drum, double cone, y-cone or cube, which is rotated about an axis, the selection of 
which depends upon the desired powder flow pattern. The movement of the vessel 
may be more complex than a simple rotation, for example, the Turbula® mixer 
comprises a cylinder which is rapidly turned in a ‘figure-8’ type motion allowing it to 
develop more shear force than conventional rotation patterns.
These mixers are most suitable for dry, free-flowing materials and are often used 
where a mild action is necessary. Segregation of materials is often a problem in 
tumbling mixers, especially with free-flowing materials with large size or density 
differences. The inclusion of baffles in the chamber design can have the effect of 
increasing convective mixing, which may help to reduce segregation (Williams, 
1968). Mixing of cohesive powders, such as those often used in DPI products may
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often require more shear than can be provided by tumbling mixers (Rees, 1977), 
although some have been fitted with high speed agitator devices which may facilitate 
the mixing of cohesive powders and limit the amount of segregation (Hamby, 1967).
The simplicity of the mixing vessel and the absence of moving parts within it allow 
easy cleaning of most tumbling mixers, although this benefit is reduced in designs 
which include baffles or agitators.
1.6.2 Agitator mixers
A second class of mixers, agitator mixers, convey a mixing action to a powder bed by 
using blades or paddles of various designs which move within a stationary mixing 
vessel.
Agitator mixers are generally able to impart high shear forces into a mixing process 
which makes them particularly useful for mixing cohesive powders.
Planetary mixers are agitator mixers which operate using a mixing shaft which 
simultaneously rotates about itself and around the circumference of a circular mixing 
bowl. Although it is possible to operate these blenders using variable shear they are 
rarely used for dry powder blending purposes (Lantz and Schwartz, 1981).
A number of designs of mixing equipment are available which are described as high 
speed or high shear mixers. Since these mixers have traditionally been used in 
preparation of wet granulations for tableting or encapsulation, they are often termed
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high shear mixer/granulators. Most designs of this type of granulator consist basically 
of a mixing chamber or bowl, a main impeller and a chopping tool.
The orientation of the mixing bowl may be horizontal as in the Loedige® mixer, or 
vertical as in the Diosna® and Gral® type mixers. Vertical mixers are more 
accessible and so are easier to clean than the Loedige®, and the design of the Gral® 
mixer is such that the mixing blades and chopper are top driven, hence are removable 
from the bowl, further simplifying cleaning (Stanley-Wood, 1990).
Powder mixing is achieved through the use of shear and compaction forces generated 
from the rapidly rotating main impeller. The dry powder is placed into the bowl and 
mixed using the main impeller at speeds generally in the range of 100 to 500 rpm.
High shear blenders often contain chopper blades that can be rotated at very high 
speeds (up to approximately 4000 rpm) in a different plane to the main impeller; this 
action is thought to break up any large agglomerates, although it has also been 
suggested that its main role is to prevent a uniform flow pattern being created within 
the mixing chamber (Holm, 1987).
The main operational influences on mixing in this type of equipment are shape, size 
and orientation of mixing chamber, design and speed of impeller and chopper and the 
amount of powder to be processed (Schasfer, 1988).
One of the disadvantages of high-shear mixer/granulators is that a large amount of 
frictional heat may be generated during their operation, which may damage some
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materials and may require a cooling jacket to be included in the design. Also, the 
presence of moving parts within the mixing vessel can make cleaning difficult and 
may lead to contamination of the granules by material still resident from previous 
batches as well as from wear of the mixing blades themselves. The correct design of 
the seals or glands around the mixing impellers is an important factor in preventing 
cross-contamination of the product (Hauser, 1992) and these are often air-flushed in 
modem equipment.
1.6.3 Air mixers
A final category of mixer operates using fluid flows to agitate powdered material. 
Although no published evidence of the use of air mixers in producing blends for 
inhalation can be found, a review of these mixers is included here since it is the 
intention of this study to investigate the potential use of an air driven system for DPI 
blend manufacture.
The technique of fluidisation is widely used in pharmaceutical operations where 
fluid/solid contact is required; general aspects of fluidisation are considered elsewhere 
(e.g. Davidson et al., 1985).
Fluidisation processing is usually carried out within a vessel in which the powder rests 
on a perforated base (distributor plate), which also serves to direct the gas flow to give 
a uniform velocity distribution throughout the cross-section of the powder bed. The 
design of the distributor plate has an important effect on the operation of the fluidised 
bed (Whitehead, 1985).
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Powder mixing using fluid flows may be described as being achieved by either a 
fluidisation or an agitation technique. Fluidisation techniques are considered here as 
being those in which a high volume of low pressure fluid is applied across a bed of 
powder. Agitation techniques are those in which particle movement is elicited by the 
injection of high pressure gas streams into the powder mass.
Segregation of material may be a problem in fluidised beds where particles of widely 
differing sizes and/or densities occur (Rowe and Nienow, 1976) and fluidised bed 
mixing is therefore precluded as a method suitable for processing of such materials in 
the dry state (Simon, 1975) unless additional turbulent flows are introduced to the 
processing environment. Mixing of solid particles within a gas fluidised bed is also 
influenced by the nature of the material, the most important properties being particle 
size and density (Shakhova and Minayev, 1972).
Another type of mixer has been described in which material is pneumatically 
conveyed upwards through a vertical tube in the centre of a mixing chamber by a 
radial fan. Blending is achieved mainly by transverse mixing, so an adequate 
homogeneity is only achieved after a number of circulations of material through this 
central tube. Increasing longitudinal mixing with the inclusion of an outer annular 
cone can reduce the number of circulations necessary for adequate mixing, since 
material is returned to the main chamber at two different heights (Krambrock, 1976).
Mixing may also be achieved by agitation of powder within a vessel by the injection 
of pressurised air into the vessel. One technique of pneumatic mixing, the Airmix
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mixer, uses a number of upwardly tilted air jet nozzles, which are arranged in a ring- 
shape at the bottom of a frusta-conical vessel (Anon., 1966). The material to be 
mixed forms a cone on the floor of the mixer from where it is carried up along the 
walls of the mixer by compressed air fed through the jet nozzles. The turbulent region 
arising from the jet nozzles imparts a mixing action to the particles causing the 
material to be deposited back onto the centre of the cone. To prevent centrifugal 
segregation of material of different densities or particle sizes, the jets may be pulsed to 
give short blasts of air (Anon., 1966; Teichmann, 1967). The performance of the 
Airmix mixer has been shown to be influenced by the operating pressure of the air 
nozzles (Ashton and Valentin, 1966).
An alternative design uses negative air pressure to mix powders (Akiyama et al.y 
1982; Akiyama and Tada, 1984; Akiyama and Tada, 1985; Akiyama et al.y 1986). In 
this system, air is drawn through a series of tangential ports located around a conical 
mixing vessel. The main advantage of the negative pressure air mixer over a 
conventional, positive pressure air mixer, is a reduced need for bag filtration.
In a comparison of the performance of a number of mixer types using differently 
coloured, non-segregating particles, an air mixer was found to be the fastest mixer of 
the seven types investigated (Miles and Schofield, 1970). An advantage of this type 
of mixer is the absence of moving parts within the product chamber; this reduces 
cross-contamination and allows easier cleaning. Additional advantages are reduced 
damage to the particles; the possibility of transporting the material by air; and the 
large batch sizes that can be handled (Akiyama et al., 1982).
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Unpublished data has described the use of cone mills in aiding dispersal of fine 
particles in DPI formulations. Cone mills employ an impeller blade which forces 
material through a screen of variable size and this application attempted to take 
advantage of the high shear conditions resulting from operation of this type of 
equipment.
19
1.7 Fluid energy milling
A brief review of particle size reduction by fluid energy milling is presented here 
since the processor under investigation in this study had an intended application for 
particle size reduction of DPI excipients and the mode of action was considered to 
possess some similarities with fluid energy milling equipment.
Fluid flows may be used to reduce particle size using the technique of fluid energy 
milling, also known as jet milling or micronising. The fluid energy mill operates by 
the acceleration of particles using a high pressure jet of gaseous fluid, usually air, so 
that they collide with each other or with a part of the grinding chamber, causing 
comminution by particle impaction and attrition. Fluid may be introduced at pressures 
ranging from 25 to 300 pounds per square inch, producing regions of turbulence in 
which sonic or supersonic velocities impart sufficient kinetic energy to the feed 
material to effect particle size reduction (Albus, 1964).
The fluid energy mill or ‘microniser’ is the type of mill most suitable for ultrafine 
impact milling of materials to a size less than 5 pm. Most conventional impact mills 
are capable only of size reduction to approximately 50 pm because neither the impact 
velocity nor the solids concentration is sufficiently high to accomplish ultrafine 
grinding (Rumpf, 1959; Leschonski and Menzel, 1986). Particles produced by 
micronising typically have a narrow size distribution and are smooth and round in 
shape (Akbarieh and Tawashi, 1987).
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Fluid energy mills are particularly useful in the fine milling of heat sensitive 
pharmaceuticals since the expansion of compressed air upon entering the milling 
chamber causes it to cool and counteracts the heat generated by milling. The milling 
atmosphere can easily be controlled by selection of the grinding fluid. For example, 
hygroscopic or hydrolysable materials can be milled using very dry air, and materials 
susceptible to oxidation could be milled using high pressure nitrogen. The turbulent 
conditions generated within a fluid energy mill may also provide an excellent 
environment for mixing of the ingredients (Albus, 1964).
A further advantage of fluid energy mills is the absence of moving parts in the 
grinding area which makes cleaning easier and reduces the likelihood of cross 
contamination (Dotson, 1962). These mills can be adapted to operate under aseptic 
conditions by sterilisation of the mill components and the use of sterilised air or high 
temperature water vapour as the jet fluid (McDonald, 1971).
Most fluid energy mills incorporate a size classifier that removes sufficiently 
comminuted material and retains the remainder for further size reduction. This allows 
efficient production of material with a narrow size distribution. Efficient operation of 
a fluid energy mill often requires the feed material to be premilled. The degree to 
which a material should be premilled is determined by the mill specifications, the 
characteristics of the material and the particle size reduction required. Typically, the 
particle size of the feed material should be between 150 to 850 pm (Parrott, 1976).
There are several basic designs of jet mill, including target jet mills, opposed jet mills, 
tangential jet mills and fluidised bed jet mills (Prior et al., 1990).
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In a target jet mill, a single jet directed onto a target plate causes particles to collide 
with the target and bring about particle fracture by impaction. Size reduction is 
achieved in an opposed jet mill by head-on impact of particles through entrainment in 
two opposing jet streams. Sufficiently fine particles will be carried towards the centre 
of the classification chamber by entrainment in the air leaving the mill, whereas larger 
particles will be forced towards the outside of this chamber by centrifugal force and 
then returned to the impact site. The fine particles are then collected from the 
escaping air by separating devices such as cyclones and bag filters.
Several types of fluid energy mill apply a tangential jet nozzle design. One such 
design is based upon a vertical, hollow toroid (Albus, 1964) although the milling 
chamber may also be cylindrical (Nair and Ramanujam, 1986). Material is fluidised 
and fed into the chamber by a high pressure air injector whereupon a number of jet 
nozzles at the base of the mill provide a region of turbulence in which size reduction 
takes place as a result of high energy particle collisions. The central classifier 
removes fines in a similar manner to that in the opposed jet mill described previously. 
An attempt has recently been made to characterise the classification system of a 
circular (cylindrical) fluid energy mill (Nair and Ramanujam, 1991).
The efficiency of an alternative tangential system, designed to operate horizontally, 
was been shown to be affected by the angle of the nozzles (Smit, 1986). This type of 
mill was the subject of a recent study, which demonstrated that particle size reduction 
was increased with increasing fluid pressure and by the installation of deflectors in the 
milling chamber (Yoon, 1994). This report also concluded that increasing the feed
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rate of material decreased the level of comminution but other workers have reported 
that, in some cases, increasing the concentration of solids in the grinding chamber 
produces finer particles due to increased collision frequency (Akbarieh and Tawashi, 
1987). An accelerating particle must have sufficient time before collision to reach a 
velocity high enough to attain maximum impact energy, and if the system is very 
highly loaded this velocity may not be achieved, so reducing the extent of 
comminution (Rumpf, 1960).
It is likely that maximum particle size reduction occurs at an intermediate level of 
particulate loading at which there is an optimal balance between the amounts of 
energy transferred to each particle and the rate of particle collisions.
Jet mills have also been designed in which grinding occurs within a fluidised bed 
incorporating a motor-driven air classifier (Ghosh, 1993). One advantage of this 
design is decreased wear of the mill parts, so that product contamination from this 
source is reduced. This benefit results from the reduction in the speed of particles as 
they get closer to the mill walls so that particle-mill collisions are prevented and 
virtually all size reduction is achieved through particle-particle collisions (Prior et al., 
1990). In addition, these mills produce particles of narrower size distributions (Prem 
and Eddington, 1988) and are more energy efficient than standard jet mills (Prem, 
1984).
The mode of action of fluid energy mills will result in some mixing of the materials 
being processed and suitably adapted mills have been used for this purpose (Albus, 
1964).
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1.8 Aims of the study
It is clear that the amount of shear imparted to a blending process during manufacture 
of powders for inhalation is critical to:
(a) Attaining a homogeneous ordered mixture by adequately dispersing fine powders 
onto carrier particle surfaces
(b) Avoiding the formation of overly large interactive forces between particles which 
may hinder liberation of fine drug particles from the formulation during patient use.
The choice of mixing equipment capable of providing the large amounts of shear for 
this process is restrictive. Furthermore it has often been found difficult to balance 
reliably the shear input within equipment which is currently available since such 
equipment usually has been designed for other purposes.
Where performance modifying agents such as fine particle lactose are added to a DPI 
formulation, the distribution of these in relation to the other components in the 
formulation is postulated to be critical to their effectiveness and hence control of the 
amount of shear available during processing of such systems is likely to be crucial.
Furthermore, the size of both drug and excipient particle ingredients is important to 
the performance of a DPI formulation and although a range of equipment is available 
to effect manipulation of particle size, it is not yet possible for this to be performed
24
within mixing equipment; such an application may have benefits in control of DPI 
blend manufacture.
Research into enhancing the performance of DPI systems has often been directed at 
formulation improvement or developments in device design rather than investigation 
of novel processing alternatives.
Consequently an attempt was made within this study to design, develop and 
characterise alternative equipment that was able to provide controllable and reliable 
levels of shear capable of achieving the required mixing and/or control particle size 
reduction processes.
These characterisations were performed using a nedocromil sodium formulation in 
order to provide a direct comparison with the established conventional processing 
techniques investigated by Clarke (1998), which are discussed in section 1.5.3.
Size reduction investigations were also undertaken within the novel processing 
equipment using a commonly used inhalation excipient, lactose powder.
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Cyclohexane, used in sample preparation for wet cell particle size analysis of nedocromil 
sodium trihydrate, was HPLC grade (BDH Limited, Poole, U.K.).
HPLC grade propan-2-ol (BDH Limited, Poole, U.K.) was used as a dispersant liquid in 
wet cell particle size analysis of fine particle lactose.
Lecithin, used as a dispersal aid during wet cell particle size analysis, was obtained from 
BDH Limited, Poole, U.K.
Water was freshly deionised.
Magnesium nitrate, used to prepare the saturated salt solutions, was obtained from BDH 
Limited, Poole, U.K.
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2.1.2 Materials used during processing





































Table 2.1. Description of materials used during processing.
* Note: Prismalac 40® is the replacement proprietary name for CrystaLac 40® (used in 
the FBSVP-A milling experiments); these are claimed by the manufacturer to be 
equivalent materials in all other respects.
2.1.3 Other materials used during testing
Cyclohaler® dry powder inhalers (PCH Pharmachemie, Haarlem, Netherlands).
Size 3 hard gelatin capsules (Davcaps®, Hertfordshire, U.K.).
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Volumetric glassware was Class A (Fisher Scientific Ltd, UK).
2.1.4 Formulation
All blending studies were carried out using the common formulation set out below:
Nedocromil sodium trihydrate 40% w/w
SorboLac 400 a-lactose monohydrate 60% w/w
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2.2 Control of relative humidity
2.2.1 Storage of drug and excipient powders
Materials used in the dry blending experiments were stored in desiccators within an 
environment of controlled relative humidity (RH) for at least 24 hours before processing. 
Optimum conditions for stable storage of nedocromil sodium trihydate have been 
determined at 22 degrees C, 50% RH (Khankari et al., 1998). A RH of approximately 
55% was readily achieved by placing a saturated solution of magnesium nitrate in the 
base of a sealed desiccator vessel. Temperature was not controlled, but was maintained 
at an ambient laboratory level, which was monitored to confirm that this did not deviate 
outside 1 5 - 3 0  degrees C. This provided a RH of between 52 -  56% within the 
desiccator environment (Pharmaceutical Handbook, 1980).
2.2.2 Storage of hard gelatin capsules
Hard gelatin capsules were also stored under conditions of approximately 55% RH. This 
was to avoid extremes of RH which have been found to cause brittleness of capsules at 
RH < 40% and moisture sorption leading to swelling of capsules at RH > 85% (Konty 
and Mulski, 1989). It was thought that capsule brittleness could lead to inconsistent 
piercing of the capsules during operation of the Cyclohaler® device, which may then 
affect the aerodynamic behaviour of the powders during aerosolisation.
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It was also considered prudent to fill powders into the capsules immediately before 
testing to minimise any effects brought about by moisture transfer between the gelatin 
and the test powder.
2.2.3 Processing and testing
All processing and testing was performed under ambient laboratory conditions. Humidity 
and temperature changes within the laboratory for the year 1998 were recorded and 
ranged from 19 to 63% RH and 16 to 29 degrees C.
Materials were kept within the above described desiccator environment until immediately 
before processing and samples were placed under similar conditions within 30 minutes 
after the completion of processing. Samples were subsequently exposed to the laboratory 
environment only during the time taken to perform individual test determinations.
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2.3 Particle size analysis
Techniques of Low Angle Laser Light Scattering (LALLS) were employed to determine 
the particle size distribution of powder samples. LALLS particle size analysis relies on 
the interaction of a beam of laser light with a suspended sample of particles. Projection 
of laser light onto a particle will cause a diffraction pattern to be superimposed onto the 
geometrical image of the particle. This pattern is large compared to the image and the 
diffraction angle, obtained by focusing the undeflected and forward scattered light 
through a lens, is inversely related to the particle size.
The pattern formed by this technique is known as a Fraunhofer diffraction pattern. 
Fraunhofer theory relates particle size to diffraction on a number of assumptions, namely 
that the particle is much larger than the wavelength of the light, that all sizes of particles 
scatter with equal efficiencies and that particles are opaque and do not transmit light 
(Allen, 1990).
For particles of a size approaching the wavelength of laser light (i.e. particles below 
about 3 pm diameter), the scattering becomes more complex and may be described by 
Mie scatter theory (Allen, 1990). One limitation of Mie theory is that the refractive index 
of the sample and dispersal medium must be known to allow accurate calculations.
Two types of LALLS equipment were employed during initial materials characterisation, 
a Malvern Mastersizer X (Model MSX02SM, Serial number 6278, Malvern Instruments
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Ltd., Malvern, UK) and a Sympatec HELOS (HELOS System HOI00, Sympatec GmbH, 
Bury, UK). Both of these instruments comprised a helium-neon laser light source, a 
sample cell, a focusing lens and a photodetector (Figure 1.5); they may be used to analyse 






Particles measured Lens 
in sample cell
Multiplexor 
Detector *-D  converter
Figure 2.1. Schematic diagram of LALLS particle size analyser.
The simplest way to expose a powder sample to a laser beam is to draw it through the 
sample cell suspended in a stream of air. In those cases where the sample powder is 
cohesive and forms agglomerates, as is often the case for very fine powders, then 
practical and effective measurement of the primary particle size usually requires dispersal 
in a contacting non-solvent within a sample cell or some other form of powder dispersal 
system.
32
The powder dispersal systems in both instruments were found to be adequate for analysis 
of the lactose powders before and after milling. However, whilst it was found that the 
Sympatec dry powder system was able to efficiently disperse micronised nedocromil 
sodium trihydrate powders, it was necessary to employ a wet cell method when using the 
Malvern equipment for analysis of this material in order to obtain consistent and reliable 
results.
The availability of equipment meant that Malvern analysis was used for routine particle 
size analysis during size reduction experimentation, although both systems were 
employed during initial size characterisation of materials.
2.3.1 Particle size characterisation of micronised nedocromil sodium trihydrate
2.3.1.1 Malvern Mastersizer particle size analyser
The large volume circulating cell was used to analyse micronised nedocromil sodium, 
using a solution of 1% w/v lecithin in cyclohexane as the dispersant liquid; cyclohexane 
was used since it has been established that it does not dissolve nedocromil sodium 
trihydrate; lecithin was introduced as a wetting agent. The solution was filtered (Type 
A/E glass 76 mm diameter, Gelman Sciences, Michigan, U.S.A.) before use and its 
refractive index measured using an optical refractometer to determine an appropriate 
presentation for the particle size calculations.
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A 45 mm lens was fitted into the Malvern instrument, which provided a detectable 
particle size range of 0.1 to 80 /mi, and the reservoir of the large volume circulating cell 
was filled with an appropriate amount (approximately 1 litre) of the filtered dispersant 
liquid. With the cell fixed into position the optics in the instrument were aligned and the 
diffracted light measured in the absence of a sample in order to establish a background 
reading.
Approximately 5ml of dispersant liquid was filled into a small test tube and 
approximately 1 mg of micronised nedocromil sodium added. The tube was manually 
agitated and subsequently placed in an ultrasonic water bath for 10 minutes, which was 
maintained at a temperature between 20 and 25°C in order to reduce the likelihood of any 
dissolution of the material. Following sonication a number of drops of the suspension 
were immediately added to the reservoir of the large volume circulating cell until an 
obscuration level of between 15% and 25% was obtained. All samples were prepared 
and analysed in duplicate.
2.3.1.2 Sympatec particle size analyser
The Sympatec HELOS system was used in conjunction with the RODOS dry disperser 
system (Sympatec GmbH, Bury, UK). The R2 lens (measuring range 0.25 -  87.5 pm) 
was selected and the disperser pressure set at 3.0 bar. Trigger conditions were set at 1% 
optical concentration for 100ms. The vibrator was set with a feed rate of 50% with a
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funnel height of 1.00mm. A reference measurement was taken then samples of
approximately 0.5 g each analysed in triplicate.
2.3.2 Particle size characterisation of fine particle lactose
2.3.2.1 Malvern Mastersizer particle size analyser
The particle size of the SorboLac 400 lactose raw material was measured using the small 
volume stirred cell in conjunction with the 100 mm lens (particle size range 0.5 to 120 
pm). The stirred cell was filled with approximately 15 ml propan-2-ol, the optics aligned 
and a background reading established with the stirrer operating at speed 3. 
Approximately 1 mg of lactose sample was placed into a test tube, which was half filled 
with propan-2-ol. This was manually shaken then sonicated for 2 minutes. Several drops 
of the suspended sample were added to the stirred cell until an obscuration level of 
between 15 and 25% was obtained and the sample analysed using 2000 sweeps of the 
light beam.
2.3.2.2 Sympatec particle size analyser
The Sympatec HELOS system and RODOS dry disperser system were set up as 
described in section 2.3.1.2, using identical operating conditions except that the vibrator 
was set with a feed rate of 75% and a funnel height of 1.00mm. A reference
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measurement was taken to establish the background reading then samples of
approximately 0.5 g each analysed in triplicate.
2.3.3 Particle size characterisation of coarse lactose raw material and products of 
milling experiments
The Malvern Mastersizer X was used, employing a dry powder feeder technique to 
present powder to the measurement array. This utilised a vacuum device (Nilfisk Type 
GS80, 700 W, Nilfisk Ltd., Suffolk, UK) to draw powder samples across two parallel 
optical glass panes within the dry powder feeder manifold (Model MSX64, Malvern 
Instruments Ltd., Malvern, UK). A flow rate of approximately 100 litres min'1 was found 
to provide the required Mastersizer obscuration value of between 15 and 25 % during 
sample detection.
The 300 mm lens (particle size range 1.2 to 600 pm) was fitted to the instrument and a 
sample of approximately 0.5 g of the test powder drawn through the sample cell. 
Otherwise, the instrument was operated as described in section 2.3.1.1 above. 
Measurements were obtained in triplicate.
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2.3.3 Particle size analysis of raw materials -  results
LALLS d(0.1)l[pm) d(0.5) [pm) d(0.9) [pm)
Raw Material instrument Mean SD Mean SD Mean SD
SorboLac 400®
Malvern
Mastersizer 1.1 0.04 6.5 0.3 19.1 2.5




Mastersizer 0.7 0.01 2.7 0.2 8.1 2.0
Sympatec 0.7 0.05 1.4 0.05 3.0 0.03
Prismalac 40®
Malvern
Mastersizer - - 460 7.1 - -
Table 2.2. Particle size analysis of raw materials by Malvern Mastersizer and/or
Sympatec LALLS instruments.
Key:
d(0 .1) = diameter below which 10% of particles are sized by mass
d(0.5) = diameter below which 50% of particles are sized by mass (mass median particle
diameter)
d(0.9) = diameter below which 90% of particles are sized by mass
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2.4 Nedocromil sodium assay
2.4.1 Equipment and materials
Helios UV spectrophotometer (Helios a, Unichem Limited, Cambridge, U.K.)





Nedocromil sodium trihydrate was stored at 55% RH. The UV spectrophotometer was 
blanked with deionised water. 10mm quartz sample cells were used. A 0.002% w/v 
solution of nedocromil sodium trihydrate was prepared in deionised water and analysed 
using the UV spectrophotometer over the range 250-450 nm to determine the absorption 
maxima. Peaks were found at 245nm, 280nm, 340nm and 373nm. A wavelength of 




A 0.040% solution of lactose in deionised water was prepared and analysed on the UV 
spectrophotometer for absorption at 373nm. No absorption was found.
Three nedocromil sodium stock solutions, A. B and C, were prepared at a concentration 
of 0.1% w/v using deionised water . Duplicate sets of dilutions (Al, A2, Bl, B2, Cl and 
C2) were made from each of the three stock solutions at concentrations of 0.001%, 
0.002%, 0.003%, 0.004% and 0.005%. Each set of solutions Al, A2, Bl, B2, Cl and C2 
was assayed three times using the UV spectrophotometer (X = 373nm) and the mean 
absorbance recorded. This enabled the statistical determination of i?,1* , taking into 
account the accuracy of weighing and preparation of dilutions.
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Results
Table 2.1 summarises the linear regression data obtained from the calibration plots for the 
solutions of nedocromil sodium prepared above. Linear regression was performed using 
Origin® v6.1 (OriginLab Corporation, MA, U.S.A.).
Stock Dilution Slop 6 ( 0 Intercept Coefficient of 
correlationValue SD Value SD
A 1 158.2 0.28 0.017 0.0092 0.99954
A 2 156.5 0.27 0.0275 0.0089 0.99956
B 1 157.2 0.24 0.025 0.0079 0.99965
B 2 157.2 0.25 0.0266 0.0081 0.99964
C 1 157.2 0.27 0.0314 0.0090 0.99956
C 2 157.5 0.25 0.0323 0.0082 0.99963
Mean 157.3 0.0266
Table 2.2. Linear regression data for calibration of UV spectrophotometer for assay of 
nedocromil sodium content (0.001 to 0.005 % w/v).
These calibration data enabled calculation of nedocromil sodium content of samples 
analysed for absorbance using the UV spectrophotometer according to the following 
formula:
xt j j - . wn, UV Absorbance -  0.0266N edocromil sodium content (% %) = ------------1 5 7 3 ------------ [Equation 2.1]
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2.5 In-vitro aerosol characterisation
A single dose capsule based dry powder inhaler device, the Cyclohaler®, was used to 
assess the in-vitro performance of blends.
All in-vitro aerosol investigations were performed using a method based on that 
described for Apparatus A in the British Pharmacopoeia 1993, Appendix XVIIC (Figure 
2.2). The standard Apparatus A has an effective cut-off diameter for 50% of the aerosol 
mass (ECD50) of 6.4pm at the prescribed flow rate of 60 litres min'1. Providing the 
apparatus conforms to impactor theory, an alternative ECD50 can be obtained by altering 
the internal diameter of the jet within stage 1 according to the following equation:
ECD50 = 0.95 W1'5 Q-*5, [Equation 2.2]
where W is the internal jet diameter (mm) and Q is the air flow rate (litres min*1) 
(Hallworth and Westmoreland, 1987). Using this equation, the internal diameter of the 
stage 1 jets was modified to 11.6mm to provide a calculated ECD50 of 4.80pm at 60 litres 
min*1. Calibration of Apparatus A using the 11.6mm stage 1 jets was performed using 
monosized methylene blue droplets produced with a vibrating orifice aerosol generator 
by AEA Technology (Harwell, UK). An ECD50 of 5.3pm was measured for the modified 
Apparatus A at 60 litres min*1. All other dimensions in the modified Apparatus A 
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Figure 2.3. Diagram of Apparatus A (British Pharmacopoeia 1993, Appendix XVIIC).
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Table 12F-I Component specific;! tiob for Fig*. 12F-M
Code Item Description Dimensions*
mm
A Mouthpiece adapter Moulded rubber adapter for actuator mouthpiece
B Throat Modified round-bottomed flask 





C Neck Modified glass adaptor 
ground-glass inlet socket 
gnmad-glass outlet cane 
Lower outlet section of predsion-bore glass tubing 
bore diameter 






n Upper impingement Modified round-bottomed flask 100 ml




F. Coupling tube Medium wall glass tubing 
ground-glass cone 
Bent section and upper vertical section 
external diameter 





F Screw-thread, side-arm Plastic screw cap 28/13
adapter Silicone rubber ring 
PTFE washer 
Glass screwhead, thread size 






G Lower jet assembly Modified polypropylene ^  filter holder connected to lower 
vertical section of coupling tube by PTFE tubing 
Acetal circular disc with the centres of four jets arranged on a 








H Lower impingement Conical flask 250 ml
chamber ground-glass inlet socket 24-29
Note: A modified part C (stage 1 jet) was used, having an internal bore diameter of
11.6mm and an external diameter o f 14.6mm.
Figure 2.4. Component specification for figure 2.3.
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The flow rate of the system was adjusted daily before testing using the following method. 
The modified Apparatus A was assembled and charged with 7ml deionised water in stage 
1 and 30ml deionised water in stage 2. A vacuum pump (Gast Manufacturing Inc., 
Michigan, USA) was attached to the system via a timer controlled solenoid valve and a 
flow rate adjustment valve. An empty size 3 hard gelatin capsule was loaded into a 
Cyclohaler® device, which was attached to the modified Apparatus A using a moulded 
silicone rubber adapter. A calibrated rotameter was attached to the apparatus, sealed over
(fb 1the Cyclohaler , and the flow rate adjusted to obtain a reading of 60 ±5 litres min* . The 
apparatus was then disassembled, emptied and dried prior to use for testing.
The modified Apparatus A was assembled and charged with 7ml deionised water in stage 
1 and 30ml deionised water in stage 2. A size 3 hard gelatin capsule (stored in RH 
controlled environment until immediately before testing as described in section 2.2.2) 
was filled with 20mg of powder blend. This was loaded into the Cyclohaler® and the 
device primed. The capsule was then inspected and if brittle fracture of the capsule had 
occurred the test was aborted.
The vacuum pump was switched on and allowed at least 5 seconds to achieve a steady 
flow rate. The solenoid valve was then opened for 4.0 seconds, which gave sufficient 
time for 4 litres of air to be drawn through the system. The apparatus was then 
dismantled and the various components rinsed with deionised water into volumetric 
flasks and made up to volume with deionised water as follows:
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Device 50ml volumetric flask
Capsule 50ml volumetric flask
Stage 1 (Parts A, B, C & D*) 100ml volumetric flask
Stage 2 (Parts E, F, G and H*) 100ml volumetric flask
* See figure 2.3.
Assay of these solutions allowed calculation of the following parameters to describe the 
in-vitro aerosol performance of each sample.
Delivered Dose
The total quantity of drug recovered from the modified Apparatus A (i.e. the amount of 
drug found in stages 1 and 2) was expressed as the Delivered Dose (DD).
Fine Particle Fraction
The amount of drug recovered in stage 2 of the modified Apparatus A indicated the 
potentially respirable or fine particle component of the sample. This was expressed as a 
percentage of the DD (Fine Particle Fraction, FPF).
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2.6 Content uniformity testing
A 20mg aliquot of sample material was accurately weighed on a calibrated four figure 
analytical balance into a 100ml volumetric flask which was accurately diluted to volume 
using freshly deionised water.
Each solution was assayed for nedocromil sodium trihydrate content using a UV 
spectrophotometer as described in section 2.4.
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3. SVP CONCEPT: 
DESIGN STRATEGY AND 
PRELIMINARY WORK
3.1 Design constraints
The objective was to develop a series of novel powder processors within the following
design criteria or constraints:
(a) Should be capable of performing multiple pharmaceutical powder processing 
operations in a single vessel. These operations may include particle size 
reduction (agglomerate break-up and/or micronisation), dry powder blending, 
wet granulation and drying.
(b) Should employ directed airflows for all kinetic energy input.
(c) Should operate without moving parts in contact with the product; i.e. it should 
be a ‘bladeless’ system.
(d) Should attempt to reproduce similar product movement and particulate 
interaction conditions to those attained in conventional high-shear 
mixer/granulators.
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(e) Should use materials of fabrication that allow visualisation of the flow fields
inducing powder movement by imaging equipment as well as by the naked 
eye.
(f) Should operate using only those utilities that would be expected to be found
within a typical cGMP pharmaceutical manufacturing environment.
(g) Although initial prototypes would be expected to be at a small batch scale,
these should be designed with consideration for effective scale-up.
(h) Should allow operation within a range of definable and mensurable process
conditions.
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3.2 Early development studies
A series of basic prototypes was developed in order to demonstrate ‘proof of 
principle’ for a design strategy based around directed high-pressure air nozzles, 
intended to replace and mimic the blades in a conventional high-shear blender.
3.2.1 Previous work
A number of alternative designs were considered during a Final Year Engineering 
Design Project (Bates and Ball, 1993). One of these was selected for further 
development and constructed as shown in Figure 3.1.
The main vessel comprised two conical sections of 10° and 45° slope so as to reduce 
the velocity of entrained powder in the top region of the vessel and thus reduce the 
amount of powder leaving the vessel. A cyclone separator with jet pump attachment 
was connected to the exit duct to collect and recycle particulate material from the air 
escaping from the vessel. Air was ducted, via a gas distributor, into a base plenum 
using a radial fan to provide fluidisation of the powder bed. It was possible to 
introduce granulation liquid through an atomising nozzle and the fluidising air could 
be heated to facilitate air drying. A series of nine jet nozzles was arranged 












Figure 3.1. Schematic diagram of ‘Bates and Ball’ SVP design.
Although this design displayed some improved characteristics over previous models 
in terms of mixing and particle size reduction there was still a number of problems 
encountered. One major defect was that a large amount of powder escaped from the 
vessel via the lid seal, the base ducting and the gas outlet of the cyclone. Powder was 
also found to adhere to the vessel walls in significant quantities and to accumulate in 
the upper conical section and around the base ducting. Another defect in the design
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was that it was necessary to provide continuous fluidising air whilst the vessel was 
loaded in order to prevent material falling through the base of the processor.
3.2.2 Pre-prototype 1
An initial prototype (Figure 3.2) was constructed from a Perspex cylinder, 
approximately 300 mm in diameter and 250 mm high. The cylinder was fitted with a 
wooden base through which six L-shaped nozzles were positioned, equally spaced in a 
circular arrangement approximately 30 mm from the vessel wall. The nozzles were 
aligned in the horizontal plane in a tangential direction to the circumference around 
the nozzle stems so as to generate a vortex air motion. A cloth filter was provided 




Figure 3.2. Schematic diagram of SVP Pre-prototype 1.
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The airflows generated in this vessel when the nozzles were operated at a pressure of 
approximately 210 kPa displayed a large zone having little or no air flow resulting in 
the formation of a static region or ‘dead spot’ in the centre of the cylinder. In 
addition, the system did not generate a sufficiently well defined or controlled 
movement of powder and so failed to achieve any of the required processing 
operations. Consequently, a number of modifications were made and these are 
described below.
3.2.3 Pre-prototype 2
In order to eliminate the large central dead zone found in the first design, the vessel 
base was fitted with a central cone so creating a flat annular region separating the cone 
rim from the cylindrical wall of the vessel (Figure 3.3). This cone and brim 
arrangement effectively space-filled the dead zone and so induced a toroidal 
movement of powder under the action of the tangential jet stream. Although this 
design feature reduced the main dead zone, regions of low velocity were still found to 
exist behind the nozzles and around the cone brim. In addition the cloth filter was 
found to be inadequate for collection of very fine particles until it had collected a 
certain amount of material. Furthermore, with prolonged usage, the filter became 








Figure 3.3. Schematic diagram of SVP Pre-prototype 2.
Although SVP Pre-prototype 2 produced air movements that were found to be 
inadequate for effective efficient powder mixing encouraging results were found in 
particle size reduction indicating that sufficient velocities could be obtained for this 
purpose using the nozzles as designed and fitted.
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3.3 Fluid Bed SVP Model A
Although the findings from the initial prototypes including SVP Pre-prototype 2 were 
mainly a result of ad hoc investigations and observations they yielded sufficient 
information to enable the development of a fourth vessel, the Fluid Bed SVP Model A 
(FBSVP-A). A summary of the design and practical investigations into the particle 
size reduction and powder blending capabilities of this vessel is given below.
3.3.1 Design
A prototype processor, the FBSVP-A, was constructed to the design shown in figure 
3.4.
A hollow cylinder of clear Perspex of wall thickness 6 mm was used for the main 
vessel wall so that powder movements could be observed during operation of the 
processor. This was fitted with a mesh base of 100pm aperture diameter that provided 
support for powder within the vessel, whilst allowing uniform fluidisation of the 
powder bed when air was introduced through the base. A lid provided with a rubber 
o-ring seal was attached to the top of the vessel using four case clasps. A 
polyethylene cone was fixed to the centre of the vessel base to prevent the formation 





























Fluidising air was ducted into the bottom of the vessel from a centrifugal fan that 
could be operated at a maximum rotational speed of 2800 r.p.m.; this produced a 
calculated maximum air flow rate of 0.0456 m3/s. Twelve L-shaped high-pressure jet 
nozzles of 1 mm output diameter were located around the base of the vessel and 
connected to a compressed air manifold. A compressed air feed of approximately 550 
kPa was able to supply each nozzle at an air pressure of up to 210 kPa. The design of 
the nozzles was such that they could be adjusted in angle and depth within the vessel 
as required. A needle valve allowed control of the nozzle output air flow rate.
The attachment of a cyclone separator to the vessel lid was intended to enable the 
arrestment and return of entrained particles from the air leaving the vessel during 
operation of the air inputs. The gas outlet of the cyclone was allowed to vent to 
atmosphere and the dust outlet was attached to a jet pump. High-pressure air was 
directed through the jet pump nozzle causing air to be drawn through the top hole. 
This produced a suction effect that returned arrested powder from the cyclone dust 
outlet back into the main vessel.
The FBSVP-A was found to provide more uniform and widespread powder 
movements than previous designs and powder losses from the vessel were also greatly 
reduced. A further advantage of this design over the previous fluidised bed vessel was 
that it was not necessary to maintain a fluidising air input at all times, thus making it 
easier to control the process and to remove powder at the end of processing.
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3.3.2 Particle size reduction
3.3.2.1 Materials.
Two grades of granular a-lactose monohydrate were selected as model test materials. 
These were of similar particle size ranges, but were prepared by different methods and 
consequently could be expected to exhibit different physical properties.
The first test material was a pharmaceutical quality commercially available granular 
lactose (CAGL), CrystaLac 40 (Meggle, Wasserberg, Germany). The second material 
was granulated lactose manufactured using SorboLac 400 lactose powder (Meggle, 
Wasserberg, Germany). This particular grade of material exhibited a higher specific 
surface area and finer particle size than CAGL. The granulation was performed in a 
high-shear mixer/granulator, using water (20%w/w) as the binding liquid. The granules 
were fluid-bed dried to a moisture content of less than 5% w/w and granules outside 
the size fraction 250 -  500pm were removed by sieving. This material was termed 
high-shear mixer/granulated lactose (HSMGL).
3.3.2.2 Methods
500g lots of lactose were placed in the processor and size reduction carried out over a 
30 minute period. Three lots of each material were processed in the vessel at nozzle 
pressures of 70, 140 or 210 kPa, corresponding to gauge readings of approximately 
10, 20 or 30 p.s.i. respectively. These nozzle input air pressures had been previously 
verified using a calibrated pressure transducer.
57
Representative samples of approximately 1.5 g of the powder were obtained from four 
positions in the powder bed using a sampling thief at 0, 60, 120, 180, 240, 300, 450, 
600, 900,1200, 1500 and 1800 seconds after the initialisation of size reduction.
Particle size analyses were performed in triplicate using low angle laser light 
scattering (LALLS) equipment and a dry powder feed technique.
Scanning Electron Microscopy (SEM) was used to obtain images of particles at 
different stages of milling.
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3.3.2.3 Results
Data describing the changes in median particle diameter during milling are presented 




Nozzle air pressure (kPa) 
70 140 210
Mean mass median 
particle diameter (pm)
0 459 459 459
60 401 345 297
120 415 358 227
180 390 287 197
240 330 261 199
300 314 281 182
450 283 211 180
600 272 233 172
900 230 196 163
1200 236 194 157
1500 221 174 160
1800 199 167 157
Table 3.1. Summary of change in mean mass median particle diameter of CAGL with 





Nozzle air pressure (kPa) 
70 140 210
Mean mass median 
particle diameter (pm)
0 373 373 373
60 355 316 245
120 304 251 238
180 317 249 202
240 339 198 164
300 274 188 155
450 297 163 134
600 241 141 131
900 195 121 107
1200 151 118 115
1500 154 115 117
1800 127 109 107
Table 3.2. Summary of change in mean mass median particle diameter of HSMGL 
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Figure 3.5. Graph showing change in particle size distribution of CAGL 
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Figure 3.6. Graph showing change in particle size distribution of HSMGL 
with milling time in FBSVP-A, operating at 30 p.s.I.
(a) unprocessed 
particle.








Figure 3.7. Scanning electron photomicrographs o f CAGL before and after milling.












Figure 3.8. Scanning electron photomicrographs o f HSMGL before and after milling.
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33.2.3 Discussion
The change in size distribution of CAGL when milled over 30 minutes at a nozzle 
pressure of 30 p.s.i was demonstrated (see Figure 3.5). It was shown that after 1 
minute of milling, the modal size of the CAGL was reduced and the material 
exhibited a unimodal particle size distribution. This latter observation was considered 
noteworthy since powders usually display bimodal distributions during the early 
stages of milling; this may therefore have been indicative of a non-standard size 
reduction mechanism or a characteristic of the proprietary material (see below).
The effect of milling time at a nozzle pressure of 210 kPa on the particle size 
distribution of HSMGL is shown in Figure 3.6. The size distribution analysis 
indicated a bimodal character after 1 minute of milling. This was considered a 
classical response profile for the early stages of a milling process.
This evidence was suggested that in the case of CAGL most of the agglomerates were 
reduced to their constituent crystallites within the first minute of milling at 210 kPa 
nozzle pressure. This stage in the milling process when practically all individual 
crystallites had been liberated from their agglomerates was termed the ‘Point of 
Complete Deagglomeration’ (POCD) and was considered to be a key parameter in the 
process under study.
In contrast to CAGL the HSMGL agglomerates appeared to be broken down less 
easily into their constituent crystallites. After a milling time of 1 minute the material 
exhibited a bimodal distribution in which many of the agglomerates were still largely
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intact with a small proportion broken into individual crystallites. The implication was 
that the bonding strengths between crystallites in HGMGL were stronger than those in 
CAGL. This theory was further supported by SEM photomicrographs (Figures 3.7 
and 3.8), which showed a larger proportion o f agglomerates in the HSMGL after 1 
minute o f milling than were present in CAGL.
Figure 3.5 shows a downward trend for the modal size o f  CAGL. However, after 
about 1 minute o f milling, the modal and median sizes were less affected by 
increasing milling time. This suggested that most o f the agglomerates had been 
broken down into their constituent crystals after 1 minute and that any further 
reduction in particle size was due to fragmentation o f the individual crystallites by 
edge abrasion as shown in figure 3.9.
Granule 
Before milling Point Of Complete 
Deagglomeration (POCD)
After further milling
Figure 3.9. Proposed milling mechanism o f CAGL and HSMGL in FBSVP-A 
showing POCD and edge abrasion after further milling.
6 6
This mechanism suggests that fragmentation of the component crystals would lead to 
the formation of a fine particle fraction in the later stages of milling and hence a 
bimodal size distribution. Since there was no evidence in the particle size data to 
suggest that this was the case the phenomenon could be caused by a preferential 
removal of fines from the processor since observation of the apparatus during milling 
indicated that a certain amount of fine material was seen to be entrained in the air 
leaving the cyclone separator.
The effect of reducing the milling nozzle pressure was investigated and as expected 
the rate of milling was reduced with decreasing nozzle pressures for both materials. 
The times taken to reach the POCD for CAGL and HSMGL at different nozzle 
pressures and the median particle diameter of the materials at these times are 








Mean mass median 
particle diameter at 
POCD (pm)
CAGL 210 60 297
HSMGL 210 300 155
CAGL 140 180 287
HSMGL 140 600 141
CAGL 70 300 314
HSMGL 70 1200 151
Table 3.3. Summary of time taken to reach POCD for CAGL and HSMGL at 
different nozzle air pressures in FBSVP-A.
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These milling data indicated that for CAGL, the maximum milling capability of the 
processor was able to mill the material to a median particle diameter of approximately 
160pm. This appeared to have been achieved at nozzle pressures between 140 and 
210 kPa. The maximum milling capability of the apparatus for HSMGL appeared to 
be to a median particle diameter of approximately 110pm. It was speculated that 
altering the milling conditions by increasing the nozzle pressures or by changing the 
geometry of the vessel could have resulted in an increase in the milling capacity as 




HSMGL was used as the major component (90%) and milled sodium chloride crystals 
(Lot No. 40414 40408011, Aldrich Chemical Company Limited, Gillingham, Dorset. 
U.K.) the minor model drug component (10%) of a 500g mass of the binary powder 
mix. Sodium chloride was selected as a model drug to allow conductivimetric 
analysis over a wide concentration range without requiring sample dilutions. The 
mass median particle diameter of the lactose was 373 pm and the sodium chloride was 
hammer-milled to a mass median particle diameter of approximately 30pm as 
measured by LALLS.
This differential in the mass median particle diameter of the two components was 
selected so as to encourage the formation of interactive mixes in which finer particles 
became adhered to the surfaces of coarser ‘carrier’ particles.
3.3.3.2 Methods
The efficiency of the FBSVP-A for mixing two dry powders was compared with two 




Geometric mixing was performed by placing 50g of milled sodium chloride crystals
and 50g of lactose granules into a large mortar and triturating thoroughly by hand for 
5 minutes using a pestle. A further lOOg of lactose was added and similarly mixed, 
followed by a 200g quantity of lactose, which was also mixed for 5 minutes. A final 
quantity of lOOg lactose was added and thoroughly mixed for a further 15 minutes. 
Thus, the total mixing time was 30 minutes.
3.3.3.2.2 Turbulent tumbling mixing
Milled sodium chloride crystals 50g and lactose granules 450g were placed into a two 
litre glass jar and the lid sealed. The jar was then loaded onto a turbulent tumbling 
mixer (Turbula® Mixer, Type T2C, Glen Creston Limited, Stanmore, Middlesex, 
U.K.), which was operated at speed II for 30 minutes.
3.3.3.2.3 FBSVP-A mixing
450g of lactose granules were placed into the FBSVP-A, and 50g of milled sodium 
chloride were gently added. The fluidising fan was turned on at its maximum speed 
providing an air volume throughput of approximately 0.02 m3sec_1; the jet nozzles 
were supplied with air at a pressure of 210 kPa.
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The above conditions were maintained for a period of 30 minutes after which the air 
supplies were terminated and the powder removed from the vessel for sampling and 
analysis.
3.3.3.2.4 Powder sampling
The material obtained from each mixing experiment was emptied onto a clean, flat 
surface with a minimum of agitation so that samples could be taken from the resulting 
powder. Thirty samples of approximately 500mg were taken at random from the 
mixture using a sample thief.
3.3.3.2.5 Model drug assay
500mg samples were placed in a 50ml volumetric flask, and diluted to 50ml using 
freshly deionised water at 25°C. A conductivity meter and cell were calibrated and 
each sample solution assayed for sodium chloride content based on the conductivity of 
the solution. Controls showed that lactose did not affect the conductivity reading.
The homogeneity obtained from each mixing technique was measured by calculating 




Mixing method Mean content %RSD
Manual geometric mixing 





Table 3.4. Mean content and %RSD obtained from each mixing technique.
3.3.3.4 Discussion
As expected, the most efficient mixing of the materials tested was obtained by manual 
geometric mixing, which provided a %RSD of 0.9%. The value of this technique was 
to provide evidence that a homogeneous mixture could be obtained using the materials 
under investigation. The results using manual geometric mixing were considered to 
be a point of reference for other mixing techniques.
Since the method of homogeneity testing was considered to give values that were a 
composite for mixing and segregation, any segregation phenomena that occurred 
during the mixing process were considered to have been taken into account.
It was notable that the results indicated a mean content that was slightly less than the 
theoretical value of 10.0% sodium chloride. This was thought to have occurred 
through agitation of the material causing entrainment of fine particles into the air, 
which were then lost to the external environment since the mixing vessel was not 
enclosed during the mixing process. This preferential loss of fine material from the
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bulk powder was considered to account for the low content assay since this material 
was likely to have been predominantly composed of sodium chloride particles.
The quality of mix obtained by using the turbulent tumbling technique was poor, 
being characterised by a %RSD of 15.2%. This was probably due to a lack of internal 
shear forces being provided by tumbling mixing, particularly between initial fine 
particle agglomerates of sodium chloride. Such forces were considered necessary for 
the formation of an interactive powder mixture in this particulate system (see below).
The effect of a shearing force imparted onto a powder mixture containing two 
components one of which was much finer than the other is shown diagrammatically 
(see Figure 3.10). This figure shows an agglomerate of the fine component, 
surrounded by larger carrier particles. A low shear force was represented as taking the 
energetically easiest route through the powder, which in this case was shown to be 
around the exterior of the carrier particles and the fines agglomerate. A high shear 
force was shown as able to pass between individual particles in the agglomerate and 
hence break it up so that it could be distributed over the carrier surfaces and form an 
interactive mix.
It is suggested that a geometric manual mixing technique imparted large shear forces 
on the powder by the grinding action of the mortar and pestle, causing the more 

















Figure 3.10. Schematic representation o f application o f (a) a low shear force and (b) a
high shear force in ordered mixing.
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Aggregates that were of a similar particle size to the carrier lactose particles were 
postulated to remain intact in the turbulent tumbling technique due to this lack of 
shear, so reducing the homogeneity of the mix.
It was considered that the high shear conditions created by the high pressure air 
nozzles within the FBSVP-A were able to break up the agglomerates during the 
mixing evaluation in a similar fashion to that which would be expected in a bladed 
high-shear mixer.
A value for %RSD of less than 5% is generally considered adequate in most 
pharmaceutical powder mixing processes. The FBSVP-A provided a mixing 
capability characterised by a %RSD of 2.5%. As shown in Table 3.4, this represented 
an improved mixing efficiency over turbulent tumbling mixing. The motion of 
powder within the vessel during its operation was observed to display large regions of 
recirculating flow, which encouraged efficient mixing to occur.
The combination of fluidising air, which was supplied to all of the flat regions of the 
vessel base, with the swirling flow fields generated by the high pressure air nozzles 
ensured that the flow patterns within the vessel attained sufficiently turbulent 
conditions and fluctuating velocities within the powder bed to perform the mixing 
process. The high shear created by the action of the high pressure air nozzles 
facilitated the mixing of a binary powder system consisting of powders of widely 
differing particle sizes, thus enabling the formation of interactive powder mixes.
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3.3.3.5 Conclusion
The prototype FBSVP-A was found to be capable of performing the sub-operations of 
granule size reduction and dry powder mixing. There was also evidence that the 
processor was capable of providing some primary size reduction of materials, 
probably by edge abrasion.
The flow patterns induced in the powder within the FBSVP-A could be readily 
observed and displayed a strong turbulent flow field that was well fluidised. 
Conditions such as these are generally considered to be beneficial in mixing 
operations.
Particle size reduction was found to be rapid for the 500g batch size investigated; the 
speed and extent of granule size reduction was considered to be at least equivalent to 
that which could be attained using conventional techniques of secondary size 
reduction in granulation. It is projected that greater size reduction could be obtained 
by increasing the nozzle pressures.
The mixing achieved within the processor was found to be more homogeneous than 
that achievable with a similar powder system using a conventional low shear mixing 
technique (turbulent tumbling).
The principle of using controllable fluid dynamics to perform multi-task processing of 
powders was demonstrated. The FBSVP-A was thought to offer a system with the
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potential for the batchwise preparation of powders for pharmaceutical use within a 
single vessel.
The arrestment and return to the powder bed of very fine particles from the gas stream 
using a cyclone separator was not as effective as needed and this aspect requires 
further attention; future designs may require the inclusion of a fibrous filter system.
The SVP concept was considered to form the basis for the design of a continuous 
bladeless processor, capable of integration into a closed, automated and controllable 
manufacturing system in which raw materials could be processed without manual 
intervention.
77
4. FLUID BED SVP MODEL B 
DESIGN AND FABRICATION
4.1 Rationale
The preliminary work detailed in Chapter 3 described a number of successful design 
features of the FBSVP-A that made it suitable for certain powder processing 
operations and recognised some design limitations.
One of the major limitations was identified when attempting to use the FBSVP-A for 
wet granulation activities. It became evident that an attempted resolution to this 
problem was likely to encompass a substantial investigation in its own right and it was 
therefore decided not to include such work within the scope of this thesis. 
Consequently it was proposed to investigate the benefits of the technology with 
respect to those procedures for which the FBSVP-A had been demonstrated to be 
potentially effective i.e. the dry processes of particle size reduction and powder 
blending.
One aspect of pharmaceutical technology that has not received significant attention in 
recent years is the development of alternative equipment for the treatment of powders 
for use in inhalation therapy. Much of the processing associated with dry powder 
inhalation products concerns particle size control and efficient dry blending and 
therefore it was intended to develop the FBSVP-A into a modified processor, the
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Fluid Bed SVP Model B (FBSVP-B), with particular emphasis on its application in 
processing powders for inhalation thus encompassing powder blending and particle 
size reduction of active compounds and/or excipient powders.
79
4.2 Modifications to FBSVP-A
4.2.1 Gas -  solids separation
The cyclone/jet pump arrangement utilised in the FBSVP-A was found to be 
inefficient particularly in its application to very fine particles such as those produced 
during size reduction experiments. Cyclone systems are often used in conjunction 
with bag filters in fluid energy mills; however, such a combination could not easily be 
incorporated into the SVP design.
Similar types of equipment found in current pharmaceutical production that utilise 
high-volume airflows, such as fluid bed granulators and driers, are generally fitted 
with bag-house filters.
For these reasons, and particularly since it was the intention to process fine particle 
drug compounds in the processor the vessel was fitted with a bag filtration system as 
described in section 4.3.2 below.
It was expected that a reduction in the pressure build-up within the vessel resulting 
from this modification would reduce leakage of material from the vessel.
4.2.2 Repositioning of nozzles
Since a significant portion of the FBSVP-A base was subject to stagnation of material 
movement during operation of the airflows the positions of the high-pressure air
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nozzles were adjusted in the FBSVP-B. It was found that positioning these nozzles 
closer to the base of the vessel provided a more comprehensive movement of powder 
in the area around the base of the cone and behind the nozzles.
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4.3 Fabrication
4.3.1 Main vessel assembly
A schematic diagram of the FBSVP-B is presented in figure 4.1.
The vessel wall comprised a Perspex® cylinder of 300mm external diameter, 550mm 
height and a wall thickness of 6mm. This was fitted with a stainless steel (Grade 304) 
mesh (John Staniar & Co., Manchester, U.K.) base of 100pm aperture width.
The mesh was supported by a coarser mesh of stainless steel wire (Grade 304) of 
1mm gauge and providing a 10mm aperture width (John Staniar & Co., Manchester, 
U.K.).
A cylindrical Perspex® skirt of 50mm height was fixed to the underneath of the base 
and fitted with an o-ring and four case clasps to enable sealed attachment of the 
fluidising air plenum.
A polyethylene cone of 200mm base diameter and 180mm height was located in the 
centre of the mesh base providing an annular ring of 44mm width through which 

















Figure 4.1. Drawing of FBSVP-B.
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Twelve holes of 7mm diameter were drilled equidistantly around the circumference of 
the vessel wall 30mm from the base. Each hole was fitted with a rubber sealing 
flange into which one of the high-pressure nozzles was seated. The nozzles were 
fabricated from 5mm O.D. brass tubing and were designed with a nozzle outlet 
diameter of 1.0mm. A diagram of the nozzle design is shown in figure 4.2.
23mm
1mm
Figure 4.2. Schematic diagram of nozzle dimensions
The nozzles were positioned in the rubber flanges so that the centre of each nozzle 
outlet was pointing at an angle of 45° below the horizontal. Each nozzle was also 
positioned so that the centre of the nozzle outlet bisected the area between the cone 
and the wall at the height of the nozzle outlet. This approximated to an insertion 
depth of 23mm as indicated in figure 4.2.
A view of the nozzle arrangement is shown in figure 4.3.
Four case clasps were arranged around the circumference, towards the top of the 
vessel and the top face of the vessel wall was fitted with a rubber o-ring of 2.9 mm 
diameter to allow the filter assembly to be secured and sealed.
84
Figure 4.3. Photograph of nozzle arrangement in FBSVP-B.
4.3.2 Filter assembly
An 80 mm high cylindrical Perspex section was fitted with a seal and clasps so as to 
enable attachment to the top of the main vessel. A woven nylon filter containing 
carbon fibre insertions to reduce static build-up (Samuel Hill Ltd., Rochdale, U.K.) 
with an approximate air permeability of 120 1 dm’ min’ was sealed into this section.
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The approximate dimensions of the filter bag are shown in figure 4.4 (six outer tubes: 
d = 80mm, h = 130mm; one central tube: d = 80mm, h = 90mm; overall diameter = 









Figure 4.4. Schematic diagram of filter bag.
4.3.3 High pressure air manifold
The twelve high-pressure nozzles were split into two banks of six. The nozzles in 
each bank were interconnected using 6mm polyethylene fittings and flexible tubing. 
Each bank was then connected using standard brass fittings to a needle valve (Part 
number B-4JNR2-RT, Nupro Company, Ohio, U.S.A.) and pressure gauge (0-160
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p.s.i., Martonair, Birmingham, U.K.) in order to allow the air supply to each bank to 
be independently regulated to a known and reproducible air pressure.
Two compressed air supplies were available which were combined to enable the 
nozzle pressure to be regulated up to a maximum of approximately 35 p.s.i.
4.3.4 Fluidising air fan and plenum
Fluidising air was supplied to the base of the main vessel from a centrifugal fan (Type 
D28 0.75 kW, Robert Stahlschmidt Elektromotorenwerk, 4801 Altenhagen, Germany) 
having the following specification:
Fan diameter: 180 mm
Blade width: 12 mm (blade angle of 20°)
Maximum blade speed: 2800 revolutions per minute
Regulation of the input voltage enabled control of the theoretical flow output from the 
fan between zero and approximately 50 Lsec'1.
The outlet was positioned horizontally and directed through a flexible corrugated 
aluminium duct of 120mm diameter into to the expansion plenum consisting of a 
frusta-conical chamber of 410 mm height so increasing the duct diameter from 120 to 
300mm. This arrangement is shown schematically in figure 4.5. The expansion 












Figure 4.5. Schematic diagram of fan, ducting and expansion plenum.
4.3.5 Anti-static treatment
One phenomenon that had been noted during previous studies had been the propensity 
for material to become adhered to the vessel walls and cone, due to the generation of 
electrostatic charge on the plastics surfaces.
In order to reduce the magnitude of this charge and make it easier to dislodge material 
from affected surfaces all insulating surfaces in product-contact zones were covered 
with an anti-static adhesive tape (12mm width, RS Components Limited, Northants., 
U.K.). The tape reduced electrostatic effects by distributing more evenly any charges 
generated across the tape surface.
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The effect of coating the internal vessel wall with this antistatic tape is shown in 
figure 4.6. In this case one section of the vessel was coated with antistatic tape with 
the remaining part of the vessel wall remaining untreated. The photograph shown in 
figure 4.6 was taken after processing lactose powder in the FBSVP-B for a period of 5 
minutes and then knocking the vessel wall with a rubber mallet. This photograph 
clearly shows that material had cleared to a much greater extent from the treated 
vessel wall than from the untreated portion.
Although the anti-static tape was found to reduce visual acuity through the vessel 
walls it was still sufficiently transparent to allow clear observation of powder 
movements. However, since the tape was cellulose based, it was not possible to clean 
down the vessel with water between experiments and therefore cleaning of powder 
residues from the vessel after use was performed by brushing and vacuum extraction.
Whilst it was recognised that such cleaning procedures would be unacceptable in a 
pharmaceutical production application it was envisaged that any production vessel 
would be constructed from earthed stainless steel, thus allowing electrostatic charges 
to be discharged to earth.
The interaction of the anti-static tape with water was found to cause a gradual 
degradation of the tape over several weeks, due to the ambient humidity of the 
laboratory. This resulted in some detachment of the tape from the surface leading to 




Area treated with 
antistatic tape
Figure 4.6. Photograph of side view of FBSVP-B showing untreated area and area 
treated with antistatic tape following operation of vessel containing lactose powder.
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4.4 Air flow determination
4.4.1 High-pressure nozzles
The air output flows from the high-pressure nozzles could be varied using needle 
valves the effects of which could be monitored on in-line pressure gauges. Whilst 
these gauges could be used to monitor the pressure within the air manifold the 
pressure readings did not give an indication of the velocity of the air at the nozzle exit. 
In order to measure the actual air output velocities it was necessary to measure the 
pressure drop immediately across the nozzle exits; this was undertaken as explained 
below by the use of a pitot tube.
A mercury U-tube manometer (Department of Mechanical Engineering, University of 
Bath, Bath, U.K.) was attached to a pitot tube and the opening of the pitot tube was 
directed in opposition to the air stream as close to the nozzle opening as possible 
without blocking the flow. The head height of mercury was recorded for each nozzle 
at a series of gauge pressures and air velocities were calculated by application of 
Bernoulli’s equation:
pt = ps + iP aiy  [Equation 4.1]
where Pt is the gauge pressure in Nm'2; Ps is atmospheric pressure in Nm’2; p air is 
the density of air in kgm'3; v is air velocity in msec'1.
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Calculation o f  atmospheric pressure.
Atmospheric pressure was measured using a mercury barometer (Department of 
Mechanical Engineering, University of Bath, Bath, U.K.), which provided an 
atmospheric pressure value in mmHg. This reading was converted to Nm' using the 
following equation:
Ps = P HgShbaro [Equation 4.2]
where Ps = atmospheric pressure (Nm’2); Pjjg  = density of mercury ( -  13560 kgm'3 
at 15°C); g  = gravitational acceleration (= 9.81 ms'2); ^  0 = head height of 
mercury in barometer (mHg).
Calculation o f density o f air.
The ambient temperature was measured using a calibrated mercury in glass 
thermometer. The density of air at ambient temperature and pressure was calculated 
for each set of experiments using the equation of state:
PsV = mRT [Equation 4.3]
where V = volume of air in m3; m = mass of air in kg; R = gas constant for air (= 
287 J/kgK); T = temperature (K).
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p  •
Since m  = - -y r , where p  ^  = density of air (kgm'3),
P
p  . = —— [Equation 4.41r air
Calculation ofgauge pressure o f each nozzle.
The values for gauge pressure obtained using the mercury manometer were converted 
from mmHg to Nm'2 using the following equation:
Pt = P tt gh  [Equation 4.5]1 H g° man
where Pt = gauge pressure (Nm'2); l^man = head height of mercury manometer 
(mHg).
Calculation o f air velocity.
The velocity of air exiting each nozzle was calculated using Bernoulli’s equation:




v = - —-—  [Equation 4.7]
\  2 ^  air
A summary of the air velocities at each nozzle pressure setting is shown in table 4.1.
Nominal nozzle pressure









1 69.5 8.2 120.7 6.6 149.0 2.1
2 78.9 4.5 120.7 4.3 148.0 6.1
3 82.7 0.8 116.5 6.4 146.8 1.5
4 83.1 4.5 116.5 4.6 145.6 1.1
5 79.3 1.2 99.7 15.6 127.9 3.1
6 82.9 5.1 77.3 2.4 130.6 15.2
7 80.5 3.3 85.1 23.5 116.5 3.8
8 76.0 2.0 97.2 3.4 132.0 0.9
9 81.6 3.9 98.7 1.2 134.7 4.2
10 76.9 3.5 96.5 3.6 134.2 0.9
11 80.0 1.0 133.6 2.0 144.9 2.3





Table 4.1. Summary of measured air velocities of each nozzle at different nominal
nozzle ring air pressures.
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4.4.2 Fluidising air
The flow rate of the fluidising air was measured by attaching a rotameter (Dept, of 
Mechanical Engineering, University of Bath, Bath, U.K.) to the output from the top of 
the vessel. The maximum flow rate of the fan (i.e. voltage output set at maximum) 
was measured at 0.02 m3sec‘1.
4.5 Computational Fluid Dynamics
Following the initial design investigations, and having identified the need to redesign 
the processor, it was considered advantageous to facilitate design development by 
using computer aided design engineering techniques.
Computational Fluid Dynamics (CFD) technology for modelling air flow fields and 
particle movements was exploited to project the air velocity profile of vessel designs 
during a range of operational conditions and also to predict likely effects of changes 
to the vessel geometry, design and operating parameters prior to undertaking any 
fabrication and testing.
The first stage in utilising the CFD technology was to prepare a model of an existing 
processor configuration and compare the modelling predictions with observed 
experimental results.
4.5.1 Introduction to CFD
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Only a brief description of the mechanics of CFD is given since more general texts are 
able to provide greater detail (e.g. Versteeg and Malalasekera, 1995).
The use of CFD is now widespread in engineering design where systems involving 
fluid flows are being developed. Applications of the technique include investigation 
of aerodynamics of aircraft and automobiles, internal combustion engines and mixing 
processes. CFD has recently been used in the modelling of human and in vitro lung 
systems for the development of medical aerosol technology and to predict the air 
flows obtained during actuation of pressurised metered dose inhalers (Versteeg et al., 
2000). In this latter study good agreement was found between the CFD predictions 
and observations using advanced image visualisation techniques.
CFD can offer a number of advantages to a design process:
(a) reduced number of prototypes and design cycles
(b) simulation of flow conditions that are difficult to study experimentally
(c) provision of comprehensive data throughout the flow domain with respect to
gas only, gas-solid and gas-solid-liquid interactions.
CFD software codes are structured in order to process the numerical algorithms that 
describe fluid flow. The codes are used to solve the partial-differential equations for 
conservation of mass, momentum, energy and species concentration. A CFD code 
generally contains three elements: a pre-processor, a solver and a post-processor.
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The pre-processor allows input of the various parameters involved within the flow 
system under investigation. The first input requirements are a definition of the region 
of interest (or computational domain) and its sub-division into a mesh (or grid) of 
non-overlapping cells. The physical and chemical phenomena (e.g. velocity) that are 
to be modelled are then selected and the physical properties of the fluid system 
defined (e.g. density, viscosity). The final requirement is to establish the specification 
for the boundary conditions at cells that coincide with or touch the domain boundary 
(e.g. solid surface, porous surface).
Each cell within a CFD model contains a cell-centred node at which the solutions of 
given flow parameters are calculated. The accuracy of a CFD model depends on the 
number of cells in the mesh, i.e. the fineness of the mesh. Meshes are often non- 
uniform in cell size such that areas of large variations in fluid activity are subject to 
grid refinement.
The solver uses various numerical solution techniques to express the mathematical 
models (e.g. turbulence models) or equations (e.g. Navier-Stokes equation) used to 
describe the flow processes. One of these techniques is termed the finite volume 
method, which is the process used to perform the modelling in this study. This 
method considers each cell as a finite volume and solves the governing equations of 
conservation for each cell using iterative processes.
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A post-processor is used to present and manipulate the solved data. Some of the data 
visualisation tools that have been employed in this study include domain geometry, 
grid display, vector plots and particle tracking.
The simplest CFD models are constructed in two dimensions, however the emergence 
of powerful microprocessors has allowed CFD to provide three-dimensional analysis 
of fluid flow problems, which are more useful for the application described in this 
thesis. It is possible to construct CFD models that predict gas flows only (single­
phase), gas flows containing solid particles (two-phase) and gas flows containing 
solid and liquid elements (three-phase models).
4.5.2 The computational model
A comprehensive description of the CFD model, including the governing equations 
used, is outside the scope of this thesis, but can be found in related publications 
(MacGregor et al., 1999); a summary is provided below.
Single-phase models were initially constructed, which provided predictive 
information pertaining to the fluid (i.e. air only) flows within the domain. These were 
then developed into more complicated two-phase models in order to predict the 
movement of powder particles within the processor under different operating 
conditions. The construction of three-phase models was considered to be outside the 
scope of the current work but the model was constructed such that it could be readily 
expanded into three phase models if this became desirable in future work in order to 
model the effects of the addition of liquids (e.g. granulating fluids) to the processor.
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In their introductory text to CFD, Versteeg and Malalasekera (1995) state that ‘...the 
results generated by a CFD code are at best as good as the physics (and chemistry) 
embedded in it and at worst as good as its operator’. Although CFD has been used 
widely in industries such as aerospace, its use in pharmaceutical equipment design 
had met with limited success to date. This may be attributable more to a lack of the 
specialist knowledge and skills required to operate the technique in this sector than to 
a limitation of the technique itself. For this reason an understanding of the technique 
and verification of its use in modelling the operation of a powder processor design 
through comparison with practical observations was undertaken.
An investigation was undertaken to utilise information that had been gathered in the 
initial phase of the current work. The FBSVP-B was used as a starting point for the 
application and for verification of CFD simulation.
The computational model was set up using Star-CD-v3000 (Computational Dynamics 
Limited, London, UK), which is a finite volume based commercial CFD package.
The following simplifications were assumed for the computational model of the SVP 
in order to make most efficient use of the processing capabilities available:
(a) The vessel outlet was constructed in the model as a simple circular opening of 
45mm diameter rather than attempting to model a cyclone system or bag filter.
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(b) The mesh base was characterised using a baffle feature incorporated in the 
CFD software, which represented the mesh as a porous material across which there 
would be a pressure drop as fluid flowed through.
(c) The high-pressure air nozzles were cylindrical, which made them difficult to 
model and therefore rectangular bodies were used to approximate nozzles with 
roughly the same cross-sectional area.
Since the main vessel was essentially axisymmetrical, only one twelfth of the cylinder 
was generated in the computational grid (see figure 4.7). The most complex parts of 
the model were at the base, where the tangential nozzles and mesh were located. The 
computational grid was made finer in these areas to facilitate the geometry generation 
and computing convergence. A local refinement to the grid was made at the top of the 




Figure 4.7. CFD computational mesh for o f  FBSVP-B.
Models with 2600, 4000 and 8000 cells were tested and the model with 4000 cells 
chosen as the final computational model since it represented a compromise between 
computing time and convergence.
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Single-phase models were constructed in which only the flow of air was investigated. 
The flow of a mixture of air and solid powder (i.e. two-phase model) was also 
modelled. The air was programmed as a continuous phase and the powder particles as 
a disperse phase. The modelling strategy was based on the Lagrangian/Eulerian kind, 
in which the fluid governing equations for the air phase were solved in the Eulerian 
co-ordinate system and the particle phase was modelled in Lagrangian co-ordinate 
systems that move with individual particles.
4.5.3 CFD model verification
A single phase CFD simulation was constructed as described above to predict the air 
velocities that would develop at different heights in the FBSVP-B when operated at a 
nozzle outlet velocity of 3msec'1 and a fluidising air velocity of 0.3msec'1.
The velocity magnitudes and fluid flow directions predicted from this simulation are 
shown in figure 4.8 below. Figure 4.9 shows the height position that is represented by 
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Figure 4.7. Example of CFD model of FBSVP-B simulating for single phase flows. 
Model shows l / 12 cross-sections of vessel in the plan view at different heights 
corresponding to locations (a), (b), (c) and (d) as shown in figure 4.8.
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Nozzle position
SVP Uadel U Ki in Single-phaaeTurbulence Flaw 
N azzlee jec lian  angle=0 1a ih e lan gen l, velaci1y=3m.'a
Figure 4.8. Cross-sectional heights corresponding to single phase flow regimes 
shown in CFD model o f FBSVP-B shown in figure 4.7.
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These predictions compared well with the powder movement observed during 
operation of the FBSVP-B. It was found that the fluid flows developed during 
FBSVP-B operation caused collection of powder residue in areas of low velocity after 
processing lactose in the vessel.
A photograph of a typical deposition pattern of lactose powder after a period of vessel 








Figure 4.9. Photograph of typical pattern of powder deposition following processing
of lactose granules in FBSVP-B.
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The deposition pattern showed that dead zones had developed near to the base of the 
vessel wall, near to the base of the cone and directly behind the nozzle outlets. A 
comparison of figure 4.7 with figure 4.9 indicates that the observed dead zones 
apparent in figure 4.9 coincided with the zones of lowest velocity predicted by the 
CFD simulation in figure 4.7 (a) and (b).
The photograph presented in figure 4.10 shows the flow of lactose powder during 
operation of FBSVP-B under typical conditions (see section 5.1.2). Powder was 
found to rotate as a cloud mass and areas of low and high powder density were found 




Figure 4.10. Photograph of flow patterns of lactose powder generated during
operation of FBSVP-B.
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If it had been possible to show the overhead view of the vessel contents it would have 
been demonstrable that there was a significant flow field close to the vessel wall in the 
region between the nozzle array and the middle of the vessel height, in the area 
indicated by the label ‘CAGL plumes’ on figure 4.10. Referral to segments (c) and
(d) of figure 4.7 indicated that the CFD simulation predicted similar flow fields in 
these areas.
4.5.4 Conclusion
The apparent agreement of the simulations with observed fluid flows in FBSVP-B 
gave verification of the ability of the CFD model to predict fluid flows in this 
application.
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5. FLUID BED SVP MODEL B 
CHARACTERISATION
5.1 Particle size reduction
5.1.1 FBSVP-B set up
Any powder residue was cleared from the inside surfaces of the vessel using a 
combination of dry wiping and vacuum extraction until visibly clean. The filter bag 
was washed in warm water until visibly clean, rinsed with deionised water and dried 
in an oven. It was allowed to cool before re-attachment to the filter assembly.
The vessel was assembled and the clips attaching the fluidising plenum and the filter 
assembly to the main vessel secured. The fluidising fan was set at maximum output 
and the nozzle pressure set to the appropriate value using the needle valves and 
making reference to the pressure gauges. The system was manually inspected for 
leaks before being loaded with test material.
5.1.2 Experimental conditions
The test material in all particle size reduction experiments was Prismalac 40® lactose 
(see Section 2.1.2), which was loaded in 500g quantities into the processor and spread
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over the mesh base using a spatula to give an approximately constant bed height 
across the base.
Ambient environmental temperature and relative humidity conditions were monitored 
during all testing and recorded, but not controlled.
The flow fields arising during processing were visually monitored and any dead spots 
or other unusual occurrences recorded.
The efficiency of the FBSVP-B for particle size reduction of the test material was 
investigated for the following processing parameters:
Nozzle ring Nozzle air Fluidising air flow




Table 5.1. FBSVP-B processing parameters for particle size reduction testing.
Three batches of test material were processed at each nozzle pressure setting and 
processing halted to allow samples to be taken for particle size analysis at the 
following processing times:
0, 30, 60, 120, 180, 240, 300, 450, 600, 900, 1200, 1500 and 1800 seconds
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Sampling necessitated removal of the filter bag assembly (see section 5.1.3 below). 
After each set of samples had been taken from the processor, the filter assembly was 
replaced and shaken to allow adhered material to fall back into the bulk powder bed. 
The walls of the processor were then knocked with a rubber mallet to allow material 
adhering to the internal surfaces of the processor to return to the powder bed.
5.1.3 Sampling
Four samples of approximately 1.5g were removed from prescribed positions (see 
figure 5.1) in the powder bed at each time point using a sample thief, the design of 
which is described below. The four samples from each time point were pooled into a 
25ml screw-top glass vial and analysed in triplicate for particle size distribution as 






X = Sampling position
Figure 5.1. Schematic representation o f sampling positions used for particle size 
analysis o f lactose granules during particle size reduction testing.
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A sample thief was designed with a flat bottom since the powder bed being sampled 
was too shallow to allow for the tapered end normally associated with commercially 
available sample thief designs.
The sample thief comprised a hollow, cylindrical, aluminium outer sheath of internal 
diameter 15mm and a cylindrical, stainless steel inner core of external diameter 
14mm. A circular hole of 10mm diameter was made in the inner core with its centre 
15mm from the base of the cylinder. The outer sheath was placed over the inner core 
and a hole of 10mm diameter was cut into the sheath. This hole was at such a height 
that when the sheath was turned to the ‘open’ position it coincided with the hole in the 
inner core so enabling a sample to be collected in the thief. The sheath was returned 
to the ‘closed’ position to retain a sample in the thief. A retaining bolt connected the 
sheath to the inner core and allowed movement of the sheath to the ‘open’ or ‘shut’ 
position.
This arrangement allowed collection of samples of approximately 3cm , 
corresponding to sample weights of approximately 1.5g.
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5.1.4 Results
Expt. No. Run 1 Run 2 Run 3 Mean SD
Milling time Mass median
(seconds) particle diameter (pm)
0 468 454 458 460 7.1
30 243 296 234 258 34.0
60 243 234 239 239 4.7
120 196 194 193 194 1.4
180 181 196 196 191 8.5
240 188 168 180 179 10.0
300 173 156 173 167 9.9
450 168 162 173 168 5.6
600 172 156 167 165 8.0
900 160 144 164 156 10.3
1200 155 138 129 141 13.6
1500 149 141 155 148 6.8
1800 173 126 155 151 23.7
Table 5.2. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in FBSVP-B at nozzle pressure of 140 kPa.
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5.1.5 Discussion
The following changes were effected in the design of FBSVP-B in order to overcome 
shortcomings identified during the operation of FBSVP-A:
(a) Replacement of the cyclone separator with a filter bag
This change was initiated in order firstly to reduce the backpressure within the vessel 
brought about by the high flow resistance characteristics of the cyclone separator 
system and secondly to reduce the quantity of fines lost from the vessel due to the 
inefficiency of the cyclone system.
The high backpressure encountered in the FBSVP-A caused increased loss of fines 
due to leakage and reduced fluidisation within the powder bed.
In addition the filter was expected to provide improved arrestment of fine particles 
which could then be returned to the powder bed rather than lost from the vessel.
(b) Lowering of the high pressure air nozzle ring assembly
This modification was expected to improve powder movement at the vessel base so 
leading to a greater proportion of the powder being introduced to the zones of high 
activity located close to the outlets of the high pressure air nozzles.
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In addition, it was expected that any effects of milling through collision of particles 
with the vessel base would be increased.
(c) Application of antistatic tape to the vessel walls
It was expected that the use of antistatic tape would reduce the quantity of powder 
adhering to the wall surfaces so improving visual acuity and allowing more powder to 
remain in circulation within the powder bed.
In summary, if the above changes were effective then it would have been expected to 
observe the following functional benefits:
(i) Reduced loss of fines
(ii) Improved fluidised bed movement
(iii) Improved visual acuity
(iv) Improved overall milling efficiency
A comparison of the particle size reduction observed in FBSVP-B compared to that 







Mean Mass Median 
Particle Diameter (\im)
0 459 460 N/A
30 Not done 258 N/A
60 345 239 -106
120 358 194 -164
180 287 191 -96
240 261 179 -82
300 281 167 -114
450 211 168 -43
600 233 165 -68
900 196 156 -40
1200 194 141 -53
1500 174 148 -26
1800 167 151 -16
Table 5.3. Comparison of mean mass median particle diameters measured at different 
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Graph 5.1. Graph showing comparison of mean mass median particle diameters 
measured at different processing times during milling of CAGL in FBSVP-A and
FBSVP-B.
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It can be seen from these data that:
(a) In the FBSVP-A, particle size was reduced to 75% of its original size within 
60 seconds and to 57% of its original size within 240 seconds
(b) In the FBSVP-B, particle size was reduced to 56% of its original size within 
30 seconds and to 52% of its original size within 60 seconds.
(c) Most of the particle size reduction is occurring within the early stages of 
milling in both vessels. A plateau in size reduction is reached where size reduction 
has progressed to 90% of its final level after 900 seconds in FBSVP-A and at between 
240 and 300 seconds in FBSVP-B.
(d) The maximum particle size reduction achieved in the FBSVP-A was a 
reduction in median particle diameter to 167pm compared to 141pm in the FBSVP-B.
In addition the following observations were made:
(e) A decrease in the amount of fine material leaving the vessel was observed. 
Fine material was found to have collected in the filter bag which was easily returned 
to the vessel by shaking.
(f) Considerably less material was observed to escape due to leakage into the 
atmosphere surrounding the vessel.
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(g) Fluidisation of the powder bed was increased leading to an improvement in 
powder movement around the base area. However, some dead zones were observed 
in the locations predicted by CFD simulations (see section 4.5.3).
Consideration of the above information set against the expected benefits is discussed 
below:
(i) Reduced loss of fines
Visual observation of a reduction in the loss of fines was further supported by a 
reduction in the median particle diameter recorded at each mixing interval when 
operating the FBSVP-B compared to FBSVP-A under identical processing conditions.
(ii) Improved powder bed movement
Overall bed movement would appear to have improved significantly on the basis that 
the time to reach steady state is reduced from a nominal 900 seconds in FBSVP-A to 
around 300 seconds in FBSVP-B.
In addition the median particle size has decreased indicating some beneficial changes 
in the overall size reduction capability of the vessel possibly as a result of an increase 
of the residence time of material in the highly energetic regions close to the nozzle 
outlets.
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However, further improvements in bed movement are needed to eliminate all areas of 
the vessel displaying low or nil powder movement (dead areas).
(iii) Improved visual acuity
The expected benefits afforded by the application of antistatic tape were achieved as 
illustrated in figure 4.4.
(iv) Improved overall mixing efficiency
Ihe data would indicate that particle size reduction was more rapid and progressed to 
a greater extent in the FBSVP-B compared to the FBSVP-A. This is thought to be as 
a result of increasing the milling efficiency by moving the nozzles closer to the vessel 
base and by reducing the loss of fine material from the processor.
However, in both vessel designs the overall particle size reduction mechanism may 
be attributed mainly to deaggregation of agglomerates rather than to milling of the 
primary crystals (see section 3.3.2.4). For useful application in particle size reduction 
of excipient ingredients of DPI formulations greater milling efficiency may be 
required.
5.1.6 Conclusions
The new design of vessel provided the following improvements:
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(a) Reduced loss of fines
(b) Improved arrestment of fines
(c) Improved powder bed movement
(d) Enhanced visual acuity
However, the milling performance of the FBSVP-B was unsatisfactory since the
particle size reduction was not seen to proceed much beyond the deaggregation of the 
basic granular material.
Additionally, areas of low powder movement were present in the vessel despite the 
design modifications made.
These problems are addressed in section 6.
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5.2 Blend content uniformity of a dry powder inhaler formulation processed in 
FBSVP-B
5.2.1 Experimental conditions
The FBSVP-B was set up as described in section 5.1.1. The nozzle air pressure was 
set at 70 kPa in order to minimise any particle size reduction effects; the fluidising air 
was set at 0.2 msec'1. SorboLac 400 lactose (60g) was introduced into the vessel and 
the powder bed levelled. Nedocromil sodium trihydrate (40g) was placed evenly on 
top of the lactose and the layer levelled off across the base.
Five batches of the nedocromil formulation were manufactured using identical 
processing conditions. Processing was interrupted after the following mixing times:
30, 60, 120, 300, 600 and 1200 seconds
Samples were removed from the powder bed at each mixing time as described in 
section 5.2.2 below after allowing time for fine powders to settle and removal of the 
filter assembly.
After removing each set of samples, the filter assembly was shaken and the vessel 







Figure 5.2. Schematic representation o f sampling positions for in-vitro aerosol 
characterisation and content uniformity testing o f nedocromil sodium trihydrate
blends processed in FBSVP-B.
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At each sampling time, five samples (A, B, C, D and E) of approximately lg were 
removed using a sampling spoon from prescribed positions in the powder bed as 
shown in figure 5.3. Samples were collected and placed into 25ml screw top glass 
vials that were hermetically sealed and labelled appropriately.
Samples A, B and C were taken from positions approximately equidistant from the 
vessel wall and central cone. Sample A was taken from the top, sample B from the 
middle and sample C from the bottom of the powder bed. Samples D and E were 
taken from the middle of the powder bed with sample D taken from a position close to 
the vessel wall and sample E taken from close to the wall of the cone. These latter 
samples (D and E) were deliberately selected from areas in the processor that were 
predicted by the CFD work to exhibit least disturbance from the airflows during 
processing (see section 4.7).
The vials containing the samples were placed into a controlled humidity environment 
within 30 minutes of processing as described in section 2.2.3.
Two sub-samples of 20 ± 0.5mg were removed from each of samples A to E and 
tested for content assay as described in section 2.6. The remainder of each sample 
was reserved for in-vitro aerosol characterisation (see section 5.3).
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5.2.3 Results
Results from the five mixing experiments are shown in tables 5.2 to 5.6 below and a 





30 60 120 300 600 1200
Nedocromil sodium tri hydrate content %w/w)
A1 40.9 43.5 36.6 40.6 37.9 37.8
A2 39.2 38.3 36.7 38.7 37.4 39.4
B1 43.9 36.1 39.1 38.0 38.9 38.8
B2 64.9 40.0 36.0 37.1 38.1 39.0
C1 33.4 40.3 38.9 36.8 40.4 38.8
C2 25.2 40.8 40.1 39.0 40.8 37.7
D1 41.7 39.3 40.2 49.7 41.9 39.1
D2 42.2 40.5 40.2 51.5 40.6 39.6
E1 12.8 20.9 25.6 33.0 34.8 39.0
E2 15.7 12.0 25.6 31.9 30.9 30.3
Mean (A-E) 36.0 35.2 35.9 39.6 38.2 38.0
RSD (A-E) 42.2 29.1 15.8 16.1 8.6 7.2
Mean (A-C) 41.3 39.8 37.9 38.4 38.9 38.6
RSD (A-C) 32.3 6.2 4.4 3.7 3.6 1.7
Table 5.2. Content uniformity data from processing nedocromil sodium trihydrate 





30 60 120 300 600 1200
Nedocromil sodium tri hydrate content %w/w)
A1 49.0 46.8 43.7 36.4 36.9 36.2
A2 42.5 47.5 41.2 37.9 39.8 35.8
B1 50.1 44.7 42.7 38.9 37.6 36.7
B2 54.2 43.7 45.0 38.7 37.6 36.9
C1 34.7 34.9 42.5 39.1 35.5 37.2
C2 27.3 33.2 43.8 38.6 36.3 36.9
D1 46.3 43.6 40.9 37.1 36.9 36.3
D2 47.6 44.3 39.8 40.8 37.2 35.7
E1 19.3 19.9 28.9 36.6 39.3 36.7
E2 20.9 34.0 29.4 34.0 38.0 37.1
Mean (A-E) 39.2 39.3 39.8 37.8 37.5 36.6
RSD (A-E) 32.5 22.0 14.6 5.0 3.5 1.5
Mean (A-C) 43.0 41.8 43.2 38.2 37.3 36.6
RSD (A-C) 23.9 14.8 3.0 2.6 3.9 1.5
Table 5.3. Content uniformity data from processing nedocromil sodium trihydrate 





30 60 120 300 600 1200
Nedocromil sodium tri lydrate content %w/w)
A1 47.1 48.4 43.2 41.6 41.3 41.8
A2 44.4 44.6 43.2 40.6 40.4 42.3
B1 29.3 40.6 46.3 41.4 40.8 40.9
B2 36.0 41.2 44.8 41.3 42.4 39.3
C1 47.8 44.5 42.5 43.1 40.5 43.0
C2 49.9 42.9 43.6 42.7 40.0 40.2
D1 48.1 44.1 43.2 42.2 39.4 38.1
D2 49.8 45.7 42.8 42.9 38.5 40.9
E1 6.1 5.2 34.4 13.9 26.2 34.1
E2 9.6 30.9 38.4 23.9 17.7 31.7
Mean (A-E) 36.8 38.8 42.2 37.4 36.7 39.2
RSD (A-E) 45.2 32.7 8.1 26.9 22.0 9.4
Mean (A-C) 42.4 43.7 43.9 41.8 40.9 41.3
RSD (A-C) 19.0 6.5 3.1 2.3 2.1 3.3
Table 5.4. Content uniformity data from processing nedocromil sodium trihydrate 





30 60 120 300 600 1200
Nedocromil sodium tri hydrate content %w/w)
A1 44.8 44.8 43.1 40.8 43.8 39.0
A2 45.3 44.8 43.6 41.1 39.5 39.6
B1 46.7 42.3 42.6 39.5 39.0 35.8
B2 40.3 40.9 42.5 40.1 40.2 35.5
C1 27.5 41.7 43.5 44.1 41.6 36.7
C2 27.5 43.5 44.2 44.0 42.4 35.7
D1 42.3 39.0 39.2 44.2 39.0 36.0
D2 42.4 40.0 37.2 40.6 41.3 34.7
E1 48.8 47.0 46.8 43.9 40.6 38.3
E2 47.1 46.5 45.0 45.3 42.2 38.5
Mean (A-E) 41.3 43.1 42.8 42.4 41.0 37.0
RSD (A-E) 18.6 6.3 6.5 5.0 3.9 4.7
Mean (A-C) 38.7 43.0 43.2 41.6 41.1 37.1
RSD (A-C) 23.0 3.8 1.5 4.7 4.5 4.9
Table 5.5. Content uniformity data from processing nedocromil sodium trihydrate 





30 60 120 300 600 1200
Nedocromil sodium tri hydrate content %w/w)
A1 43.4 42.6 41.1 37.6 38.1 38.8
A2 44.0 43.9 42.6 36.9 37.2 36.3
B1 24.5 37.8 40.9 40.9 38.5 38.0
B2 32.4 32.8 41.8 40.2 37.2 36.8
C1 47.9 46.5 41.9 39.0 38.6 38.0
C2 46.7 45.2 42.4 38.5 38.5 38.0
D1 43.1 40.4 44.6 40.9 36.4 43.7
D2 44.1 40.0 41.7 40.4 37.5 39.2
E1 49.4 27.5 42.4 18.4 40.9 37.8
E2 50.1 30.3 45.8 22.4 41.4 38.9
Mean (A-E) 42.6 38.7 42.5 35.5 38.5 38.6
RSD (A-E) 18.9 16.8 3.6 22.9 4.1 5.3
Mean (A-C) 39.8 41.5 41.8 38.8 38.0 37.6
RSD (A-C) 23.4 12.6 1.6 4.0 1.7 2.4
Table 5.6. Content uniformity data from processing nedocromil sodium trihydrate 
formulation in FBSVP-B, experiment #5
129
Processing time (seconds)
Experiment 30_____ 60 120 300 600 1200
number________ % Relative standard deviation (n=10)
#1 42.2 29.1 15.8 16.1 8.6 7.2
#2 32.5 22.0 14.6 5.0 3.5 1.5
#3 45.2 32.7 8.1 26.9 22.0 9.4
#4 18.6 6.3 6.5 5.0 3.9 4.7
#5 18.9 16.8 3.6 22.9 4.1 5.3
Table 5.7. Summary of percent relative standard deviation of content uniformity 
samples taken from positions A, B, C, D and E at different processing times during 
blending of nedocromil sodium trihydrate formulation in FBSVP-B.
Processing time (seconds)
Experiment 30 60 120 300 600 1200
number % Relative standard deviation
#1 32.3 6.2 4.4 3.7 3.6 1.7
#2 23.9 14.8 3.0 2.6 3.9 1.5
#3 19.0 6.5 3.1 2.3 2.1 3.3
#4 23.0 3.8 1.5 4.7 4.5 4.9
#5 23.4 12.6 1.6 4.0 1.7 2.4
Table 5.8. Summary of percent relative standard deviation of content uniformity 
samples taken from positions A, B and C only at different processing times during 
blending of nedocromil sodium trihydrate formulation in FBSVP-B.
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5.2.4 Discussion
The mean drug content was in the range 35 - 45%w/w, close to the nominal drug 
content of 40%w/w, at each time point in all experiments. Furthermore the mean drug 
content was not found to change significantly during the processing period. Since the 
drug particles were approximately one third the size of the lactose, the results suggest 
that there was no significant preferential loss of fines from the vessel over time, as 
had been experienced in previous SVP designs (see section 3.3.3.4).
Overall blend uniformity, indicated by %RSD, was generally reasonable but poor in 
those areas of the vessel that had been predicted to have poor flow characteristics 
using CFD simulations (see section 4.5.3). If the data from those samples taken from 
areas of predicted poor flow were discounted, the calculated %RSD was found to be 
<5% after 2 minutes mixing in all cases, thus falling marginally within commercially 
acceptable levels.
There was no evidence of demixing occurring as mixing times were extended up to a 
period of 20 minutes, indicating a robust mixing process that would lend itself well to 
commercial validation
5.2.5 Conclusions
The homogeneity of the nedocromil sodium formulation processed in the FBSVP-B 
was found to attain acceptable levels in samples taken from areas where high air flows 
were predicted in the CFD simulation of the FBSVP-B and poor in samples taken
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from areas of predicted low flow. This gave confidence that the CFD simulations 
gave valid predictions that could be applied to future vessel designs.
A mixing time of approximately 2 minutes was sufficient to achieve homogeneity in 
areas of good powder movement and an extension of this time to periods of up to 20 
minutes did not adversely affect the mixing quality.
Redesign of the vessel should be undertaken in order to address the problem of poor 
distribution of air flows throughout the vessel.
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5.3 Functionality of a dry powder inhaler formulation processed in FBSVP-B
5.3.1 Experimental conditions and sampling
The samples collected at each time point during blend content uniformity tests 
(section 5.2) were also characterised for their functionality in terms of delivery of 
potentially respirable fine particle doses from the samples when loaded into a 
proprietary DPI device. Two sub-samples of 20 ± 0.5mg from each of the vials 
containing the samples taken from positions A, B and C were filled into size 3 gelatin 
capsules. These locations were selected (in preference to locations D or E) since they 
were expected to be more representative of the bulk properties of the powder blend 
within the free-moving parts of the powder bed. The capsules were treated as 
described in section 2.5.
5.3.2 Results
Results from in-vitro aerosol impingement testing of the above samples are presented 
in tables 5.9 to 5.13. A summary table of the %FPF values obtained throughout these 
experiments is given in table 5.14. Overall mean results are presented in graph 5.2.
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Processing time (seconds)
Sample 30 60 120
num ber C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S 1 S 2 Rec DD FPF
A1 0.7 3.4 1.9 73.3 5.2 35.7 2.1 3.4 2.5 99.5 5.8 42.2 1.8 3.0 2.7 92.1 5.6 47.2
A2 1.4 3.2 1.7 79.0 4.9 35.2 2.8 3.6 2.6 111.5 6.1 41.8 1.6 3.2 2.7 92.8 5.9 45.7
B1 2.8 3.7 2.6 113.9 6.4 41.5 2.0 2.9 2.6 93.5 5.5 46.6 1.6 3.4 2.7 96.7 6.1 44.7
B2 2.9 3.9 2.4 115.1 6.3 38.1 2.7 3.4 2.6 107.3 5.9 43.1 1.8 2.8 2.8 91.8 5.5 50.1
C l 2.1 3.7 1.6 91.8 5.3 30.3 2.2 3.0 2.6 97.6 5.6 46.0 1.6 3.2 2.7 93.0 5.9 45.8
C2 1.3 3.6 1.5 79.4 5.1 29.5 2.2 3.1 2.6 97.8 5.7 45.3 1.7 2.9 2.8 91.6 5.6 49.0
M ean 1.9 3.6 1.9 92.1 5.5 35.1 2.3 3.2 2.5 101.2 5.8 44.2 1.7 3.1 2.7 93.0 5.8 47.1
SD 0.9 0.3 0.5 18.4 0.6 4.6 0.3 0.2 0.0 6.8 0.2 2.1 0.1 0.2 0.1 1.9 0.2 2.1
RSD 47.7 7.4 23.6 19.9 11.6 13.0 14.2 7.5 1.7 6.7 3.9 4.7 6.1 7.5 1.9 2.0 3.7 4.4
Processing time (seconds)
Sample 300 600 1200
num ber C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.5 3.7 2.3 93.0 5.9 38.1 1.7 3.1 2.5 91.2 5.6 44.4 1.4 4.0 2.1 93.7 6.1 34.8
A2 1.9 3.2 2.4 95.0 5.7 42.8 1.3 3.2 2.3 85.4 5.5 41.7 1.4 3.8 2.3 94.3 6.1 37.6
B1 2.6 2.1 2.2 85.6 4.3 50.7 1.4 3.7 2.2 91.2 5.9 37.1 1.5 4.0 2.1 94.0 6.1 34.4
B2 2.3 2.4 2.5 89.1 4.9 51.2 2.3 3.4 2.2 97.4 5.5 39.0 1.8 3.6 1.9 91.2 5.5 34.8
C l 1.5 3.2 2.2 85.1 5.4 41.1 1.5 4.0 2.0 92.6 5.9 33.0 1.5 4.0 2.0 93.1 5.9 33.3
C2 1.7 2.8 2.4 86.1 5.2 45.7 1.9 3.5 2.1 94.9 5.7 37.6 1.7 3.7 2.1 93.0 5.8 36.6
Mean 1.9 2.9 2.3 89.0 5.2 44.9 1.7 3.5 2.2 92.1 5.7 38.8 1.5 3.8 2.1 93.2 5.9 35.2
SD 0.5 0.6 0.1 4.2 0.6 5.3 0.4 0.3 0.2 4.1 0.2 3.9 0.2 0.2 0.1 1.1 0.2 1.6
RSD 23.7 20.1 5.9 4.7 11.4 11.7 21.0 9.3 7.9 4.4 3.2 10.2 10.3 4.5 6.5 1.2 4.1 4.5
_________________ Kev__________________
C+D Dose recovered in capsule and device
S 1 Dose recovered in stage 1
S 2 Dose recovered in stage 2
Rec Percent total recovery / nominal recovery
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 5.9. In-vitro functionality data from TSI testing o f  samples obtained during
processing o f  nedocromil sodium trihydrate formulation in FBSVP-B, experiment #1.
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Processing time (seconds)
Sample 30 60 120
num ber C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S 1 S 2 Rec DD FPF
A1 2.1 3.9 2.0 100.0 6.0 34.3 2.5 4.1 2.6 114.8 6.7 39.0 2.1 3.5 2.6 103.3 6.2 42.6
A2 2.8 4.2 2.4 116.8 6.6 35.9 2.0 3.9 2.9 110.4 6.8 42.1 3.9 2.3 2.0 103.2 4.4 46.4
B1 2.7 5.0 2.1 122.7 7.1 29.4 2.6 3.7 2.9 113.6 6.5 44.0 3.0 2.9 2.5 104.6 5.4 45.7
B2 3.5 4.2 2.0 122.2 6.3 32.6 1.3 3.4 2.9 94.6 6.3 45.3 2.2 2.8 2.4 92.0 5.2 45.7
C l 0.9 2.3 1.3 55.1 3.5 35.5 1.8 2.9 2.3 86.4 5.2 44.3 3.2 2.5 2.6 103.2 5.1 50.8
C2 1.4 3.7 1.9 87.7 5.6 33.7 1.1 2.2 1.9 65.0 4.1 46.8 2.3 3.5 2.6 105.4 6.1 43.3
M ean 2.2 3.9 1.9 100.7 5.8 33.6 1.9 3.4 2.6 97.5 5.9 43.6 2.8 2.9 2.4 102.0 5.4 45.8
SD 1.0 0.9 0,4 26.3 1.2 2.4 0.6 0.7 0.4 19.6 1.1 2.7 0.7 0.5 0.2 5.0 0.7 2.9
RSD 43.5 23.3 19.1 26.1 21.3 7.1 31.6 21.6 15.5 20.1 18.4 6.2 25.3 16.8 9.7 4.9 12.7 6.3
Processing time (seconds)
Sample 300 600 1200
num ber C+D S 1 S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 2.8 2.6 1.9 91.0 4.5 43.0 1.9 2.8 2.5 89.5 5.3 46.9 2.2 2.2 2.6 86.7 4.8 53.6
A2 2.2 2.9 2.2 91.1 5.1 43.2 2.7 2.1 2.8 95.2 4.9 57.3 1.7 2.4 2.7 84.5 5.0 52.9
B1 2.1 3.5 2.3 99.9 5.9 40.1 1.9 2.5 2.8 89.1 5.3 52.2 1.9 2.6 2.6 89.0 5.3 49.9
B2 3.0 2.8 2.4 101.0 5.1 46.3 1.9 2.5 2.6 87.6 5.1 51.4 1.9 3.1 2.1 88.3 5.2 40.0
C l 2.2 2.6 2.6 91.0 5.1 50.0 2.2 2.3 3.0 93.7 5.4 56.8 1.8 2.6 2.6 86.0 5.1 50.0
C2 2.7 2.7 2.3 95.0 5.0 46.0 1.9 2.7 2.2 86.4 5.0 45.1 2.2 2.4 2.2 84.8 4.6 47.0
Mean 2.5 2.8 2.3 94.8 5.1 44.8 2.1 2.5 2.7 90.3 5.2 51.6 1.9 2.6 2.4 86.5 5.0 48.9
SD 0.4 0.4 0.2 4.6 0.4 3.4 0.3 0.3 0.3 3.5 0.2 5.0 0.2 0.3 0.3 1.8 0.3 4.9
RSD 14.3 12.6 9.0 4.9 8.4 7.7 15.6 10.5 10.4 3.9 3.5 9.6 10.5 12.3 10.3 2.1 5.3 10.1
 ____________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF  Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 5.10. In-vitro functionality data from TSI testing o f  samples obtained during
processing o f  nedocromil sodium trihydrate formulation in FBSVP-B, experiment #2.
135
Processing time (seconds)
Sample 30 60 120
num ber C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 2.0 3.7 2.5 102.5 6.2 40.0 2.2 3.9 2.9 112.3 6.8 42.8 2.3 3.2 2.8 104.0 6.0 47.1
A2 2.1 3.8 2.8 108.8 6.6 42.3 2.4 4.1 2.9 117.4 7.0 41.4 2.3 4.0 3.0 116.4 7.0 43.1
B1 0.7 1.7 1.4 47.3 3.1 45.4 0.7 1.8 1.0 44.0 2.9 36.4 2.3 3.3 3.0 107.3 6.2 47.2
B2 1.1 2.7 1.6 67.8 4.3 37.6 1.5 3.7 1.9 88.9 5.6 33.8 2.0 3.4 3.1 106.1 6.5 47.5
C l 2.6 4.0 2.9 119.7 7.0 42.2 2.0 3.4 3.1 106.8 6.5 47.8 2.5 3.3 2.7 106.1 6.0 44.5
C2 2.5 4.7 3.0 127.9 7.7 39.3 2.1 3.0 2.9 100.1 5.9 49.1 2.6 3.4 2.6 107.3 6.0 43.8
M ean 1.8 3.4 2.4 95.7 5.8 41.1 1.8 3.3 2.5 94.9 5.8 41.9 2.3 3.4 2.9 107.9 6.3 45.5
SD 0.8 1.1 0.7 31.5 1.7 2.8 0.7 0.8 0.8 26.8 1.5 6.1 0.2 0.3 0.2 4.4 0.4 1.9
RSD 42.3 31.0 29.4 32.9 30.1 6.7 35.6 25.0 33.1 28.3 26.3 14.5 8.9 8.4 6.6 4.0 6.5 4.2
Processing time (seconds)
Sample 300 600 1200
num ber C+D S I S 2 Rec DD FPF C+D S 1 S 2 Rec DD FPF C+D S 1 S 2 Rec DD FPF
A1 2.2 3.5 2.5 102.2 6.0 41.6 2.1 3.1 2.5 95.2 5.5 44.4 2.0 3.9 2.3 102.0 6.1 36.6
A2 2.3 3.7 2.6 107.1 6.3 41.7 2.2 3.3 2.7 102.5 6.0 45.4 2.9 3.1 2.3 102.9 5.4 41.7
B1 1.8 3.3 2.5 94.8 5.8 42.5 2.6 3.0 2.6 102.4 5.6 46.6 2.5 2.8 2.4 97.2 5.3 46.4
B2 1.9 3.9 2.5 103.2 6.4 39.2 3.1 2.8 2.3 102.5 5.1 45.9 2.2 3.3 2.3 97.2 5.6 40.8
C l 2.4 3.4 2.7 106.7 6.2 44.2 1.9 3.0 2.5 91.8 5.5 45.3 2.2 3.6 2.5 103.8 6.1 40.5
C2 2.3 3.2 2.4 98.3 5.6 42.3 2.0 3.3 2.4 95.4 5.6 41.6 2.0 3.5 2.8 102.0 6.2 44.4
M ean 2.2 3.5 2.5 102.1 6.0 41.9 2.3 3.1 2.5 98.3 5.6 44.9 2.3 3.4 2.4 100.8 5.8 41.8
SD 0.2 0.2 0.1 4.8 0.3 1.6 0.5 0.2 0.2 4.7 0.3 1.8 0.3 0.4 0.2 2.9 0.4 3.4
RSD 11.4 6.7 5.1 4.7 5.0 3.9 19.9 6.4 6.0 4.8 5.1 3.9 14.6 11.2 8.3 2.9 7.3 8.1
    Ke> . _
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD S tandard deviation 
RSD Relative standard deviation
Table 5.11. In-vitro functionality data from TSI testing o f  samples obtained during
processing o f  nedocromil sodium trihydrate formulation in FBSVP-B, experiment #3.
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Processing time (seconds)
Sample 30 60 120
num ber C+D S I S 2 Rec DD FPF C+D S 1 S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.9 4.2 2.6 108.4 6.7 37.9 2.3 3.6 2.8 108.9 6.4 43.4 2.7 3.2 2.4 104.0 5.7 43.2
A2 2.1 4.9 2.1 113.0 7.0 30.4 2.2 3.7 2.5 104.4 6.2 40.4 2.2 3.7 2.4 103.4 6.1 39.7
B1 1.6 3.6 2.0 89.3 5.5 35.4 2.9 3.7 2.1 109.4 5.9 36.5 1.4 3.4 2.2 87.7 5.6 40.0
B2 2.4 3.6 2.1 100.7 5.7 36.3 1.8 3.5 2.4 97.0 5.9 41.0 2.3 3.3 2.8 104.5 6.0 45.9
C l 0.6 1.9 1.0 43.8 2.9 35.8 1.8 3.7 2.5 99.2 6.2 40.1 2.3 4.0 2.4 109.6 6.5 37.7
C2 1.1 1.7 1.1 47.6 2.8 39.5 1.9 3.6 2.5 99.9 6.1 40.5 2.0 4.0 2.2 102.9 6.2 35.2
Mean 1.6 3.3 1.8 83.8 5.1 35.9 2.1 3.6 2.5 103.1 6.1 40.3 2.1 3.6 2.4 102.0 6.0 40.3
SD 0.7 1.3 0.6 30.6 1.8 3.1 0.4 0.1 0.2 5.2 0.2 2.2 0.4 0.4 0.2 7.4 0.3 3.8
RSD 41.8 38.6 33.7 36.5 36.2 8.6 19.1 2.2 8.3 5.1 3.2 5.5 19.4 10.2 8.6 7.3 5.5 9.5
Processing time (seconds)
Sample 300 600 1200
num ber C+D S I S 2 Rec DD FPF C+D S 1 S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 2.1 3.4 2.5 99.4 5.9 42.2 2.0 3.4 2.4 98.1 5.8 41.4 1.5 3.6 2.6 95.6 6.2 42.0
A2 1.8 3.7 2.3 96.8 5.9 38.3 2.1 3.1 2.6 98.2 5.7 45.2 1.5 3.3 2.6 93.0 5.9 43.8
B1 1.9 3.5 2.4 97.2 5.9 40.5 1.8 3.8 2.3 99.0 6.1 38.4 1.6 2.7 2.4 83.8 5.1 47.3
B2 1.8 3.3 2.6 95.7 5.9 43.5 1.7 3.6 2.2 93.1 5.8 38.2 1.4 2.5 2.9 84.2 5.4 53.3
C l 2.7 3.6 2.4 108.9 6.0 39.5 3.0 2.6 2.0 95.3 4.6 43.5 1.5 2.8 2.6 86.1 5.4 48.1
C2 2.2 3.6 2.4 103.0 6.0 40.1 2.6 3.2 2.3 101.8 5.5 41.7 1.9 2.4 2.6 85.3 4.9 51.6
Mean 2.1 3.5 2.4 100.2 5.9 40.7 2.2 3.3 2.3 97.6 5.6 41.4 1.6 2.9 2.6 88.0 5.5 47.7
SD 0.4 0.1 0.1 5.0 0.1 1.9 0.5 0.4 0.2 3.0 0.5 2.7 0.2 0.5 0.1 5.0 0.5 4.3
RSD 16.9 3.8 4.1 5.0 1.0 4.6 22.4 12.1 8.5 3.1 9.1 6.6 11.0 16.3 5.4 5.7 8.6 9.1
_________________ JKcn__________________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 5.12. In-vitro functionality data from TSI testing o f  samples obtained during
processing o f  nedocromil sodium trihydrate formulation in FBSVP-B, experiment #4.
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Processing time (seconds)
Sample 30 60 120
num ber C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.8 4.3 2.1 103.2 6.5 32.7 2.2 4.2 2.5 110.8 6.7 37.6 1.9 3.8 2.1 98.2 6.0 35.9
A2 1.7 5.0 1.7 105.7 6.8 25.3 2.1 4.6 2.7 116.9 7.3 37.3 2.4 3.6 1.9 98.2 5.5 34.9
B1 0.5 2.0 1.0 42.6 3.0 33.3 0.6 2.4 0.9 49.6 3.4 27.7 2.1 3.9 2.2 102.8 6.1 36.1
B2 1.0 3.0 1.7 70.8 4.7 35.4 0.5 2.2 0.9 44.2 3.1 27.6 2.3 3.3 2.2 97.8 5.5 39.7
C l 2.3 4.3 2.1 109.2 6.4 33.2 2.4 5.6 2.3 128.8 7.9 29.4 1.6 4.0 1.9 93.3 5.9 31.8
C2 2.2 4.6 2.0 110.2 6.6 30.7 2.1 5.3 2.4 122.8 7.7 31.1 1.7 4.4 2.3 104.2 6.7 34.2
M ean 1.6 3.9 1.8 90.3 5.6 31.8 1.6 4.1 2.0 95.5 6.0 31.8 2.0 3.8 2.1 99.1 5.9 35.4
SD 0.7 1.2 0.4 27.6 1.5 3.5 0.9 1.4 0.8 38.2 2.2 4.6 0.3 0.4 0.2 3.9 0.4 2.6
RSD 45.3 29.8 24.7 30.6 27.1 11.0 52.5 35.3 42.8 40.0 36.7 14.4 17.2 9.6 7.9 3.9 7.4 7.4
Processing time (seconds)
Sample 300 600 1200
num ber C+D S 1 S 2 Rec DD FPF C+D S 1 S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 2.3 3.2 2.2 95.8 5.4 40.6 2.1 3.1 2.1 90.5 5.2 40.1 1.9 2.8 2.5 90.5 5.3 46.3
A2 2.0 3.4 2.2 94.7 5.6 39.6 1.8 3.1 2.6 93.4 5.7 46.3 1.9 3.1 2.5 93.1 5.6 44.3
B1 2.4 3.1 2.0 94.3 5.1 39.1 1.7 3.0 2.4 88.3 5.4 44.1 1.9 2.8 2.5 90.4 5.3 47.1
B2 2.3 3.3 2.3 98.4 5.6 41.2 3.2 2.3 1.9 92.7 4.2 45.8 2.0 2.9 2.3 89.6 5.2 44.9
C l 2.2 3.7 2.2 102.0 5.9 37.6 1.8 3.2 2.5 93.0 5.6 43.8 1.8 3.0 2.7 94.1 5.7 47.8
C2 2.1 3.0 2.3 92.8 5.3 43.0 2.0 3.0 2.6 95.3 5.6 46.6 1.9 3.1 2.4 93.2 5.6 43.8
Mean 2.2 3.3 2.2 96.3 5.5 40.2 2.1 2.9 2.3 92.2 5.3 44.5 1.9 3.0 2.5 91.8 5.4 45.7
SD 0.1 0.2 0.1 3.4 0.3 1.8 0.6 0.3 0.3 2.5 0.6 2.4 0.1 0.1 0.1 1.9 0.2 1.6
RSD 5.9 7.2 4.6 3.5 5.0 4.6 27.4 11.3 12.6 2.7 10.9 5.4 2.8 4.6 5.3 2.0 3.6 3.6
_____________  Key_____________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard  deviation
Table 5.13. In-vitro functionality data from TSI testing o f  samples obtained during
processing o f  nedocromil sodium trihydrate formulation in FBSVP-B, experiment #5.
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Expt. Sample 30
Processing time (seconds) 
60 120 300 600 1200
no. position Percent fine particle fraction
Expt #1 A1 35.7 42.2 47.2 38.1 44.4 34.8
Expt #1 A2 35.2 41.8 45.7 42.8 41.7 37.6
Expt #1 B1 41.5 46.6 44.7 50.7 37.1 34.4
Expt #1 B2 38.1 43.1 50.1 51.2 39.0 34.8
Expt #1 C1 30.3 46.0 45.8 41.1 33.0 33.3
Expt #1 C2 29.5 45.3 49.0 45.7 37.6 36.6
Expt #2 A1 34.3 39.0 42.6 43.0 46.9 53.6
Expt #2 A2 35.9 42.1 46.4 43.2 57.3 52.9
Expt #2 B1 29.4 44.0 45.7 40.1 52.2 49.9
Expt #2 B2 32.6 45.3 45.7 46.3 51.4 40.0
Expt #2 C1 35.5 44.3 50.8 50.0 56.8 50.0
Expt #2 C2 33.7 46.8 43.3 46.0 45.1 47.0
Expt #3 A1 40.0 42.8 47.1 41.6 44.4 36.6
Expt #3 A2 42.3 41.4 43.1 41.7 45.4 41.7
Expt #3 B1 45.4 36.4 47.2 42.5 46.6 46.4
Expt #3 B2 37.6 33.8 47.5 39.2 45.9 40.8
Expt #3 C1 42.2 47.8 44.5 44.2 45.3 40.5
Expt #3 C2 39.3 49.1 43.8 42.3 41.6 44.4
Expt #4 A1 37.9 43.4 43.2 42.2 41.4 42.0
Expt #4 A2 30.4 40.4 39.7 38.3 45.2 43.8
Expt #4 B1 35.4 36.5 40.0 40.5 38.4 47.3
Expt #4 B2 36.3 41.0 45.9 43.5 38.2 53.3
Expt #4 C1 35.8 40.1 37.7 39.5 43.5 48.1
Expt #4 C2 39.5 40.5 35.2 40.1 41.7 51.6
Expt #5 A1 32.7 37.6 35.9 40.6 40.1 46.3
Expt #5 A2 25.3 37.3 34.9 39.6 46.3 44.3
Expt #5 B1 33.3 27.7 36.1 39.1 44.1 47.1
Expt #5 B2 35.4 27.6 39.7 41.2 45.8 44.9
Expt #5 C1 33.2 29.4 31.8 37.6 43.8 47.8
Expt #5 C2 30.7 31.1 34.2 43.0 46.6 43.8
Mean 35.5 40.4 42.8 42.5 44.2 43.9
SD 4.5 5.8 5.1 3.6 5.4 6.0
RSD 12.6 14.4 12.0 8.4 12.2 13.6
Table 5.14. Summary o f percent fine particle fraction determined for samples 
obtained during processing o f nedocromil sodium trihydrate formulation in FBSVP-B,
experiments #1 to #5.
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Processing Time (seconds)
Graph 5.2. Graph showing mean %FPF results from five batches o f the nedocromil 
sodium trihydrate DPI formulation at different processing times in FBSVP-B.
5.3.3 Discussion
As shown in graph 5.2, mean %FPF was found to stabilise after 120 seconds of 
processing time and was not found to change significantly during a processing time o f  
20 minutes.
However, considerable variability was found between experiments. Whilst some of 
this variability may be attributed to the inherent variability o f in-vitro aerosol
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impingement testing, a significant contributor to this can be attributed to the lack of 
consistent flow conditions throughout the processor, which were seen to cause 
problems in the milling and mixing studies (see sections 5.1 and 5.2 respectively).
5.3.4 Conclusion
The high shear conditions generated in the FBSVP-B appeared well suited to 
processing the nedocromil sodium DPI formulation although the presence of areas of 
low airflow velocity has again caused problems with reproducibility of the process.
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6. SWEPT BED SVP DESIGN AND 
FABRICATION
6.1 Rationale
Although the FBSVP-B design demonstrated considerable promise in providing a 
processing environment suitable for manufacture of nedocromil sodium trihydrate 
blends for dry powder inhalation, a number of design flaws were also evident which 
were analysed and further considered in chapters 4 and 5.
As a result of this assessment further vessel refinements were engineered in order to 
address the main constraints of the FBSVP-B. Particular consideration was paid to 
the elimination of dead zones in the vessel, which are described in chapter 5. The 
strategy for this redesign was to provide high volumes of fluidising air movement that 
were directed in a more controlled manner in order to prevent areas of low velocity 
from developing within the processing area.
CFD technology was used as a predictive tool for investigating a number of design 
alternatives prior to fabrication of the new processor. The refinements that were 
developed and applied are considered below.
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6.2 Design background
It was considered that the presence of dead zones within a powder bed undergoing 
processing in the FBSVP-B may be avoided by either increasing significantly the 
volume of fluidising air or by more carefully predicting and controlling the airflow 
directions.
It was likely that increasing airflow and consequently raising air pressure within the 
vessel would make particle arrestment from air leaving the vessel more difficult and 
also exacerbate problems of powder leakage from the vessel. Additionally, it was 
anticipated that an increasing air input volume would result in less powder being 
present in the zone of high activity associated with the high pressure air nozzles in the 
bottom part of the vessel, which in turn was likely to reduce the efficiency of the 
processing operations. Because of this it was not considered desirable to increase the 
air input volume but to modify the air input characteristics and consider alternative 
vessel designs. The basis of these redesigns was directed at targeting the high volume 
(fluidising) air in a more controlled fashion using CFD simulations as an adjunct in 
this design.
It was decided to retain the basic geometry of the vessel with a central cone positioned 
at the base of the cylindrical main vessel but replace the mesh base with a solid base 
and use high volume air inputs directed from the side close to the solid vessel base in 
order to ‘sweep’ away powder gathered on the base.
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This method of introducing air for mass powder movement was termed a ‘swept bed’ 
system and the new processor was referred to as the Swept Bed Single Vessel 
Processor (SBSVP). The design of the SBSVP is shown in figures 6.1 and 6.2 and 
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The SBSVP was constructed from a series of modules so that design modifications 
could be incorporated into the structure without major reconstruction of the processor. 
These modules were the air plenum, the base plate, the high pressure air nozzles, the 
low pressure air nozzles, the vessel walls and the filter assembly. Each of these is 
described below.
6.3.2 Air plenum
The air plenum sub-assembly comprised the following modular components as shown 
in figure 6.3:
Air plenum base plate 
Nozzle plates (four)
Air plenum top plate 

















Figure 6.3. Drawing showing SBSVP air plenum components.
Each o f these parts was fabricated from aluminium and when assembled together 
formed the air plenum, which contained the low and high pressure air nozzles and 
ducting for their air supplies. The air plenum was closed at the bottom by the air 
plenum base plate and at the top with a flanged ring (the air plenum top plate), which 
allowed attachment o f the cylindrical vessel wall.
The high volume air nozzle ring, three interchangeable high pressure air nozzle rings 
(see below) and the air plenum outer ring were positioned in-between the top and the 
base plates and the assembled module held together with sixteen 8mm stainless steel
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bolts. The high pressure air nozzle rings were designed such that each interlocked and 
could be stacked on top of each other on either face and in any order.
The total height of the assembled air plenum was 65mm above the vessel base.
The air plenum was affixed to a stand and connected to the compressed air supplies 
using standard fittings. The high pressure air nozzles and the high volume air nozzles 
were provided with compressed air from separate supplies. A pressure gauge and 
needle valve were placed into each compressed air line to allow the airflow rate to be 
controlled. The air flow to each set of nozzles was switched on and off using in-line 
solenoid valves of an appropriate rating. During operation, the high volume air 
supply was introduced by gradually opening the needle valve over approximately 2 
seconds to avoid over pressurising the vessel. The high pressure air supply was 
introduced immediately at the correct pressure.
A cone was milled from a solid block of aluminium and the surface polished. The 
dimensions were as follows: height 180mm; base diameter 208mm; slope 60° from 
horizontal. A cylindrical stub on the base of the cone having a diameter of 50mm and 
height of 15mm allowed the cone to rest in the centre of the base plate where it was 
held in position under its own mass. This arrangement provided an annular track of 
40mm width between the base of the cone and the side of the air plenum.
6.3.2.1 High pressure air nozzles
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One o f the three high pressure air nozzle rings was fitted with a series o f 24 slots in 
each o f which a high pressure air nozzle could be inserted. The slots allowed the 
nozzles to be inserted tangentially around the circumference o f the nozzle ring as 
shown in figure 6.4 with each nozzle having a circular opening o f 1 .Omm diameter. It 
was possible to mount the ring in alternative positions giving a clockwise or an anti­




Figure 6.4. Plan view drawing o f high pressure nozzle ring showing 4 o f 24 nozzles
only.
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The height of the centre of each nozzle ring when assembled into the air plenum 
module (and hence the height of the centre of any nozzles in that ring) is shown in 
table 6.1 below.
151
Nozzle Approximate height of centre of




Table 6.1. Approximate height of high pressure air nozzles above vessel base.
6.3.2.2 Flat (high volume) air nozzles
The fluidised mesh base used in FBSVP-A and FBSVP-B was replaced with a solid 
base and a further nozzle ring was fitted with eight flat slots of 2.0mm height and 
70mm circumference as shown in figure 6.5. When positioned in the air plenum this 
formed eight flat nozzles, which enabled high volumes of air to sweep the vessel base. 
This nozzle ring was designed so that it could be located in one position only so 
causing air to be directed clockwise.
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Figure 6.5. Plan view drawing of flat (high volume) nozzle ring.
The optimal angle of the flat (high volume) air nozzles was determined by performing 
single phase velocity simulations using the CFD software. This software allowed a 
study of the predicted flow patterns for three alternative nozzle angles; 0°, 15° and 30° 
to the tangent of the nozzle ring. A schematic diagram of the model input to the CFD 
software is shown in figure 6.6. The vessel was modelled as a one eighth segment to 
reduce computational complexity.
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Figure 6.6. Schematic diagram o f model used for CFD predictions.
The results o f this study are shown in figures 6.7, 6.8 and 6.9.
Figure 6.7 shows the flow simulation for a nozzle angle o f 0° to the tangent. The 
model predicted an area o f low velocity close to the cone which could potentially lead 
to a dead zone in the vessel.
The simulation for a nozzle angle o f 15° is shown in figure 6.8. This indicated a good 
distribution o f airflow across the vessel base with a main flow channel in the middle 
of the annulus. A small region of low velocity was indicated near to the cone.
With the nozzle angle set to 30°, as shown in figure 6.9, the model predicted that all o f  
the base powder was activated to flow. However, it was also predicted that a large 
proportion o f the airflow would impinge on the cone surface, which could lead to a 
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Figure 6.6. Single phase CFD flow simulation model of SBSVP with flat nozzles at 
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Figure 6.8. Single phase CFD flow simulation model of SBSVP with flat nozzles at 
30° from the tangent and nozzle air outlet velocity set at 2msec'1.
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As a result of the above considerations it was deduced that the flow conditions 
predicted for a nozzle angle of 15 degrees would be optimal for this system and 
consequently this was implemented into the vessel design.
6.3.3 Vessel walls
The vessel walls were constructed from cylindrical Perspex® pipe of 300mm external 
diameter and 6mm wall thickness. Three sections of wall were fabricated having 
heights of 150mm, 300mm and 600mm. The top and bottom edges of each section 
were machined with a groove to enable them to be seated onto the air plenum. It was 
also possible to interlock the different sections making available the following range 
of vessel wall heights: 150mm, 300mm, 450mm, 600mm, 750mm, 900mm and 
1050mm.
A further section of Perspex® was cut to a length of 100mm and a wooden clamping 
ring firmly attached to its circumference (see figure 6.2); the clamping section was 
placed on top of the wall section(s) during assembly of the vessel. Four case clasps 
were affixed to the top of the clamping section to allow attachment of the filter 
assembly.
All internal Perspex® wall surfaces were coated with an antistatic tape in a similar 
manner to that described for FBSVP-B in section 4.3.5.
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Four 8mm threaded clamping rods of 1.5m length were attached to the air plenum as 
shown in figure 6.2. These were inserted through holes in the clamping ring, four 
springs of suitable size placed onto each rod and nuts tightened over each until 
sufficient tension was held in the springs to ensure that all sections of the vessel wall 
were fixed in place and sealed with the top of the air plenum.
6.3.4 Filter assembly
The filter assembly was that used in FBSVP-B. This is described in detail in section 
4.3.2.
6.3.5 Airflow determination for high pressure air nozzles
The velocity of the airflow leaving the high pressure air nozzles was measured by 
using the technique described in section 4.3.1.
The velocity profile of the nozzles was measured for the following nominal air 
pressures measured in the air plenum:
70,140, 210, 280 and 350 kPa
A summary of the air velocities at each air plenum pressure setting is shown in table 
6.1. These are also summarised in graphical form and a regression analysis of the 
data presented in graph 6.1.
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Nominal nozzle pressure


















1 56.0 2.9 76.7 3.2 91.5 6.4 102.5 3.5 140.1 7.3
2 37.7 2.9 56.5 3.2 68.5 5.2 101.7 17.8 151.7 1.6
3 33.7 7.1 47.1 6.2 55.9 3.8 79.4 4.1 145.3 4.7
4 41.3 6.4 89.2 3.3 122.7
CD'
id 152.1 3.1 147.4 4.0
5 25.0 1.3 35.8 1.6 45.3 5.8 56.6 2.5 64.4 4.0
6 44.4 5.1 57.5 3.3 85.0 13.2 91.4 4.2 106.3 2.8
7 56.2 1.7 70.4 2.1 96.0 5.2 116.1 3.1 150.0 3.1
8 81.6 0.5 111.4 7.9 154.5 3.3 152.3 3.5 154.1 4.0
9 27.7 1.5 64.5 2.5 83.3 2.6 106.5 5.7 102.4 9.0
10 88.2 2.9 110.0 11.5 150.2 5.2 158.1 3.6 162.3 7.2
11 61.1 5.9 88.8 4.6 108.9 13.0 124.7 4.2 140.0 3.8
12 33.0 8.7 57.6 4.5 69.5 0.9 84.2 1.8 113.1 8.8
13 20.8 3.2 37.7 8.1 62.4 7.3 94.9 17.4 129.1 13.7
14 57.3 7.1 84.5 2.3 119.9 10.7 151.4 2.6 150.4 5.9
15 89.4 6.6 115.9 9.0 150.2 3.8 154.1 5.2 149.4 4.4
16 90.1 2.2 115.1 8.5 150.7 3.4 154.3 5.1 154.8 4.3
17 91.5 0.8 111.9 30.0 153.7 5.7 156.4 4.5 156.8 4.2
18 55.9 2.2 73.5 4.9 100.7 8.3 116.1 5.3 131.2 2.0
19 48.9 1.5 71.5 3.0 73.2 24.7 111.3 2.4 140.4 8.1
20 46.0 1.3 71.5 6.2 83.6 3.8 100.5 3.2 108.6 4.2
21 36.2 1.5 74.6 8.9 86.9 4.4 112.5 12.2 144.2 3.8
22 36.9 1.5 54.3 3.2 84.4 9.8 100.9 4.2 114.9 0.7
23 43.2 0.6 61.1 15.5 83.7 6.6 115.7 3.4 129.7 4.8
24 52.1 3.1 73.9 1.5 120.3 19.5 151.5 6.5 145.2 6.4
Approx.
overall 52 22 75 24 100 33 119 29 135 23
mean
Table 6.1. Summary of measured air velocities of each nozzle at different 
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Graph 6.1. Graph showing mean air velocities at each nominal air plenum pressure in 
SBSVP and regression information for a linear fit o f the data.
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6.4 Summary of changes in vessel design of SBSVP compared to FBSVP-B
(a) Number of high pressure air nozzles increased from 12 to 24
(b) Three variable height positions for the high pressure air nozzles
(c) Fluidised air flow replaced with flat swept bed air nozzles
(d) Mesh base replaced with a solid base
(e) Vessel fabricated in a modular design to allow variation of individual parts
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7. SWEPT BED SVP 
CHARACTERISATION
7.1 Rationale
Characterisation of the SBSVP was undertaken using similar analytical concepts to 
those used in the development of FBSVP-A and FBSVP-B and consequently much of 
the work described in this section is related closely to the studies reported in chapter 
5.
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7.2 Particle size reduction
7.2.1 Introduction
The aim of this study was to assess the particle size reduction performance of the 
SBSVP.
The work was conducted in three groups of experiments. The first group compared 
the performance of the SBSVP with that of the FBSVP models A and B in effecting 
particle size reduction using the same types of materials under similar processing 
conditions. In these experiments the SBSVP was operated with both the high pressure 
air nozzles and the high volume air nozzles engaged in a clockwise direction; this 
configuration was designated co-current flow.
The second group of experiments studied the effect of reversing the direction of the 
high pressure nozzles such that they were in opposition to the direction of flow of the 
high volume air nozzles; this arrangement was termed counter-current flow. The 
effect of differing nozzle air velocities within this vessel configuration was also 
investigated.
The final group of experiments varied the height of the high pressure air nozzle ring in 
the air plenum at a single nozzle air pressure and also examined the effects of co­
current and counter-current flow of the high pressure and high volume air nozzle 
inputs at the different heights.
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7.2.2 The effect of changes in high pressure nozzle air velocity on particle size 
reduction characteristics of SBSVP compared to FBSVP-A and FBSVP-B
7.2.2.1 SBSVP set up
The vessel was cleaned as described for the FBSVP-B (see section 5.1.1).
The air plenum was assembled with the high volume nozzles directed clockwise and 
the high pressure nozzles directed clockwise and positioned in the middle of the three 
possible locations (see section 6.3.2).
The 300mm and 150mm sections of vessel wall were attached to the air plenum 
followed by the clamping section and the filter assembly. The appropriate clasps and 
clamps were secured as described in section 6.3.3.
The high pressure air was set to the appropriate flow rate adjusting the needle valve 
with reference to the pressure gauge. The high volume air was set at a flow rate of
o i
25.5 m hr' . The system was manually inspected for leaks before loading of the test 
material.
1 2 2 2  Experimental conditions
Using the linear regression formula from graph 5.1, it was possible to extrapolate an 
approximate plenum pressure that would provide equivalent nozzle air velocities to
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those tested when investigating particle size reduction in the FBSVP-B (see section 
5.1).
The air plenum set pressures and corresponding nozzle air velocity values are shown 
in table 7.1 below.
FBSVP-B SBSVP
Nozzle ring air Approx. mean Air plenum Approx. mean
pressure nozzle air set pressure nozzle air
(kPa) velocity (msec-1) (kPa) velocity (msec'1)
70 78 140 75
140 107 245 105
210 138 350 135
Table 7.1. Table showing set pressures required in SBSVP air plenum to provide 
approximately equivalent nozzle outlet air velocities to those used during FBSVP-A 
and FBSVP-B particle size reduction experiments.
It was therefore concluded that particle size reduction experiments should be carried 
out at air plenum set pressures of 140, 245 and350 kPa.
The test material in all particle size reduction experiments was Prismalac 40® lactose 
(see Section 2.1.2), which was loaded in quantities of 500g. The material was spread 
around the base of the vessel using a spatula in order to ensure a constant bed height 
over the annular section.
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Ambient environmental temperature and relative humidity conditions were monitored 
and recorded during all tests.
The flow fields arising during processing were visually monitored and any dead spots 
or other unusual occurrences recorded.
Three batches of test material were processed at each of the nozzle pressure settings 
and processing halted to allow samples to be taken for particle size analysis at 
processing times of 0, 30, 60, 120, 180, 240, 300, 450, 600, 900, 1200, 1500 and 1800 
seconds for experiments conducted using 75 and 105 msec'1 high pressure nozzle air 
velocities and 0, 30, 60, 120, 180, 240, 300, 450, 600, 900 and 1200 seconds for 
experiments performed using a high pressure nozzle air velocity of 135 msec"1.
The filter assembly was removed to allow sampling, which was performed following 
the method described in section 5.1.3. After each set of samples had been taken from 
the processor, the filter assembly was replaced and shaken to allow adhered material 
to fall back into the bulk powder bed. The walls of the processor were then knocked 
with a rubber mallet to allow material adhering to the internal surfaces of the 
processor to return to the powder bed.
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1.2 .23 Results
Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 374 371 361 368 6.9
30 216 200 195 204 10.8
60 173 178 171 174 3.5
120 160 121 154 145 20.8
180 138 152 108 133 22.4
240 139 135 70 115 39.0
300 105 37 116 86 43.1
450 42 49 53 48 5.2
600 29 21 48 33 14.0
900 21 22 20 21 1.1
1200 18 21 19 20 1.4
1500 19 18 18 18 0.6
1800 25 17 19 20 4.0
Table 7.2. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 75 msec'1 
High pressure air nozzle height: central position
High pressure air nozzle direction: co-current with high volume air nozzles
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 364 333 351 350 15.5
30 161 155 151 156 4.8
60 134 133 123 130 5.9
120 65 58 42 55 11.7
180 38 76 28 47 25.3
240 22 35 30 29 6.4
300 20 33 26 27 6.5
450 21 21 21 21 0.1
600 20 23 22 22 1.8
900 20 22 23 22 1.3
1200 21 21 23 22 1.3
1500 19 23 22 21 2.2
1800 17 23 22 21 3.0
Table 7.3. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 105 msec'1 
High pressure air nozzle height: central position
High pressure air nozzle direction: co-current with high volume air nozzles
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 382 398 353 378 22.9
30 137 129 131 132 4.1
60 68 68 34 56 19.7
120 26 20 25 23 3.2
180 23 19 22 21 1.8
240 18 17 22 19 2.6
300 19 17 21 19 1.9
450 18 15 22 18 3.4
600 16 15 23 18 4.1
900 15 15 21 17 3.1
1200 16 15 22 17 3.6
Table 7.4. Mass median particle diameters obtained at different times during milling 
period of 20 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 135 msec'1 
High pressure air nozzle height: central position
High pressure air nozzle direction: co-current with high volume air nozzles
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7.2.3 The effect of directing the high pressure nozzles to a position in opposition to 
the direction of the high volume air nozzles on the particle size reduction 
characteristics of SBSVP
7.2.3.1 SBSVP set up
The SBSVP was configured as described in section 7.2.2.1 except that, in this case, 
the air plenum was assembled in such a way that the high pressure air nozzle plate 
directed its airflows in an anticlockwise direction, i.e. counter-current to the high 
volume airflow from the flat nozzles.
1.2.3.2 Experimental conditions
The experimental conditions were those described in section 7.2.2.1.
7.2.3.3 Results
The results from each set of experiments are shown in tables 7.5 to 7.7.
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 389 388 335 371 30.8
30 198 193 188 193 4.9
60 171 162 170 168 4.8
120 157 148 134 147 11.6
180 145 121 114 127 16.2
240 106 101 54 87 28.4
300 124 106 65 98 30.4
450 41 41 24 35 9.5
600 67 45 26 46 20.4
900 31 27 24 27 3.4
1200 24 22 17 21 3.3
1500 22 25 22 23 2.0
1800 19 19 16 18 2.1
Table 7.5. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 75 msec'1 
High pressure air nozzle height: central position
High pressure air nozzle direction: counter-current to high volume air nozzles
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 382 452 333 389 59.7
30 145 164 178 162 16.7
60 75 147 170 131 49.5
120 27 97 145 89 59.1
180 42 49 132 74 50.0
240 27 57 114 66 44.1
300 20 32 91 48 38.1
450 20 25 78 41 32.0
600 19 22 29 23 4.8
900 19 19 18 19 0.6
1200 19 18 17 18 1.1
1500 18 18 16 17 1.5
1800 18 16 17 17 0.7
Table 7.6. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 105 msec'1 
High pressure air nozzle height: central position
High pressure air nozzle direction: counter-current to high volume air nozzles
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 360 317 329 335 21.9
30 167 186 162 171 12.4
60 156 146 146 149 5.8
120 81 101 110 97 14.5
180 70 50 32 51 19.1
240 35 39 31 35 4.1
300 24 36 26 29 6.5
450 18 19 17 18 0.9
600 15 16 15 16 0.4
900 17 16 15 16 1.3
1200 16 15 15 15 0.7
Table 7.7. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 135 msec'1 
High pressure air nozzle height: central position
High pressure air nozzle direction: counter-current to high volume air nozzles
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7.2.4 The effect of changing the height position of the high pressure nozzles on the 
particle size reduction characteristics of SBSVP
7.2.4.1 SBSVP configuration
The SBSVP was configured as described in section 7.2.2.1 except that, in this case, 
the air plenum was assembled in such a way that the high pressure air nozzle plate 
was positioned in either the top position or the bottom position and directed airflows 
in either an anticlockwise direction, i.e. counter-current to the high volume airflow 
from the flat nozzles or in a clockwise direction, i.e. co-current with the high volume 
airflow from the flat nozzles.
7.2.4.2 Experimental conditions
The experimental conditions were those described in section 7.2.2.1.
7.2.4.3 Results
The results from each set of experiments are shown in tables 7.8 to 7.11.
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 460 455 460 458 2.6
30 162 158 173 165 7.8
60 131 137 154 141 12.0
120 85 120 132 112 24.7
180 34 76 115 75 40.8
240 43 66 116 75 37.5
300 22 36 100 53 41.5
450 19 18 36 24 10.4
600 18 16 33 22 9.4
900 19 16 22 19 3.0
1200 19 15 21 19 3.1
1500 18 15 22 18 3.5
1800 18 16 21 18 2.5
Table 7.8. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 105 msec"1 
High pressure air nozzle height: bottom position
High pressure air nozzle direction: co-current with high volume air nozzles
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 461 465 469 465 3.8
30 176 166 186 176 10.1
60 153 142 162 152 10.3
120 268 107 135 170 86.1
180 114 81 116 104 19.5
240 104 58 92 85 23.5
300 77 31 92 66 31.8
450 27 20 26 24 3.6
600 20 19 23 21 2.0
900 20 18 21 20 1.7
1200 19 17 20 19 1.4
1500 19 17 21 19 1.9
1800 19 16 20 18 1.6
Table 7.9. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 105 msec'1 
High pressure air nozzle height: bottom position
High pressure air nozzle direction: counter-current to high volume air nozzles
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 464 471 463 466 4.2
30 179 148 167 165 16.0
60 153 141 143 146 6.3
120 133 107 130 123 14.6
180 118 81 104 101 18.6
240 93 62 33 63 29.8
300 90 46 31 56 30.4
450 28 24 27 26 2.1
600 25 23 22 24 1.5
900 23 21 20 21 1.2
1200 22 22 20 22 1.2
1500 22 22 22 22 0.3
1800 23 21 20 22 1.3
Table 7.10. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 105 msec’1 
High pressure air nozzle height: top position
High pressure air nozzle direction: co-current with high volume air nozzles
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Expt. no. Run 1 Run 2 Run 3 Mean SD
Milling time 
(seconds)
Mean mass median 
particle diameter (pm)
0 463 444 459 455 10.3
30 199 191 251 213 32.7
60 170 159 187 172 14.2
120 153 140 155 149 8.4
180 136 137 141 138 2.2
240 109 110 119 113 5.3
300 99 105 132 112 17.6
450 25 81 113 73 44.6
600 23 46 67 45 21.6
900 21 24 32 26 5.8
1200 22 22 27 24 2.9
1500 22 20 21 21 1.3
1800 20 18 20 20 1.0
Table 7.11. Mass median particle diameters obtained at different times during milling 
period of 30 minutes in SBSVP set up under following conditions:
Approximate nozzle air velocity: 105 msec'1 
High pressure air nozzle height: top position
High pressure air nozzle direction: counter-current to high volume air nozzles
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7.2.5 Discussion
Table 7.12 sets out a summary of the results obtained showing the following three sets 
of conditions:
(a) Nozzles at position M, in a clockwise direction and at three levels of pressure
(b) Nozzles at position M, in an anti-clockwise direction and at three levels of
pressure
(c) Nozzles at the two other heights, at a fixed pressure of 245 kPa, and in a
clockwise and anti-clockwise direction for each of the two heights.
The results from set (a) indicate that the rate of size reduction increases with 
increasing pressure but that the same level of size reduction is achieved at the end of 
the three processes.
Set (b) indicates a much lower difference in the rate of particle size reductions at the 
various pressures; the final particle size is similar in all cases to the results obtained in 
set (a).
Set (c) shows similar size reductions in all variations but again the final particle size is 
similar in all cases to the results obtained in sets (a) and (b).
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It is of interest to note that starting material having somewhat different initial particle 
size characteristics nonetheless follow a similar size reduction pattern resulting in a 
similar final particle size in all cases.
When compared to the results obtained from FBSVP-A and FBSVP-B (see table 5.3), 
substantial reductions in final particle size were achieved in all cases. The degree of 
size reduction was at a level more suited to processing of powders for DPI use.
The variation between particle sizes determined for separate, identical runs was found 
to be consistently low after approximately 600 seconds processing time. The final 
deviation in all cases was well within acceptable commercial limits at the end of the 
process. This contrasts to high variability found during processing in the FBSVP-A 
and FBSVP-B.
This indicated that the design improvements were effective, providing a robust system 
lending itself to commercial validation.
7.2.6 Conclusions
The processor has been shown to be suitable for particle size reduction of excipient 
products for DPI use.
It is conceivable that the processor could be further developed to provide conditions 















0 30 60 120
Milling time (seconds) 
180 240 300 450 600 900 1200 1500 1800
Mean mass median particle diameter (pm)
75 Co M 368 204 174 145 133 115 86 48 33 21 20 18 20
105 Co M 350 156 130 55 47 29 27 21 22 22 22 21 21
135 Co M 378 132 56 23 21 19 19 18 18 17 17
75 Counter M 371 193 168 147 127 87 98 35 46 27 21 23 18
105 Counter M 389 162 131 89 74 66 48 41 23 19 18 17 17
135 Counter M 335 171 149 97 51 35 29 18 16 16 15
105 Co B 458 165 141 112 75 75 53 24 22 19 19 18 18
105 Counter B 465 176 152 170 104 85 66 24 21 20 19 19 18
105 Co T 466 165 146 123 101 63 56 26 24 21 22 22 22
105 Counter T 455 213 172 149 138 113 112 73 45 26 24 21 20
Key:
Counter - Counter-current B - Bottom
Co - Co-current M - Middle
T - Top
Table 7.12. Summary of changes in mean mass median particle size during particle size reduction experiments in SBSVP.
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7.3 Blend content uniformity of a dry powder inhaler formulation processed in 
SBSVP
7.3.1 Experimental conditions
The SBSVP was set up as described in section 7.1.2 and the high pressure air nozzle 
pressure set at 140 kPa. All other experimental conditions were as described in 
section 5.2.1.
7.3.2 Sampling
Sampling was conducted as described in section 5.2.2.
7.3.3 Results
The results from each experiment are shown in tables 7.13 to 7.17 below and a 






30 60 120 300 600 1200
Nedocromil sodium trihydrate content %w/w)
A1 39.7 40.6 41.1 39.7 42.4 38.9
A2 38.5 40.7 40.0 39.5 39.2 38.7
B1 39.6 37.3 40.7 39.7 40.0 38.3
B2 38.7 39.2 40.1 38.9 40.8 41.8
C1 41.3 41.3 39.5 39.9 40.5 38.8
C2 38.9 39.2 39.5 39.2 39.5 40.1
D1 39.1 40.5 39.6 39.6 40.3 38.8
D2 37.7 40.7 39.6 39.7 41.6 39.0
E1 39.9 39.6 40.5 39.6 39.5 39.0
E2 42.7 40.6 40.7 39.9 39.6 39.6
Mean (A-E) 39.6 40.0 40.1 39.6 40.3 39.3
RSD (A-E) 3.7 2.9 1.5 0.8 2.6 2.6
Mean (A-C) 39.4 39.7 40.1 39.5 40.4 39.4
RSD (A-C) 2.6 3.7 1.6 0.9 2.9 3.4
Table 7.13. Content uniformity data from processing nedocromil sodium trihydrate





30 60 120 300 600 1200
Nedocromil sodium trihydrate content %w/w)
A1 38.7 39.2 40.8 39.7 39.6 38.6
A2 38.9 39.6 41.4 40.1 39.0 38.8
B1 40.0 39.0 39.4 39.7 38.9 38.8
B2 39.2 41.3 41.2 39.8 38.8 38.9
C1 42.1 39.8 39.4 39.6 39.2 38.3
C2 40.0 40.1 40.8 39.7 39.0 38.5
D1 37.8 39.5 39.5 40.8 40.8 38.9
D2 39.0 35.3 40.2 40.2 39.8 39.1
E1 37.7 39.3 38.5 39.8 39.1 38.8
E2 39.6 39.8 39.4 39.8 39.0 39.3
Mean (A-E) 39.3 39.3 40.1 39.9 39.3 38.8
RSD (A-E) 3.2 3.9 2.4 0.9 1.5 0.7
Mean (A-C) 39.8 39.8 40.5 39.8 39.1 38.6
RSD (A-C) 3.1 2.0 2.2 0.4 0.7 0.6
Table 7.14. Content uniformity data from processing nedocromil sodium trihydrate





30 60 120 300 600 1200
Nedocromil sodium trihydrate content [%w/w)
A1 37.7 40.0 39.1 38.9 37.7 39.3
A2 39.6 39.6 39.3 39.0 38.1 38.5
B1 38.3 40.2 40.0 39.8 38.4 38.3
B2 39.2 40.0 39.6 39.5 38.4 39.2
C1 37.8 40.0 39.9 38.2 38.2 37.9
C2 37.7 40.1 40.7 38.7 38.0 37.9
D1 36.5 39.5 40.2 38.3 38.0 38.1
D2 38.9 39.8 40.4 38.9 38.6 38.1
E1 39.9 39.5 39.3 38.5 38.6 37.9
E2 40.1 39.9 40.2 38.7 38.3 37.1
Mean (A-E) 38.6 39.9 39.9 38.8 38.2 38.2
RSD (A-E) 3.0 0.6 1.4 1.3 0.8 1.7
Mean (A-C) 38.4 40.0 39.8 39.0 38.1 38.5
RSD (A-C) 2.2 0.5 1.5 1.4 0.7 1.7
Table 7.14. Content uniformity data from processing nedocromil sodium trihydrate





30 60 120 300 600 1200
Nedocromil sodium tri hydrate content :%w/w)
A1 38.1 38.8 39.5 38.4 38.1 38.0
A2 39.8 39.1 39.3 38.5 38.3 38.8
B1 38.6 39.2 40.5 39.4 39.8 38.1
B2 40.1 39.2 39.7 38.5 39.0 39.0
C1 38.2 38.8 39.7 38.5 38.6 38.7
C2 38.7 39.1 38.8 38.5 38.7 38.8
D1 38.3 39.4 39.0 38.4 38.9 39.1
D2 37.8 38.7 38.7 39.1 39.2 39.2
E1 40.2 38.4 38.8 38.0 38.0 38.3
E2 40.0 38.8 40.0 38.5 38.5 38.8
Mean (A-E) 39.0 38.9 39.4 38.6 38.7 38.7
RSD (A-E) 2.4 0.8 1.5 1.0 1.4 1.1
Mean (A-C) 38.9 39.0 39.6 38.6 38.8 38.6
RSD (A-C) 2.1 0.5 1.4 0.9 1.5 1.1
Table 7.15. Content uniformity data from processing nedocromil sodium trihydrate





30 60 120 300 600 1200
Nedocromil sodium trihydrate content %w/w)
A1 40.2 38.1 38.2 37.5 37.6 37.5
A2 40.1 41.5 38.1 38.7 38.2 37.6
B1 39.1 38.9 38.4 37.6 37.9 37.4
B2 39.0 38.8 38.9 37.9 41.6 37.4
C1 40.2 39.6 37.8 38.1 37.9 37.3
C2 43.1 38.6 38.2 37.8 38.0 37.2
D1 36.5 39.5 38.3 38.3 37.7 38.1
D2 37.6 39.2 38.8 38.3 38.0 37.3
E1 40.8 38.4 38.6 37.9 37.3 37.7
E2 40.3 38.4 38.3 38.5 37.8 38.7
Mean (A-E) 39.7 39.1 38.4 38.0 38.2 37.6
RSD (A-E) 4.5 2.5 0.8 1.0 3.2 1.2
Mean (A-C) 40.3 39.2 38.3 37.9 38.5 37.4
RSD (A-C) 3.7 3.1 0.9 1.1 3.9 0.4
Table 7.16. Content uniformity data from processing nedocromil sodium trihydrate
formulation in SBSVP, experiment #5
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Processing time (seconds)
Experiment 30 60 120 300 600 1200
number % Relative standard deviation (n=10)
#1 3.7 2.9 1.5 0.8 2.6 2.6
#2 3.2 3.9 2.4 0.9 1.5 0.7
#3 3.0 0.6 1.4 1.3 0.8 1.7
#4 2.4 0.8 1.5 1.0 1.4 1.1
#5 4.5 2.5 0.8 1.0 3.2 1.2
Table 7.17. Summary of percent relative standard deviation of content uniformity 
samples taken from positions A, B, C, D and E at different processing times during 
blending of nedocromil sodium trihydrate formulation in SBSVP.
Processing time (seconds)
Experiment 30 60 120 300 600 1200
number % Relative standard deviation
#1 2.6 3.7 1.6 0.9 2.9 3.4
#2 3.1 2.0 2.2 0.4 0.7 0.6
#3 2.2 0.5 1.5 1.4 0.7 1.7
#4 2.1 0.5 1.4 0.9 1.5 1.1
#5 3.7 3.1 0.9 1.1 3.9 0.4
Table 7.18. Summary of percent relative standard deviation of content uniformity 
samples taken from positions A, Band C only at different processing times during 
blending of nedocromil sodium trihydrate formulation in SBSVP.
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7.3.4 Discussion
Comparing the results set out in table 7.17 using SBSVP to those obtained from 
FBSVP-B shown in table 5.7 it is evident that comparable %RSD levels are 
substantially different and that the improvements expected through redesign of the 
vessel have been achieved.
With the SBSVP the %RSD falls to below 5% within 30 seconds and below 2% 
within 2 minutes thus indicating a rapid speed of mixing.
There is no evidence of demixing occurring during extended mixing times and loss of 
fine particles is controlled within acceptable limits.
7.3.5 Conclusions
The SBSVP provided suitable mixing conditions for the powder system investigated 
and has the potential to be developed into a commercial product.
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7.4 Functionality of a dry powder inhaler formulation processed in SBSVP
7.4.1 Experimental conditions and sampling
The samples collected during blend content uniformity testing as described in section 
7.3 were also used for in-vitro aerosol functionality testing. Experimental conditions 
and sample treatment were otherwise as described in section 5.3.1.
7.4.2 Results
The results are presented in tables 7.19 to 7.24 below. A summary table of the %FPF 
values obtained throughout these experiments is given in table 7.25. Overall mean 





number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.3 3.4 2.6 91.2 6.0 43.9 1.5 3.4 2.9 97.1 6.3 45.9 1.4 3.0 3.1 93.2 6.1 50.8
A2 0.7 3.1 3.0 85.6 6.1 49.2 1.6 2.9 3.3 97.5 6.2 52.6 1.4 3.0 3.1 93.7 6.1 50.4
B1 1.4 3.2 3.0 95.7 6.2 48.0 1.4 3.1 2.9 93.7 6.1 48.4 1.5 3.3 2.8 94.0 6.0 46.2
B2 1.4 3.3 2.7 92.6 6.0 45.3 1.5 3.4 2.9 98.0 6.4 46.2 1.6 3.0 3.1 95.8 6.1 50.6
Cl 1.5 3.9 2.4 97.4 6.3 38.0 1.6 3.3 2.9 98.2 6.3 47.0 1.5 3.1 3.1 96.4 6.3 50.3
C2 1.6 3.5 2.7 97.5 6.2 43.1 1.4 3.2 2.8 93.2 6.0 46.7 1.4 3.3 2.9 96.2 6.3 46.9
Mean 1.3 3.4 2.7 93.3 6.1 44.6 1.5 3.2 3.0 96.3 6.2 47.8 1.4 3.1 3.0 94.9 6.1 49.2
SD 0.3 0.3 0.2 4.6 0.1 4.0 0.1 0.2 0.2 2.3 0.1 2.5 0.1 0.1 0.1 1.4 0.1 2.1




number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.4 3.0 3.0 93.3 6.0 49.8 1.5 3.2 2.9 94.3 6.1 47.1 1.4 2.8 3.2 92.9 6.1 53.3
A2 1.5 3.1 3.3 98.8 6.4 52.0 1.4 3.4 2.8 95.3 6.2 45.1 1.5 2.6 3.4 93.2 6.0 57.2
B1 1.3 3.0 3.2 94.4 6.2 52.1 1.5 2.6 3.5 95.1 6.1 57.4 1.4 2.5 3.3 89.9 5.8 56.4
B2 1.5 3.1 3.1 96.4 6.2 50.1 1.5 2.8 3.4 96.4 6.2 54.5 1.5 2.8 3.3 93.9 6.0 54.3
Cl 1.5 2.9 3.0 92.2 5.9 50.8 1.4 2.7 3.3 92.6 6.0 55.0 1.5 2.5 3.4 92.4 5.9 57.4
C2 1.4 3.3 2.9 94.4 6.2 47.4 1.5 2.8 3.1 92.0 5.8 52.6 1.6 2.5 3.3 91.4 5.8 56.9
Mean 1.4 3.1 3.1 94.9 6.2 50.4 1.5 2.9 3.2 94.3 6.1 52.0 1.5 2.6 3.3 92.3 5.9 55.9
SD 0.1 0.1 0.2 2.4 0.2 1.7 0.0 0.3 0.3 1.7 0.1 4.8 0.1 0.1 0.1 1.4 0.1 1.7
RSD 5.0 4.0 5.0 2.5 2.9 3.4 3.1 10.7 9.3 1.8 2.3 9.3 5.0 5.5 2.2 1.5 2.0 3.0
__________________ Key__________________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 7.19. In-vitro functionality data from TSI testing of samples obtained during





number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.4 3.3 2.8 93.3 6.1 46.0 1.4 3.4 2.7 94.7 6.1 44.6 1.6 2.8 3.2 94.8 6.0 53.5
A2 1.5 3.4 2.6 93.0 6.0 42.8 1.5 3.2 3.2 97.9 6.3 50.1 1.6 3.2 3.1 98.8 6.3 48.7
B1 1.4 3.0 2.8 90.5 5.8 48.1 1.5 3.0 3.0 94.8 6.1 50.0 1.5 2.9 3.2 95.8 6.2 52.4
B2 1.7 2.9 3.1 96.2 6.0 51.3 1.6 2.8 3.1 94.6 5.9 52.7 1.6 3.2 2.8 94.3 6.0 46.6
C l 1.5 3.3 2.7 93.2 6.0 45.1 1.4 3.1 2.9 94.1 6.1 48.3 1.5 3.1 3.1 96.7 6.2 49.8
C2 1.5 3.2 3.1 97.3 6.3 48.9 1.6 3.0 3.0 95.0 6.0 50.5 1.9 2.8 3.4 100.8 6.2 54.4
Mean 1.5 3.2 2.8 93.9 6.0 47.0 1.5 3.1 3.0 95.2 6.1 49.4 1.6 3.0 3.1 96.9 6.1 50.9
SD 0.1 0.2 0.2 2.5 0.1 3.0 0.1 0.2 0.2 1.4 0.1 2.7 0.1 0.2 0.2 2.5 0.1 3.0




number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 2.0 2.4 3.1 93.2 5.5 56.3 1.6 2.8 3.0 91.8 5.8 52.4 1.5 2.6 3.4 94.6 6.1 56.7
A2 1.6 2.9 3.3 97.9 6.2 53.8 1.4 2.6 3.2 90.1 5.8 54.6 1.6 2.6 3.2 92.4 5.8 55.1
B1 1.5 2.9 3.4 98.1 6.3 53.8 1.5 2.7 3.2 93.4 5.9 54.1 1.5 2.8 3.2 94.6 6.0 53.4
B2 1.5 2.9 3.2 94.3 6.1 52.5 1.5 2.8 3.1 92.3 5.9 52.2 1.8 2.7 3.1 94.9 5.8 52.6
C l 1.7 2.8 3.2 96.0 6.0 53.7 1.9 2.4 3.4 95.4 5.8 58.7 1.3 2.9 3.1 90.8 5.9 52.0
C2 1.6 2.8 3.3 95.1 6.1 53.7 1.8 2.6 3.1 93.1 5.7 53.8 1.5 2.9 3.0 93.4 5.9 50.4
Mean 1.6 2.8 3.2 95.8 6.0 54.0 1.6 2.7 3.2 92.7 5.8 54.3 1.5 2.8 3.2 93.5 5.9 53.4
SD 0.2 0.2 0.1 2.0 0.3 1.2 0.2 0.1 0.1 1.8 0.1 2.4 0.1 0.1 0.2 1.6 0.1 2.3
RSD 10.8 6.9 3.4 2.1 4.7 2.3 11.0 5.6 4.3 1.9 1.4 4.3 9.7 4.8 5.0 1.7 1.9 4.2
__________________ Key__________________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 7.20. In-vitro functionality data from TSI testing of samples obtained during





number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.6 3.1 2.9 94.5 6.0 48.6 1.3 3.3 3.1 97.5 6.5 48.4 1.7 3.0 2.9 95.2 5.9 49.9
A2 1.2 3.5 2.6 91.8 6.1 43.0 1.6 3.3 3.1 100.3 6.5 48.2 1.4 2.9 3.3 94.7 6.2 53.0
B1 1.3 3.5 2.8 95.4 6.3 44.8 1.5 3.1 3.1 95.6 6.2 50.4 1.4 2.8 3.3 93.7 6.1 53.5
B2 1.3 3.5 2.9 96.0 6.4 45.6 1.5 3.4 3.1 99.3 6.5 47.3 1.4 2.9 3.1 93.2 6.0 52.0
Cl 1.6 3.4 2.5 94.2 5.9 42.7 1.6 3.0 3.1 96.9 6.1 50.6 1.4 3.1 3.1 94.1 6.2 50.4
C2 1.3 3.1 2.9 91.2 6.0 48.2 1.2 3.1 3.1 93.3 6.2 50.1 1.5 2.9 3.2 93.7 6.0 52.3
Mean 1.4 3.3 2.8 93.8 6.1 45.5 1.4 3.2 3.1 97.1 6.3 49.1 1.5 2.9 3.1 94.1 6.1 51.8
SD 0.2 0.2 0.2 2.0 0.2 2.5 0.1 0.2 0.0 2.5 0.2 1.4 0.1 0.1 0.1 0.7 0.1 1.4
RSD 12.7 5.7 6.1 2.1 3.2 5.5 9.9 5.2 0.9 2.6 2.6 2.8 8.7 2.8 3.7 0.8 1.6 2.8
Processing time (seconds)
Sample 300 600 1200
number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.4 2.9 3.2 94.9 6.1 52.8 1.5 2.7 3.3 94.6 6.0 54.7 1.6 2.9 2.9 93.8 5.9 50.3
A2 1.6 2.8 3.2 95.0 6.0 53.8 1.7 2.6 3.2 92.9 5.8 55.3 1.5 2.7 3.2 91.8 5.9 54.0
B1 1.5 3.0 3.0 93.5 6.0 49.9 1.8 2.5 3.4 95.9 5.9 57.4 1.7 2.5 3.2 92.1 5.7 55.9
B2 1.5 3.0 3.3 97.6 6.3 51.8 1.5 3.0 3.0 93.8 6.0 50.2 1.7 2.8 3.0 92.3 5.7 51.6
Cl 1.5 2.7 3.3 93.9 6.0 55.0 1.6 2.5 3.3 92.1 5.8 57.5 1.6 2.6 3.2 92.0 5.8 55.1
C2 1.6 2.6 3.5 95.5 6.1 57.6 1.6 2.7 3.2 93.5 5.9 54.4 1.4 2.8 2.9 88.7 5.7 50.8
Mean 1.5 2.8 3.3 95.1 6.1 53.5 1.6 2.7 3.2 93.8 5.9 54.9 1.6 2.7 3.1 91.8 5.8 52.9
SD 0.1 0.2 0.2 1.4 0.1 2.7 0.1 0.2 0.1 1.3 0.1 2.6 0.1 0.2 0.1 1.7 0.1 2.4
RSD 4.5 6.4 5.1 1.5 2.2 5.0 6.5 7.0 4.2 1.4 1.8 4.8 8.1 5.6 4.2 1.8 1.4 4.5
__________________ Key__________________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 7.21. In-vitro functionality data from TSI testing of samples obtained during





number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.4 3.8 2.5 96.6 6.4 39.8 1.5 2.8 3.3 94.4 6.1 54.0 1.5 2.9 3.2 95.1 6.1 52.2
A2 1.3 3.5 2.8 96.1 6.3 44.8 1.4 3.0 3.1 93.3 6.0 50.9 1.5 2.8 3.1 93.5 5.9 52.6
B1 1.5 3.5 2.8 97.3 6.3 44.6 1.5 3.3 3.2 98.8 6.4 49.1 1.5 3.2 3.0 95.5 6.1 48.2
B2 1.4 3.7 2.7 97.0 6.3 41.9 1.6 3.2 3.0 97.2 6.2 47.7 1.6 2.8 3.2 95.1 6.0 53.0
C l 1.6 3.1 2.8 94.4 5.9 47.8 1.5 3.3 2.9 97.2 6.3 47.0 1.6 3.0 3.2 97.3 6.2 51.4
C2 1.4 3.5 2.7 95.5 6.2 42.8 1.4 3.3 3.0 96.5 6.3 47.4 1.4 2.8 3.3 93.1 6.1 53.8
Mean 1.4 3.5 2.7 96.1 6.3 43.6 1.5 3.1 3.1 96.2 6.2 49.4 1.5 2.9 3.2 95.0 6.1 51.9
SD 0.1 0.2 0.1 1.1 0.2 2.7 0.1 0.2 0.1 2.0 0.2 2.7 0.1 0.1 0.1 1.5 0.1 2.0
RSD 6.3 6.8 4.8 1.1 2.5 6.3 3.4 7.1 4.2 2.1 2.4 5.5 4.3 5.1 3.2 1.6 1.5 3.8
Processing time (seconds)
Sample 300 600 1200
number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.5 3.0 3.0 92.9 6.0 50.1 1.6 3.0 3.1 96.3 6.1 50.5 1.6 2.5 3.4 93.3 5.9 57.3
A2 1.4 3.1 3.1 95.0 6.2 50.2 1.6 3.0 3.0 94.1 5.9 50.1 1.3 3.0 3.1 93.2 6.1 50.8
B1 1.6 2.7 3.2 94.0 5.9 53.8 1.6 2.7 3.1 92.3 5.8 53.9 1.4 2.9 3.1 92.2 5.9 52.1
B2 1.3 3.1 3.2 95.3 6.3 50.5 1.3 3.0 3.0 91.6 6.1 50.2 1.5 2.9 3.2 94.3 6.0 52.5
C l 1.7 2.8 3.0 94.3 5.8 51.9 1.4 3.1 3.0 94.1 6.1 49.6 1.4 2.7 3.3 92.0 5.9 54.9
C2 1.4 3.1 2.8 90.7 5.9 47.9 1.5 3.1 2.8 93.5 5.9 47.7 1.4 2.8 3.3 92.9 6.1 54.1
Mean 1.5 3.0 3.0 93.7 6.0 50.7 1.5 3.0 3.0 93.7 6.0 50.3 1.4 2.8 3.2 93.0 6.0 53.6
SD 0.1 0.2 0.1 1.7 0.2 2.0 0.1 0.2 0.1 1.6 0.1 2.0 0.1 0.2 0.1 0.8 0.1 2.3
RSD 9.2 5.2 4.5 1.8 3.0 3.9 8.9 5.3 3.5 1.8 2.0 4.0 6.7 6.2 3.3 0.9 1.6 4.3
__________________ Key__________________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 7.22. In-vitro functionality data from TSI testing of samples obtained during





number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.4 3.7 2.8 97.9 6.4 42.9 1.3 3.1 3.2 96.0 6.4 50.9 1.6 3.2 3.1 98.4 6.3 49.1
A2 1.4 4.0 2.7 101.3 6.7 40.3 1.4 2.9 3.3 94.1 6.2 53.7 1.4 3.3 3.1 96.6 6.3 48.4
B1 1.2 3.4 2.9 93.7 6.3 45.7 1.3 3.0 3.3 94.4 6.3 52.5 1.4 2.8 3.3 93.2 6.0 53.9
B2 1.4 3.3 2.9 95.0 6.2 47.2 1.5 2.7 3.3 93.9 6.0 55.0 1.5 3.2 3.0 95.9 6.2 48.0
C l 1.4 3.5 2.8 96.8 6.3 44.2 1.8 2.8 3.1 95.7 5.9 52.0 1.4 3.2 3.0 95.0 6.2 48.5
C2 1.5 3.7 2.7 99.7 6.5 42.0 1.4 3.0 3.3 95.8 6.3 52.2 1.5 3.1 3.3 98.5 6.4 52.1
Mean 1.4 3.6 2.8 97.4 6.4 43.7 1.4 2.9 3.2 95.0 6.2 52.7 1.5 3.1 3.1 96.3 6.2 50.0
SD 0.1 0.3 0.1 2.8 0.2 2.5 0.2 0.2 0.1 0.9 0.2 1.4 0.1 0.2 0.1 2.0 0.1 2.4




number C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF C+D S I S 2 Rec DD FPF
A1 1.4 3.1 3.1 94.5 6.2 49.9 1.7 2.7 3.1 93.2 5.8 53.6 1.5 2.5 3.3 90.9 5.7 56.8
A2 1.5 2.9 3.3 95.7 6.1 53.1 1.4 2.8 3.0 90.1 5.8 52.1 1.4 2.9 3.2 93.6 6.1 53.2
B1 1.4 2.9 3.0 91.5 5.9 50.9 1.6 2.9 2.9 93.1 5.8 49.7 1.6 2.8 3.1 93.1 5.9 52.8
B2 1.4 2.9 3.2 93.9 6.1 52.3 1.4 2.7 3.0 89.5 5.7 53.1 1.6 2.4 3.3 90.8 5.6 58.0
Cl 1.4 2.9 3.2 93.4 6.1 52.4 1.5 3.0 3.0 93.2 6.0 50.7 1.5 2.7 3.1 91.4 5.8 53.0
C2 1.5 2.7 3.1 91.0 5.8 53.0 1.5 2.9 3.2 94.7 6.1 53.0 1.4 3.1 3.2 97.7 6.4 50.9
Mean 1.4 2.9 3.1 93.4 6.0 51.9 1.5 2.8 3.1 92.3 5.9 52.0 1.5 2.7 3.2 92.9 5.9 54.1
SD 0.1 0.1 0.1 1.8 0.1 1.3 0.1 0.1 0.1 2.1 0.1 1.6 0.1 0.3 0.1 2.6 0.3 2.7
RSD 4.4 3.8 3.2 1.9 2.4 2.4 8.2 4.3 3.5 2.2 2.4 3.0 5.4 9.9 2.6 2.8 4.5 5.0
__________________ Key__________________
C+D Dose recovered in capsule and device 
S 1 Dose recovered in stage 1 
S 2 Dose recovered in stage 2 
Rec Percent total recovery / nominal recovery 
DD Delivered dose (stage 1 + stage 2)
FPF Fine particle fraction 
SD Standard deviation 
RSD Relative standard deviation
Table 7.23. In-vitro functionality data from TSI testing of samples obtained during
processing of nedocromil sodium trihydrate formulation in SBSVP, experiment #5.
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Expt. Sample 30
Processing time (seconds) 
60 120 300 600 1200
no. position Percent fine particle fraction
Expt #1 A1 43.9 45.9 50.8 49.8 47.1 53.3
Expt #1 A2 49.2 52.6 50.4 52.0 45.1 57.2
Expt #1 B1 48.0 48.4 46.2 52.1 57.4 56.4
Expt #1 B2 45.3 46.2 50.6 50.1 54.5 54.3
Expt #1 C1 38.0 47.0 50.3 50.8 55.0 57.4
Expt #1 C2 43.1 46.7 46.9 47.4 52.6 56.9
Expt #2 A1 46.0 44.6 53.5 56.3 52.4 56.7
Expt #2 A2 42.8 50.1 48.7 53.8 54.6 55.1
Expt #2 B1 48.1 50.0 52.4 53.8 54.1 53.4
Expt #2 B2 51.3 52.7 46.6 52.5 52.2 52.6
E xpt#2 C1 45.1 48.3 49.8 53.7 58.7 52.0
Expt #2 C2 48.9 50.5 54.4 53.7 53.8 50.4
Expt #3 A1 48.6 48.4 49.9 52.8 54.7 50.3
Expt #3 A2 43.0 48.2 53.0 53.8 55.3 54.0
Expt #3 B1 44.8 50.4 53.5 49.9 57.4 55.9
Expt #3 B2 45.6 47.3 52.0 51.8 50.2 51.6
Expt #3 C1 42.7 50.6 50.4 55.0 57.5 55.1
Expt #3 C2 48.2 50.1 52.3 57.6 54.4 50.8
Expt #4 A1 39.8 54.0 52.2 50.1 50.5 57.3
Expt #4 A2 44.8 50.9 52.6 50.2 50.1 50.8
Expt #4 B1 44.6 49.1 48.2 53.8 53.9 52.1
Expt #4 B2 41.9 47.7 53.0 50.5 50.2 52.5
Expt #4 C1 47.8 47.0 51.4 51.9 49.6 54.9
Expt #4 C2 42.8 47.4 53.8 47.9 47.7 54.1
Expt #5 A1 42.9 50.9 49.1 49.9 53.6 56.8
Expt #5 A2 40.3 53.7 48.4 53.1 52.1 53.2
Expt #5 B1 45.7 52.5 53.9 50.9 49.7 52.8
Expt #5 B2 47.2 55.0 48.0 52.3 53.1 58.0
Expt #5 C1 44.2 52.0 48.5 52.4 50.7 53.0
Expt #5 C2 42.0 52.2 52.1 53.0 53.0 50.9
Mean 44.9 49.7 50.8 52.1 52.7 54.0
SD 3.1 2.7 2.3 2.3 3.2 2.4
RSD 6.8 5.3 4.6 4.3 6.1 4.4
Table 7.24. Summary of percent fine particle fraction determined for samples
obtained during processing of nedocromil sodium trihydrate formulation in SBSVP,








Graph 7.1. Graph showing mean %FPF results o f five batches o f  nedocromil sodium 
DPI formulation at different processing times in FBSVP-B.
7.4.3 Discussion
A comparison o f the results set out in table 7.24 using SBSVP to those obtained from 
FBSVP-B shown in table 5.14 indicates that comparable %FPF levels are 
substantially different and that the improvements expected through redesign o f the 
vessel have been achieved.
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The mean standard deviation value during the last 900 seconds of processing time for 
the SBSVP was 2.6% and the mean %FPF was 52.9%. This compares to a value of 
5.0% for the mean standard deviation value during the last 900 seconds of processing 
time in the FBSVP-B and a %FPF of 43.5%.
After 60 seconds of processing the %FPF remained constant over a period of 20 
minutes processing time. This robustness is considered highly desirable in production 
of DPI blends.
Comparison of graphs 7.1 and 5.2 clearly illustrate the improvements achieved in the 
redesign of the vessel.
7.4.4 Conclusions
The environment generated within the SBSVP provided suitable conditions of high 
shear which were suitable for robust and reliable production of nedocromil sodium 
blends for dry powder inhalation.
It is considered that the SBSVP could be developed for commercial application in 




More specific discussions are presented with each part of the experimental work in 
sections 3.3.3.4, 5.1.5, 5.2.4, 5.3.3, 7.2.5, 7.3.4 and 7.4.3.
8.1 Overview of design development and comparison with conventional processes
An initial processor was developed, the FBSVP-A, which was characterised for its 
performance in reducing the particle size of two grades of lactose and for dry blending 
of a lactose/fine particle sodium chloride powder system.
Although some particle size reduction was observed and mixing performance was 
found to be superior to a turbulent tumbling method, large areas of low powder 
activity were observed in certain regions of the vessel. In addition to these problems 
it was found that the cyclone system employed for arrestment of particles from air 
exiting from the vessel was inefficient which, along with other leakages, caused a 
large proportion of fine material to be lost from the processor.
In order to address these faults the vessel was redesigned by replacing the cyclone 
separator with a bag filter and lowering the high pressure air nozzles, resulting in the 
fabrication of a new processor, the FBSVP-B. These design modifications were 
found to greatly increase the degree of fluidisation of the powder bed, thus reducing 
regions of low activity, although these were not completely eliminated. The problems
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of escape of excessive amounts of powder from the vessel were largely solved by the 
inclusion of the filter bag.
A CFD simulation model was constructed for the processor in which a number of 
areas of low flow activity were predicted.
The FBSVP-B was characterised for its performance in size reducing a lactose 
material, which was selected to allow a direct comparison to be made with the 
comminuting performance of the FBSVP-A.
One minor modification to the vessel was the application of antistatic tape to all 
polymeric vessel surfaces since these were found to become electrostatically charged 
during operation (i.e. vessel walls and central cone). This was found to assist in 
reducing the amount of material adhered to the vessel wall and also to reduce the 
degree of adhesion of material that did become attached to the walls during 
processing.
The perceived extent and rate of milling were increased in the redesigned vessel and 
this was attributed to two factors; these were firstly improved milling efficiency due 
to repositioning of the air nozzles close to the vessel base and secondly a reduction in 
the expulsion of fine material from the vessel as a result of replacing the cyclone with 
a filter bag.
In investigating the use of the FBSVP-B for processing a DPI nedocromil sodium 
formulation it was found that selected parts of the vessel were able to produce
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homogeneous blends but that samples from those areas of the processor that were 
predicted by the CFD simulations to exhibit poor flow characteristics were 
considerably less homogeneous. It was therefore concluded that the CFD model was 
able to predict the flow characteristics of the processor and that a redesign was 
necessary in order to eliminate areas of low flow activity.
The functionality of the nedocromil sodium blends was also evaluated in terms of in- 
vitro aerosol particle characteristics. The results obtained for %FPF were somewhat 
variable but compared well to alternative techniques of blending reported in other 
studies (Clarke, 1998) for a similar formulation as did those for blend homogeneity.
In Clarke’s investigations content uniformities characterised by RSDs of 1.35% and 
2.28% were obtained from blends manufactured using hand blending in a pestle and 
mortar and blends processed in a high shear mixer respectively. The mean %RSD for 
blends after 2 minutes of processing in the FBSVP-B was 2.72%.
The %FPF results for blends produced in the FBSVP-B displayed a mean value of 
43% which compared to 33% FPF in Clarke’s pestle and mortar mixing and 50% FPF 
for blends produced in a high shear blender. This was thought to indicate that the 
shear levels generated in the FBSVP-B were somewhere in-between those generated 
in pestle and mortar mixing and processing in a bladed high shear system.
In order to address the need for greater shear forces, improve flow activity throughout 
the vessel environment and hence increase blend content uniformity, a further vessel 
was designed using CFD technology to optimise air input trajectories.
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This redesigned equipment was termed the SBSVP and employed high volume air 
transmitted tangentially to the powder bed rather than vertical fluidising air. In 
addition, the number of high pressure air nozzles was doubled from 12 to 24. The 
total energy input from these nozzles was much increased compared to those in the 
FBSVP-B as the air velocity output from each nozzle was maintained at the same 
level as that provided by FBSVP-B nozzles by increasing the pressure and volume of 
the supply air. It was also possible to alter the height and direction of these nozzles to 
achieve optimal performance.
The increased energy supplied to the processing environment within the new vessel 
was apparent by a dramatic increase in the rate and extent of milling when similar 
lactose materials to those investigated in previous vessels were presented to the 
processor for size reduction testing. Median particle size of lactose granules was 
found to reduce from 460pm to 23 pm within 2 minutes in the SBSVP at the optimal 
vessel configuration compared to a maximum reduction in the median size of similar 
material to 141 pm in 20 minutes processing in the FBSVP-B.
When applied to processing of the nedocromil sodium DPI formulation, the SBSVP 
again showed improved characteristics over its predecessor.
Activation of the powder bed was extensive, resulting in rapid attainment of blend 
homogeneity; %RSDs were obtained that were consistently below 5% after only 30 
seconds of processing time. A mean RSD of 1.5% was attained at mixing times in 
excess of two minutes.
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The increased shear available in the SBSVP also had a beneficial effect on in-vitro 
aerosol deposition characteristics of the blends. These were characterised by a mean 
%FPF of 51% after two minutes mixing, rising to 54% after twenty minutes. 
Variability between blends was low and changes in functionality over extended 
mixing times were small.
This robustness in the process was considered highly desirable since other DPI 
formulations have been known to be particularly susceptible to deterioration in 
performance due to mixing time effects.
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8.2 Future work
Since the nedocromil sodium formulation appeared to be influenced by the amount of 
shear imparted into it during mixing, a future study could investigate the effects of 
increasing the high pressure air nozzle velocity on blend performance.
The performance of a range of DPI powder systems using different drugs for 
processing in the SVP equipment would also make a useful study.
It is possible that the SVP equipment could be further developed to produce wet 
granulation products; this could provide an alternative to bladed high shear systems 
which if successful could potentially offer closer control of processing conditions.
A number of modifications to the vessel configuration and fabrication could be 
considered in future work.
It is thought that fabrication of the processor from mirror polished stainless steel may 
decrease adhesion of material to the vessel walls and also allow control of 
electrostatics during production of DPI or other powder blends.
Further studies might also involve optimisation of the vessel height, which could be 
variable for different operations.
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The application of CFD technology to vessel design has proved particularly successful 
and it is anticipated that further work would benefit immensely from increased use of 
this tool.
For example, CFD models may be developed that predict the effects of changes to the 
swept bed or high pressure nozzle characteristics.
A particularly interesting area is the use of CFD in predicting the movement of solid 
and also liquid particles under the influence of fluid flows. Two phase and three 
phase models could therefore be constructed to further investigate and optimise vessel 
performance.
It is anticipated that further development of the vessel could potentially result in a 
capability for performing micronisation of drug and/or excipient particles, thus 
providing a complete processing environment for powders for inhalation.
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9. CONCLUSIONS
A series of three novel air driven powder processors was developed and each 
characterised for its performance in processing pharmaceutical powder systems.
The first vessel, the FBSVP-A, operated using a fluidised bed and tangential high 
pressure air nozzles to provide powder agitation. The processor was found to provide 
some particle size reduction performance when used to mill two different grades of 
granular lactose. Processing of a simple binary ordered mix to within acceptable 
blend homogeneity parameters was also found to be possible within this vessel.
However, the FBSVP-A was found to exhibit large regions of powder stagnation 
during normal operation, leading to inefficiency in particle size reduction and mixing 
performance. This was found to be due largely to difficulties with the efficiency of 
cyclone separation apparatus employed for particle arrestment.
It was concluded that modifications to the equipment were required and a second 
processor was therefore developed, the FBSVP-B.
Characterisation of the FBSVP-B indicated that particle size reduction characteristics 
were slightly improved over the previous design.
Manufacture of a nedocromil DPI formulation was carried out and the FBSVP-B 
found to produce blends of poor overall content uniformity. In-vitro aerosol
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performance of the blends was found to be less efficient and more variable than that 
of blends produced using conventional high shear techniques.
It was concluded that increased levels of shear energy were required in the processing 
environment to improve dispersal of the formulation components.
It was apparent that areas of powder stagnation were also occurring in the FBSVP-B. 
These were observed in CFD simulation predictions of the fluid flows in the vessel. 
A further redesign was therefore deemed necessary.
Furthermore it was recognised that the concurrence of CFD flow predictions with 
observed conditions provided verification of the capability of this software to reliably 
predict complex fluid flows in this application and CFD simulation models were 
therefore used as an aid in redesigning the vessel.
The final vessel design, the SBSVP, utilised high volume tangential air flows in place 
of vertical fluidising air and contained an increased number of tangential high 
pressure air nozzles compared to the FBSVP-B. Design of the high pressure air 
nozzles was determined by CFD simulations
Particle size reduction in the SBSVP was found to be rapid and extensive. It is 
concluded that further refinement of the vessel design would result in a processor with 
satisfactory milling performance in producing fine particle excipients for inhalation 
products and that it may eventually be possible to utilise equipment based around this 
design for micronisation of drug powders for inhalation.
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On characterisation of the performance of the SBSVP for blending the type of 
nedocromil formulations examined in the previous design, it was found that the 
processor produced very homogeneous mixtures with comparable in-vitro aerosol 
performance to optimal processing using conventional techniques.
Hence it was concluded that a processor utilising controllable fluid dynamics and 
designed with the aid of CFD modelling technology was capable of providing uniform 
high shear conditions, ideal for consistently producing nedocromil sodium trihydrate 
blends for inhalation and potentially having a use as an alternative to conventional 
mixing equipment for DPI and other pharmaceutical blend production.
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Abstract
This study introduces a motionless novel single vessel powder processor designed to carry out all of the unit 
operations in the preparation of powders for tableting. The processor used controllable fluid dynamics to provide the 
energy for each unit operation. The vessel design was evaluated using a computational fluid dynamics model which 
indicated the flow necessary for the intended processing operations to take place. The processor performance was 
evaluated experimentally for two unit processes: particle size reduction and dry powder mixing. The processor was 
found capable of reducing the size of lactose granules from a median particle diameter of 459 pm to a median particle 
diameter of 182 pm within 5 min under optimal process conditions. It was found that a formulation containing 
lactose granules (373 pm median particle diameter) and a model drug, sodium chloride (30 pm), could be mixed to 
an improved degree of homogeneity in comparison with equivalent powders blended using a conventional turbulent 
tumbling technique. It was concluded that a processor having controllable fluid dynamics offered the potential to 
perform multi-task processing of powders. © 1999 Elsevier Science B.V. All rights reserved.
Keywords: Particle size reduction; Powder mixing; Single vessel processing; Granulation; Equipment design
1. Introduction
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The most commonly used techniques in prepar­
ing powders for tableting are wet granulation and 
direct compression (Armstrong, 1988). Direct 
compression is the simpler technique, requiring
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only the blending of the drug with specialised 
excipients prior to tablet compaction. In many 
cases, however, the properties of pharmaceutical 
powders do not allow successful tableting, and 
these powder systems require modification, most 
commonly by employing a wet granulation pro­
cess. Conventional wet granulation techniques 
can involve up to eight separate unit operations 
(see Fig. 1), each requiring transfer of material 
from one processing vessel to another (Arm­
strong, 1988). Modem processing equipment, 
such as fluid bed granulators and high-speed 
mixer/granulators, are able to combine some 
of the unit operations, thereby reducing the 
number of material transfers. The benefits of 
this approach include increased economy, im­
proved quality assurance and, in some cases, en­
hanced product functionality (Cliff, 1991; Kay, 
1997). A number of attempts have been made to 
minimise the number of processing vessels re­
quired (Poska, 1991; Robin et al., 1994), how­
ever, the technology to perform all of the 
sub-operations required for wet granulation pro­
cessing between ingredient dispensing and com­
paction of the final granules into tablets is not 
yet available.
This study introduces a number of prototype 


















□  Processes to be carried out in SVP
Fig. I. A summary o f the sub-operations performed during 
tablet manufacture using wet granulation.
ment of carrying out the following sub-opera­
tions within a single vessel: drug and excipient 
milling, dry mixing, wet massing/granulation, 
drying, granule milling and secondary blending. 
A further design constraint was that all powder 
movement within the vessel should be carried 
out without the presence of moving parts within 
the vessel chamber. In this preliminary work, 
the characterisation of a novel single vessel pro­
cessor (SVP) for the unit processes of particle 
size reduction and dry powder mixing is consid­
ered.
A number of different techniques may be used 
in milling pharmaceutical powders, the most 
common being ball milling, hammer milling, 
cone milling and fluid energy milling (Lantz, 
1990). Fluid energy or jet mills operate by the 
acceleration of particles using high pressure jets 
of a gaseous fluid (usually air), so that they 
collide with each other or a part of the grinding 
chamber, causing comminution by particle im­
pact and attrition. In some processing applica­
tions, such as ordered mixing (Staniforth, 1980) 
and dry powder inhalation products (Johnson, 
1997), powder particles must be milled to sizes 
below 5 pm, which is usually achieved by fluid 
energy milling (Hallworth, 1987). This method 
of milling also has the advantage that no mov­
ing parts come into contact with the product.
The most widely used mixers in pharmaceuti­
cal dry mixing operations are tumbling and 
bladed agitator mixers (Lantz and Schwartz, 
1990). A further group of powder mixers is that 
which employs fluid flows providing either agita­
tion (Akiyama et al., 1986) or fluidization 
(Krambrok, 1976). This group of mixers is able 
to mix powders very quickly (Miles and 
Schofield, 1970) and also without contact of 
moving parts with the pharmaceutical materials. 
The use of fluid flows in fluid bed granulation 
and drying is a well established technique (Kris- 
tensen and Schaefer, 1987).
It was therefore intended to investigate 
whether fluid flows could be used to achieve a 
combination of the milling, mixing and granula­
tion processes by developing a processor based 
on controllable fluid dynamics.
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Jet Pump Assembly.
Fig. 2. The SVP Mark IV.
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2. Prototype design
2.1. Pre-prototype development
An initial prototype was constructed using a 
Perspex cylinder, approximately 300 mm in di­
ameter and 250 mm high. Six L-shaped nozzles 
positioned in a circular arrangement around the 
base of this vessel provided a vortex air motion 
which was intended to be similar to the flow 
pattern found in a bladed system such as a con­
ventional high-speed mixer/granulator (Holm, 
1997). It was found that a conical structure, 
placed in the centre o f the base, was able to 
eliminate a region o f low particulate movement in 
this part of the vessel and some particle size 
reduction and limited powder mixing was found 
to occur.
In order to increase the movement of particles 
around the base o f the vessel, it was found that 
the addition of fluidizing air, directed through the 
base, was able to reduce frictional contact be­
tween the particles and the base sufficient to allow 
improved size reduction and mixing characteris­
tics (Bates and Ball, 1993). In this case the central 
cone was replaced by a ‘honeycomb’ distributor 
plenum.
2.2. The SVP Mark IV
Following these initial investigations, a proto­
type processor, the ‘SVP Mark IV’, (Kay, 1997) 
was constructed as shown in Fig. 2.
A hollow cylinder o f  clear Perspex o f wall 
thickness 6 mm was used for the main vessel wall 
so that powder movements could be observed 
during operation o f the processor. This was fitted 
with a mesh base o f  100 pm aperture diameter. 
This provided support for powder within the ves­
sel, whilst allowing uniform fluidization o f the 
powder bed when air was introduced through the 
base. A lid provided with a rubber o-ring seal was 
attached to the top o f the vessel using four case 
clasps. A polyethylene cone was fixed to the cen­
tre of the vessel base to prevent the formation of 
a dead area in this part o f the vessel.
Fluidizing air was ducted into the bottom of 




Fig. 3. Photograph of flow patterns of lactose powder gener­
ated during the operation of the SVP Mark IV.
kW, Robert Stahlschmidt Elektromotorenwerk, 
Germany) o f fan diameter 180 mm, blade width 
12 mm and blade angle 20°. This could be oper­
ated at a maximum rotational speed o f 2800 rpm, 
which produced a calculated maximum air flow 
rate o f 0.0456 m3/s.
Twelve L-shaped high pressure jet nozzles o f 1 
mm output diameter were located around the base 
o f the vessel and connected to a compressed air 
manifold. A compressed air feed o f approximately 
550 kPa was able to supply each nozzle at a 
validated (Kay, 1997) pressure of up to 30 psi 
(207 kPa). The design of the nozzles was such that 
they could be adjusted for angle and depth within 
the vessel as required. A needle valve allowed 
control o f the nozzle output pressure.
The attachment o f a cyclone separator to the 
vessel lid enabled the removal o f entrained parti­
cles from air leaving the vessel during operation 
o f the air inputs. The gas outlet o f the cyclone 
was allowed to vent to atmosphere and the dust 
outlet was attached to a jet pump. High pressure 
air was directed through the jet pump nozzle, 
causing air to be drawn through the top hole. 
This produced a suction effect which returned 
powder from the cyclone dust outlet back into the 
main vessel.
The Mark IV SVP was found to provide more 
uniform and widespread powder movement than 
previous designs and powder losses from the ves­
sel were also greatly reduced. The powder flow 
patterns achieved within the vessel can be seen in 
Fig. 3. A further advantage of the Mark IV design 
over the previous designs was that it was not
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necessary to maintain a fluidizing air input at 
all times, thus making it easier to control the 
process and to remove powder at the end of 
processing.
3. Particle size reduction
3.1. M aterials
Two grades of granular lactose (a-lactose 
monohydrate) were selected as model test materi­
als. These were of similar particle size ranges, but 
were prepared by different methods and conse­
quently could be expected to exhibit different 
physical strength properties.
The first test material was a pharmaceutical 
quality commercially-available granular lactose 
(CAGL), CrystaLac 40 (Meggle, Wasserberg, 
Germany). The second material was granulated 
lactose manufactured using SorboLac 400 lactose 
powder (Meggle, Wasserberg, Germany). - This 
particular grade of material has a higher specific 
surface area and finer particle size than CAGL. 
The granulation was performed in a high-speed 
mixer/granulator, using water (20% w/w com­
pared to dry powder) as a binding liquid. The 
granules were fluid-bed dried to a moisture, con­
tent of less than 5% w/w and granules outside the 
sieve fraction 250-500 pm were discarded. This 
material was termed high-speed mixer/granulated 
lactose (HSMGL).
3.2. M ethods
Either CAGL or HSMGL material in 500g lots 
were placed in the SVP vessel and size reduction 
carried out over 30 min. Three lots of each mate­
rial were processed in the SVP at nozzle pressures 
of 10, 20 or 30 psi. (69, 138 and 207 kPa, respec­
tively) and the nozzle output air pressures were 
validated using a pressure transducer (type P722- 
022 pressure sensor, Schaevitz, UK.).
Representative samples of approximately 1.5 g 
were obtained from four positions in the powder 
bed using a sampling thief at each of the follow­
ing times after the initialisation of size reduction: 
0, 1, 2, 3, 4, 5, 7.5, 10, 15, 20, 25 and 30 min. 
Particle size analysis was performed in triplicate 
with low angle laser light scattering (LALLS) 
equipment (Malvern Mastersizer X, Malvern In­
struments, Malvern, UK) using a dry powder 
feeder technique.
Scanning electron microscopy (SEM) was used 
to produce images of particles at different stages 
of milling. The specimens were prepared by 
mounting a representative powder sample onto a 
conducting carbon-coated adhesive pad fixed to 
an aluminium stub. The sample was then coated 
with a layer of gold using a sputter coater (EHV 
model S150B, Edwards High Vacuum, Sussex, 
UK). Specimens prepared in this manner were 
examined using a scanning electron microscope 
(JEOL T330 SEM, Japanese Electron Optics, 
Tokyo, Japan) operating with an incident beam of 
10 keV at a working distance of 25 mm.
Table 1
Summary o f change in median particle diameter during milling o f CAGL in the SVP Mark IV at different nozzle pressures
Nozzle pressure (psi) Median particle diameter (pm)
Milling time (min)
0 1 2 3 4 5 7.5 10 15 20 25 30
10 459 401 415 390 330 314 283 272 230 236 221 199
20 459 345 358 287 261 281 211 233 196 194 174 167
30 459 297 227 197 199 182 180 172 163 157 160 157
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Table 2
Summary of change in median particle diameter during milling of HSMGL in the SVP Mark IV at different nozzle pressures 
Nozzle pressure (psi) Median particle diameter (pm)
Milling time (min)
0 1 2 3 4 5 7.5 10 15 20 25 30
10 373 355 304 317 339 274 297 - 241 195 151 154 127
20 373 316 251 249 198 188 163 141 121 118 115 109
30 373 245 238 202 164 155 134 131 107 115 117 107
3.3. Results and discussion
Data describing the changes in median particle 
diameter during milling are summarised in Tables 
1 and 2 for CAGL and HSMGL, respectively.
Fig. 4 shows the change in size distribution of 
CAGL when milled over 30 min at a nozzle 
pressure o f 30 psi. It can be seen from this graph 
that after 1 min o f milling, firstly that the modal 
size o f the CAGL was reduced and secondly it 
exhibited a unimodal distribution. This latter ob­
servation is noteworthy since milling operations 
usually result in bimodal distributions and may 
therefore be indicative o f a non-standard size 
reduction mechanism.
The effect o f milling time at a nozzle pressure 
of 30 psi on the particle size distribution of 
HSMGL can be seen in Fig. 5. In this case, the 
size distribution takes on a bimodal character 
after 1 min milling time. This is a classical re­
sponse profile for the early stages o f a milling 
process.
On this evidence, it is suggested that in the case 
of CAGL, most o f the agglomerates were reduced 
to their constituent crystallites within the first 
minute o f milling at 30 psi; the stage o f milling at 
which all, or nearly all, individual crystallites have 
been liberated from the agglomerates is termed 
the ‘point o f complete deagglomeration’ (POCD) 
and is considered to be a key SVP process 
parameter.
In contrast to CAGL, the HSMGL agglomer­
ates appear to be broken down less easily into 
their constituent crystallites and hence, after a 
milling time o f 1 min, exhibit a bimodal distribu­
tion in which many o f the agglomerates are still 
largely intact, but a proportion o f them have been 
broken into individual crystallites. This implies 
that the bond strength between crystallites in HG- 
MGL are stronger than those in CAGL. This 
theory is further supported by the SEM photomi­
crographs (Figs. 6 and 7), which show a larger 
proportion o f agglomerates in the HSMGL after 
1 min o f milling than are present in CAGL.
Further examination o f Fig. 4 presents a down­
ward trend for the modal size o f CAGL. How­
ever, after about 1 min milling time, the modal 
and median sizes are less affected by increasing 
milling time. This suggests that most o f the ag­
glomerates have been broken down into their 
constituent crystals after 1 min and any further 
reduction in particle size is probably due to frag­
mentation o f the individual crystallites by edge 
abrasion as shown in Fig. 8.
7 5 Milling Time 
t4 (minutes)
Particle Size (Mm)
Fig. 4. Relationship between particle size distribution of 
CAGL and milling time in the SVP Mark IV at a nozzle 
pressure of 30 psi.
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Fig. 5. Relationship between particle size distribution of 
HSMGL and milling time in the SVP Mark IV at a nozzle 
pressure of 30 psi.
This mechanism may suggest that fragmenta­
tion o f the component crystals would lead to the 
formation o f a fine particle fraction in the later 
stages of milling and hence a bimodal size distri­
bution. However, there is no evidence in the parti­
cle size data to suggest this is the case. This may 
be explained by a preferential removal o f fines by 
the SVP since observation o f the SVP during 
milling indicated that a certain amount o f fine 
particulate material was entrained in the air leav­
ing the cyclone separator.
The effect o f reducing the milling nozzle pres­
sure was investigated. As expected, the rate of 
milling was reduced with decreasing nozzle pres­
sures for both materials. The times taken to reach 
the POCD for CAGL and HSMGL at different 
nozzle pressures and the median particle diameter 
o f the materials at these times are summarised in 
Table 3.
The milling data suggests that for CAGL, the 
maximum milling capability o f the SVP was to 
mill the material to a median particle diameter of 
approximately 160 pm. This appears to have been 
achieved at nozzle pressures o f 30 and 20, but not 
at 10 psi. The maximum milling capability o f the 
SVP for HSMGL appears to be to a median 
particle diameter o f approximately 110 pm. It is 
speculated that different milling conditions, such 
as higher nozzle pressures or changing the geome­
try o f the vessel, may result in an increase in the
A 0 4 1 8 8  1 8 K U  X 9 5  2 4 m m
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Fig. 6. Scanning electron micrographs of CAGL before and 
after milling at a nozzle pressure of 30 psi: (a) unprocessed 
particle, (b) after 1 min processing, and (c) after 30 min 
processing.
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Fig. 7. Scanning electron micrographs of HSMGL before and 
after milling at a nozzle pressure of 30 psi: (a) unprocessed 
particle, (b) after 1 min processing, and (c) after 30 min 
processing.




Lactose powder (CrystaLac 40, Meggle, 
Wasserberg, Germany) was used as the major 
component (90%) and sodium chloride crystals 
(Lot No. 40414 40408011, Aldrich Chemical, 
Gillingham, Dorset, UK) the minor model drug 
component (10%) o f a 500 g binary powder mix. 
Sodium chloride was selected as a model drug to 
allow conductivimetric analysis over a wide con­
centration range without requiring sample dilu­
tions. The median particle diameter of the lactose 
was 373 pm and that o f the sodium chloride was 
30 pm as measured by LALLS.
This difference in the particle diameters o f the 
two components was deliberately selected so as to 
encourage the formation o f interactive mixes in 
which finer particles become adhered to the sur­
faces o f coarser, ‘carrier’ particles.
4.2. Methods
The efficiency o f the SVP for mixing two dry 
powders was compared with other mixing tech­
niques with known efficiencies: geometric mixing 
and turbulent tumbling mixing.
4.2.1. Geometric mixing
Geometric mixing, or trituration, was per­
formed by placing 50 g sodium chloride crystals 
and 50 g lactose granules into a large mortar and 
mixing thoroughly by hand for 5 min using a 
pestle. A further 100 g lactose was added and 
similarly mixed, followed by a 200 g quantity of 
lactose, which was also mixed for 5 min. The final 
100 g o f lactose was added and the whole mixture 
thoroughly mixed for a further 15 min.
4.2.2. Turbulent tumbling mixing
Milled sodium chloride crystals (50 g) and lac­
tose granules (450 g) were placed into a 2 1 glass 
jar and its lid was sealed. This was then posi-
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tioned in a Turbula mixer (type T2C, Glen Cre- 
ston, Stanmore, Middlesex, UK), which was oper­
ated at speed II for 30 min.
4.2.3. Operation o f  the SVP
Lactose granules (450 g) were placed into the 
bottom of the SVP, on top o f which 50 g of 
sodium chloride was gently loaded. The fluidizing 
fan was turned on at its maximum speed provid­
ing an air volume throughput o f approximately 2 
m3/h and the jet nozzles supplied with air at a 
pressure of 30 psi.
These conditions were maintained for a period 
o f 30 min after which the air supply was termi­
nated and the powder removed from the vessel for 
sampling and analysis.
4.2.4. Powder sampling
The material obtained from each mixing experi­
ment was emptied onto a clean, flat surface with a 
minimum of agitation, so that samples could be 
taken from the resulting powder heap. Thirty 
samples o f approximately 500 mg were taken at 
random from the mixture using a sample thief.
4.2.5. Model drug assay
The samples (500 mg) were placed in a 50 ml 
volumetric flask, then dissolved and diluted to 50 
ml using freshly distilled, deionised water at 25°C. 
A conductivity meter (type CDM80, Radiometer, 
Denmark) and cell (type CDC104, Radiometer,
Denmark) was calibrated, then each sample solu­
tion was assayed for sodium chloride content 
based on the conductivity o f the solution. Con­
trols showed that, as expected, lactose did not add 
to the conductivity.
4.3. Results and discussion
As expected, the most efficient mixing of the 
materials tested was obtained by manual geomet­
ric mixing, which provided a coefficient o f varia­
tion o f 0.93%. The value o f using this technique 
was to provide evidence that a homogeneous mix­
ture could be obtained using the materials under 
investigation. The results using manual geometric 
mixing may be considered as a benchmark for 
other mixing techniques. Since the method o f 
homogeneity testing can be considered to give 
values that are a composite for mixing and segre­
gation, any segregation phenomena that occur 
during the mixing process are taken into account.
It is notable that the results indicate a mean 
content which is slightly less than the theoretical 
value o f 10.0% sodium chloride. This may have 
occurred through agitation of the material causing 
a loss o f fine particles to the external environment 
since the mixing vessel was not enclosed during 
the mixing process. Since this lost fine material 
would have been predominantly composed of 




Point of Complete 
Deagglomeration (POCD).
After further milling.
Fig. 8. Proposed milling mechanism of CAGL and HSMGL in the SVP Mark IV.
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Table 3
Summary of time taken to reach POCD and median particle diameter at POCD for CAGL and HSMGL at different nozzle 
pressures


















The quality o f mix obtained by using the turbu­
lent tumbling technique was poor, being charac­
terised by a coefficient o f variation o f 15.20%. 
This was probably due to a lack o f internal shear 
forces, particularly between initial fine particle 
agglomerates o f sodium chloride, provided by 
tumbling mixing. These forces are necessary for 
the formation o f interactive powder mixtures.
The effect of the shearing force which is im­
parted onto a powder mixture containing two 
components, one of which is much finer than the 
other is shown diagrammatically in Fig. 9. This 
figure shows an agglomerate o f the fine compo­
nent, which is mixed with larger carrier particles. 
A low shear force takes the easiest route through 
the powder, which in this case is around the 
exterior of the carrier particles and the fines ag­
glomerate. A high shear force is able to pass 
between individual particles in the agglomerate 
and hence break it up so that it may be dis­
tributed over the carrier surfaces and form an 
interactive mix. The geometric manual mixing 
technique imparts a large shear force on the pow­
der by the grinding action o f the mortar and 
pestle. This causes the adhesive component 
(sodium chloride) to be redistributed onto the 
carrier particle surface.
Aggregates, which may be o f a similar particle 
size to the carrier lactose particles, remain intact 
in the turbulent tumbling technique due to this 
lack of shear, so reducing the homogeneity o f the 
mix.
It was considered that the high shear conditions 
created by the high pressure air nozzles within the 
SVP would be able to break up the agglomerates 
during the mixing evaluation in a similar fashion
to that which would be expected in a bladed 
mixer.
A value for the coefficient of variation o f less 
than 5% is generally considered necessary in most 
pharmaceutical powder mixing processes (Kay,
1997). The SVP provided a mixing capability 
characterised by an average coefficient of varia­
tion o f 2.49%. As shown in Table 4, this is 
represents an improved mixing efficiency over tur­
bulent tumbling mixing. The motion o f powder 
within the SVP during its operation was observed 
to display large regions of recirculating flow, 
which enable mixing to occur (see Fig. 3).
The SVP design was tested using a computa­
tional fluid dynamics (CFD) model (STAR _ CD, 
Version 3, Computational Dynamics, London, 
UK). The model allowed different flow regimes to






Agglomerate o f 
fine particles
Fig. 9. Schematic representation of the path of the shear force 
following application of high and low shear forces in interac­
tive mixing.
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Table 4
Coefficient of variation obtained from each mixing technique
Mixing method Coefficient of varia- Mean content 
tion (%) (%)
Manual geomet- 0.93 9.41
ric mixing
Turbulent turn- 15.20 9.49
bling mixing 
Mixing in the 2.49 8.17
SPV Mark IV
fields generated by the high pressure air nozzles 
ensured that the flow patterns within the SVP 
attained sufficiently turbulent conditions and fluc­
tuating velocities within the powder bed to per­
form the mixing process. The high shear created 
by the action o f the high pressure air nozzles 
facilitated the mixing o f a binary powder system 
consisting of powders o f widely differing particle 
sizes, thus enabling the formation o f interactive 
powder mixes.
be studied, an example o f which is shown in Fig. 
10, and indicated relatively few dead regions 
where particles could settle (MacGregor et al.,
1998). Experimental testing showed that the CFD 
predictions appeared to be exhibited by the SVP. 
The lack o f dead spots predicted in the CFD  
model was also considered to exist experimentally 
and was assumed to be a major reason for en­
hanced mixing efficiency. The combination of 
fluidizing air, which was supplied to all o f the flat 
regions o f the vessel base, with the swirling flow
5. Conclusion
A prototype SVP was designed with the aid of  
a computational fluid dynamics model and was 
found to be capable o f performing the sub-opera­
tions o f granule size reduction and dry powder 
mixing. There was also some evidence that the 
SVP was capable o f providing primary size reduc­
tion o f materials. The flow patterns induced in 
powder within the processor could be readily ob­
served and displayed a strong swirling flow field 
which was well fluidised.
Legend 
■  0.57 m/s
0.39 m/s
Fig. 10. Example of the CFD model of the SVP Mark IV for single phase flows. The model shows 1/12 cross-sections of the vessel 
in the plan view at (a) the base o f the vessel, (b) 50 mm from the base (nozzle outlet height), (c) 100 mm from the base, and (d) 
180 mm from the base (apex of the cone). The arrows indicate the direction of the airflow. Relative flow velocity magnitudes are 
indicated by reference to the colours in the legend.
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Particle size reduction was found to be rapid 
for the batch size investigated; the speed and 
extent o f granule size reduction was considered to 
be at least equivalent to that which could be 
attained using conventional techniques o f sec­
ondary size reduction in granulation. It is envis­
aged that greater size reduction could be obtained 
by increasing the nozzle pressures.
The mixing achieved within the SVP was found 
to be rapid and more homogeneous than that 
achievable with a similar powder system using a 
conventional low shear mixing technique.
The principle o f using controllable fluid dynam­
ics to perform multi-task processing o f  powders 
has been demonstrated. The SVP offers the poten­
tial for the batchwise preparation o f  powders for 
tableting and capsule filling within a single vessel.
One problem that was' encountered with the 
current SVP design was in separating very fine 
particles from the gas stream using a cyclone 
separator. In order to improve this aspect o f  
processing, it is anticipated that future designs 
will require the addition o f  a fibrous filter system.
The SVP concept is considered to form the 
basis for a continuous bladeless processor, capa­
ble o f  integration into a closed, automated and 
controllable manufacturing system in which raw 
materials can be processed into final dosage forms 
without manual intervention.
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The application of computational fluid dynamics to 
the development of a pharmaceutical processor
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Abstract: The use of computational fluid dynamics (CFD) in the design of a pharmaceutical 
processor is described. A simple computational model of the process vessel was developed using a 
single-phase flow. The results of this preliminary study showed good agreement with experimental 
tests. The model was further developed to consider the effect of solid particles on the processes 
occurring within a single vessel pharmaceutical processor. Having obtained converged solutions, the 
model was used to optimize the design of the processor. The model was used to develop new designs 
of the vessel. The design optimization was done on the basis of comparisons with conventional 
pharmaceutical processing equipment. Optimization of the process parameters is important, as they 
are known to affect the functionality of the final product. The study reported here discusses one step 
in the design process, showing how changes to the inlet configuration can be modelled to show the 
potential for improved performance.
Keywords: CFD, pharmaceutical processors, powders
1 INTRODUCTION
In the preparation of powders for tabletting, techniques 
such as wet granulation and direct compression are 
widely used. Conventional wet granulation techniques 
may involve as many as seven individual subprocesses. 
Initially the excipients and drug substance are 
screened. The drug and excipients are then mixed. In 
the next phase liquid is added and granules are formed. 
This is followed by a drying phase before final size 
reduction (forced screening) and mixing are completed. 
These processes are often carried out in separate ves­
sels, thus making the overall process inefficient and 
with reduced quality due to the need for transportation 
of materials, holding the powders in situ and long 
changeover times between batches. In an attempt to 
rationalize the process by reducing the number of pro­
cessing vessels or process steps, there are examples of
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single-vessel processors, which combine some but not 
all of the individual subprocesses [1-3].
The current study focuses on the design of a single 
vessel in which all seven subprocesses are carried out. 
Computational fluid dynamics (CFD) has been used 
extensively in the design phase of the processor. The 
use of CFD is now commonplace and there are many 
examples of its application [4-6].
2 PHYSICAL MODEL
A schematic diagram of the single-vessel processor is 
shown in Fig. 1. The vessel consists of a cylindrical 
section that has a cone at the base. The purpose of the 
cone is to fill the central region to avoid the settling out 
of powder in regions where the velocity is low. There 
are two sets of air inlets to the vessel. One, which 
provides air for fluidizing the powder, is of low velocity 
but has a high volume flowrate. The fluidizing air not 
only lifts the powder from the base of the vessel but 
also provides some of the air motion, which enhances 
the mixing and size reduction processes. The second set
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supplies the ring of high-pressure nozzles around the 
periphery o f the vessel, just above the base. These 
high-velocity jets provide energy for the various unit 
subprocesses. The outlet from the vessel passes 
through a cyclone dust separator, where any powder 
that escapes from the processing section is collected 
and returned to the main vessel through a jet pump. 
In future designs it is anticipated that the cyclone 
separator will be replaced by a more effective filtra­
tion system, which is more effective with small-diameter 
particles, i.e. a bag filter.
A second design was developed in which the 
fluidized bed was replaced by a series o f ‘flat’ tangen­
tial nozzles. Again the nozzles not only provided the 
air to lift the particles off the base of the vessel but 
also provided the initial bulk motion for the particles 
within the vessel.
3 COMPUTATIONAL MODELS
The CFD model was constructed using the code 
STAR _ CD and consisted o f a three-dimensional 
axisymmetrical sector o f the vessel. The computa­
tional grid consisted o f 4000 cells and is shown in 
Fig. 2. Near the exit o f the vessel the velocity gradi­
ents are significant and hence the grid has been 
refined in this region. Similarly, near the base o f the 
vessel where the size reduction and mixing processes 
are most intense, the grid has also been refined. In 
order to model the high-pressure nozzles, the nozzle 
inlet velocity magnitude and direction have been set 
at the wall. It was not necessary to model the actual 
geometry o f the nozzles as they were small by com­
parison with the rest o f the vessel and thus had little 











Fig. 1 Schematic diagram of a single-vessel processor
Fig. 2 Computational model of a single-vessel processor
The software offered a number o f options in the 
use o f turbulence models. However, it was found that 
the best convergence and most consistent results were 
achieved using a k - e  model. The model was run for 
both single- and two-phase flow cases. In the latter 
the solids loading was varied between 10 and 40 per 
cent by volume. For a solids loading o f 10 per cent it 
was relatively easy to achieve consistent convergence. 
Although this level o f solids loading was not repre­
sentative o f an actual processor, it was useful in or­
der to check the validity o f the results. A  solids 
loading o f 40 per cent was considered to be represen­
tative o f the loading that would be present in an 
industrial-scale system. However, it was more difficult 
to achieve converged solutions. In the main volume 
the bottom two layers o f the computational grid are 
loaded with particles. This investigation focused on 
particles that had a diameter of 50 pm. This particle
size lies within the range o f powders used in the
pharmaceutical industry for tablet production. In later 
models various size distributions were used. However, 
this was found to have only a minimal effect on the
results. The major factor was the actual size o f the
solid particles. It should be noted that only the parti­
cle movement has been considered in this study. N o  
attempt has been made to model the particle-particle 
interactions in terms o f particle break-up or agglom­
eration.
The values for the fluidizing and nozzle velocities 
were selected based on preliminary experimental test­
ing. Only the results for two-phase flows are pre­
sented in the current study.
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4 RESULTS
Two cases are presented, although many other cases 
have been considered and modelled. Figure 3a shows 
the case for a vessel with a fluidized bed. The fluidiz- 
ing velocity was set at a value o f 0.2 m/s, while the 
inlet velocity for the high-pressure jets was 3.68 m/s. 
These values were found to give the best results. It is 
clear from Fig. 3a that a large region of recirculating 
flow dominates the flow field. Particles are carried up 
the central region o f the vessel. As they reach the 
upper part o f the vessel, the influence o f the inlet jets 
is reduced and the majority o f the particles are car­
ried in the recirculating flow back to the base near 
the wall.
Near the top o f the vessel there is a region where 
the flow accelerates due to the outlet pipe. This is 
clearly seen in single-phase predictions carried out on 
this geometry. Some particles may be carried out o f  
the vessel with this flow. This is especially so o f any 
smaller particles that may be present. Loss o f parti­
cles from the main vessel causes the process to be­
come inefficient, as these particles must be collected 
and recycled to the main vessel. It may also result in 
final mixtures that have poor homogeneity, as many 
o f the excipients, which are being mixed in the vessel, 
will have different size ranges.
In Fig. 3b the flow field is predicted for the case 
where the fluidized bed has been replaced by a series 
o f tangential inlets. Comparing Figs 3a and b shows
(a) (b)
Fig. 3 Predicted particle tracks for a vessel with fluidized 
bed and tangential inlets
Bulk Motion 
o f Particles
Fig. 4 Enlarged three-dimensional particle tracks for a ves­
sel with tangential inlets
that the behaviour o f the particles is completely dif­
ferent in the two cases considered. In the latter case 
the particles are concentrated in the region close to 
the base o f the vessel. Very little solid material is able 
to penetrate the upper part o f the vessel. There are a 
number o f advantages associated with this flow field 
from the point o f powder processing. Concentrating 
the powder in the base means that it is difficult for 
solid particles to escape from the vessel. It might be 
possible to reduce the height o f the vessel as the pro­
cess is confined to a relatively small volume. By con­
centrating the solid material in a particular region of 
the vessel it ensures that there are many particle in­
teractions, which are essential to generate both good 
mixing and size reduction. In a final design it may 
well be advantageous to combine the best features 
from both flow fields, i.e. the large recirculation re­
gion which enhances the mixing processes and regions 
where the particle concentration is high, thus ensuring 
many particle collisions, etc., when size reduction is 
required.
The results o f the predictions for the case with tan­
gential inlets rather than a fluidized bed showed that 
with some inlet conditions there was a possibility 
that there could be problems with powder deposition 
[7]. These predictions were made on the basis o f pow­
der concentration throughout the vessel. Regions with 
high concentrations of solids were found to coincide 
with regions where powder collected during experi­
mental testing.
Figure 4 shows a three-dimensional enlarged view 
o f the particle tracks for the vessel with tangential
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ports around the base. The particles are seen to 
move up the side of the cone and then radially 
outwards before returning to the base of the vessel. 
The particle motion generated by the air inlet jets is 
similar to that seen in conventional mixer and 
granulators.
5 CONCLUSIONS
The use of computational fluid dynamics has been 
considered for the optimization of the design of a 
single-vessel pharmaceutical processor. The results 
from an investigation were presented, which showed 
that by predicting flow field parameters and particle 
dynamics it was possible to improve the geometry of 
a powder processor. It was also possible to assess the 
effects o f inlet conditions. By considering both flow 
vector plots and particle trajectories the performance 
of new design proposals can be compared with that 
of conventional pharmaceutical processors. It is possi­
ble to show that the proposed design will achieve the 
levels o f performance required for the new design to 
be successful. The use of CFD to design the proces­
sor removes the need to build and test expensive pro­
totype equipment.
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